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The emergence of resistance from bacteria to the conventional antibiotics has 
become a serious global problem during the last years. The onset of resistance is 
mainly due to the massive and out-of-control use of these drugs in our community. 
In fact, microorganisms have developed a series of mechanism which render 
antibiotics ineffective. Therefore, seeking for new anti-infective agents is becoming 
increasingly necessary. Among these antimicrobial peptides (AMPs) have been 
proposed. 
AMPs are a class of peptides with a broad spectrum of activity against different 
pathogenic organisms (e.g. bacteria, fungi, viruses and cancer cells) and they are part 
of the innate immune system of virtually all forms of life. Usually, they are composed 
by 10-50 amino acids and are enriched of positively charged (e.g. lysine and 
arginine) and hydrophobic residues. Even if the exact action mechanism is still under 
debate, it is widely accepted that the primary target is represented by the lipid matrix 
of the pathogens’ membranes. Thus, AMPs interact with them in a non-specific way, 
inducing membrane destabilization and finally cell death. It is believed that, due to 
the unique mode of action, AMPs could overcome the problem of resistance to 
conventional antibiotics in multi-drug resistant bacteria and even to currently used 
anticancer drugs for the treatment of tumor cells. For these reasons, AMPs have 
attracted great attention as drugs of the future. Thus, the final goal in studying AMPs 
is their use as drugs. However, AMPs pharmacological application is not 
straightforward. Many aspects must be considered. A good AMP should interact 
selectively with the bacterial membrane, should not be toxic to eukaryotic cells and 
should be resistant to proteases degradation. To develop AMPs with these improved 
features it is of fundamental importance to understand the role played by lipid 
composition and peptide physico-chemical properties in determining peptides 
activity. To this aim, in my PhD thesis I studied the molecular details, at level of 
peptide-lipid interaction, of the action mechanism of several antimicrobial peptides 
by a series of biophysical techniques. In particular, I characterized the interaction of 
natural amino acids-containing peptide as well as of synthetic peptides composed by 
unnatural amino acids with model biomembranes. 
In the first part of the project, I carried out the synthesis of the 9-residue peptide 
P9Nal(SS) which contains unnatural amino acids. It was designed in order to obtain 
a peptide with a good antimicrobial activity, low cytotoxicity and high resistance to 
proteases. Then, biophysical studies of its interaction with eukaryotic and bacterial 
model membranes were carried out. The obtained information can be very useful in 
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developing antimicrobial agents for biomedical applications. This study is described 
in detail in the chapter 3. 
In the chapter 4 is reported the biophysical characterization of the interaction of two 
P9Nal(SS)-derived peptides, named P9Nal(SR) and P9Trp(SS), with liposomes 
mimicking bacterial membrane. The two peptides were obtained by replacing some 
residues in the primary sequence of P9Nal(SS). As shown in chapter 4, the peptides 
are less hydrophobic than the parent peptide. The obtained data reveal how these 
substitutions can modulate the membranotropic activity of peptides. 
In the second part of the project, I faced the problem to understand the molecular 
details of the action mechanism of (P)GKY20, a natural amino acids-containing 
peptide modelled on the C-terminus region of the human thrombin. Its good 
antimicrobial activity and low cytotoxicity is well known. However, its action 
mechanism has never been studied before. Thus, I performed an extensive 
biophysical characterization of the interaction of the (P)GKY20 with model 
membranes. The obtained results elucidated its mechanism of action against bacterial 
model membrane and, at the same time, allow to understand its low cytotoxicity. All 
the results concerning this AMP are presented in the chapter 5. 
The last part of this thesis is devoted to an idea developed during the third year: the 
encapsulation of AMPs with cyclodextrins (CDs) as a way to protect the peptides 
from degradation and improve their pharmacological properties. Indeed, 
antimicrobial peptides containing natural L amino acids are, unfortunately, prone to 
degradation which limits seriously AMPs applications as drugs. To verify the ability 
of CDs to encapsulate AMPs without altering their antimicrobial properties, I studied 
the interaction of (P)GKY20 peptide with sulfobutylether-β-CD and of the obtained 
complex with bacterial-like liposomes. 
These preliminary results reveal that (P)GKY20 form a 1:1 stable complex with 
sulfobutylether-β-CD. Further, the obtained complex is able to perturb the stability 
of bacterial-like liposomes. Thus, the sulfobutylether CD could represent a suitable 
encapsulating agent for (P)GKY20 peptide which could improve its pharmacological 
profile. The obtained results are presented in the chapter 6. 
 
Since the peptide interaction with model membranes is quite complex being 
composed by many steps, a strategy which involves different biophysical techniques 
was adopted to study a particular aspect of the interaction process. Calorimetric, 
spectroscopic and microscopic techniques were applied (where possible) and by 
combining the data, it was possible to depict a possible action mechanism 
highlighting the key steps. Differential Scanning Calorimetry (DSC) was 
employed to study the effect of peptide interaction on the liposomes thermotropic 
properties. Moreover, using an appropriate lipid system, information about lipid self-
organization (e.g. lipid domains formation) can be obtained. Steady-State 
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Fluorescence Spectroscopy and Fluorescence Anisotropy were extensively 
employed to obtain information on both AMPs (e.g. determination of binding 
constants, degree of insertion into the lipid bilayer) and lipids (e.g. changes in 
membrane viscosity due to changes in lipid packing).  Liposomes morphological 
changes were monitored by Dynamic Light Scattering (DLS). Instead, changes in 
peptide secondary structure upon binding were followed by means of Circular 
Dichroism (CD) and an estimation of secondary structure content was obtained by 
the spectra deconvolution. Atomic Force Microscopy (AFM) and Confocal 
Fluorescence Microscopy instruments were employed to directly visualize the 






































The increasing spread of bacteria resistant to conventional antibiotics has become a 
worldwide emergence [1,2]. In fact, due to massive and out-of-control use of these 
drugs in humans and animals, bacteria have developed a series of mechanisms [3] 
which render antibiotics ineffective. For example, about 80% of bacterial strains of 
Staphylococcus aureus are immune to the penicillin [4]. Moreover, the number of 
new discovered (or synthetized) antibiotics is decreasing [5]. Thus, there is an urgent 
need of a new class of antimicrobial agents. 
Antimicrobial peptides (AMPs) are an interesting class of small peptides which can 
overcome this problem. It is believed that, due their unique and non-specific action 
mechanisms which involve a direct interaction with the lipid matrix of pathogens’ 
membranes, they could help in fighting infections caused by multidrug-resistant 
(MDR) bacteria [6,7]. For this reason, AMPs represent serious candidates as 
alternative to conventional antibiotics and have attracted much attention in the 
scientific community. 
AMPs are primary known for their antibacterial activity, but they are also active 
against other microorganisms such as fungi (antifungal peptides), viruses (antiviral 
peptides), parasites (anti-parasite peptides) and even cancer cells (anticancer 
peptides) [8–10]. AMPs are part of the defense system of virtually of form of life, 
from prokaryotic bacteria to eukaryotic mammals and plants [11]. Some of them may 
be expressed constitutively. Others are inducible and are expressed only in response 
to the presence of a foreign microorganism [12]. AMPs can be modified after their 
expression (post-translational modification). The most common modifications are: 
amidation, glycosylation, acylation and halogenation [13,14]. They represent the 
first defense line against invading microorganisms. In fact, they are particularly 
abundant in all tissues that are in some way in contact with external world. For 
example, in humans AMPs are found in the skin, intestinal and oral mucosa [15]. 
The era of amino-acids based antimicrobials started in 1922, when Fleming 
discovered lysozyme [16]. This small globular protein can hydrolyze the glycosidic 
bond between the N-acetylglucosamine and N-acetylmuramic acid residues in the 
peptidoglycan, the constituent of the bacterial cell wall [17]. This discovery was 
overshadowed when the same scientist discovered penicillin in 1928 [18] starting the 
antibiotic era. Due to this important discovery, the interest on AMPs drastically 
diminished. In the 1960s, the development of multi-drug resistant bacteria brought 
7 
 
the attention again to AMPs as alternative to antibiotics. The first antimicrobial agent 
discovered was the gramicidin in 1939 in Bacillus strains [19,20]. Despite, its 
cytotoxicity, gramicidin was found effective for topical treatments of wounds and 
ulcers. Probably, the first eukaryotic AMPs was found in plants. From the plant 
Triticumaestivum, an AMP named purothionin was isolated. Purothionin showed a 
good activity against some bacterial strains [21]. In the 1960s, the first AMP from 
animals was reported. It was the brombinin from frogs [22]. In the following years, 
a series of new AMPs were reported thus increaseing our knowledge on the subject. 
Just to cite two important studies, it is possible to report the discovery of two well 
studied peptides: cecropins and magainins (a brief and comprehensive review about 
history of AMPs can be found in [23]). In the 1980s, Boman reported the discovery 
of the potent AMPs cecropins in Hyalophora cecropia after bacteria injection in the 
insect. It was the first report of an α-helix antimicrobial peptide [24,25]. In 1987, 
Zasloff reported the isolation and characterization of cationic AMPs magainins from 
the African frog Xenopus laevis, pointing out its defensive role in the organism [26]. 
Today, more than 3000 antimicrobial peptides are known. Information about them 
can be found in an online database [27] at http://aps.unmc.edu/AP/main.php which 
is constantly update. It is probably that this database represents only a small fraction 
of existing AMPs and others will be discovered in the future. 
 
1.2 AMPs Properties 
 
Antimicrobial peptides are a heterogeneous class of small peptides composed by 10-
50 amino acids [12]. The primary target of AMPs is represented by the lipid matrix 
of the cytoplasmic bacterial membrane that they destabilize leading to the pathogen 
death [28]. As stated in the previous section, more than 3000 different peptide 
sequences are known. Despite this, all AMPs share common physico-chemical 
properties which are fundamental for their biological activity. The general features 







 Polar angle. 
 
Sequence. AMPs can be composed by any combinations of amino acids. Essentially, 
they are enriched of hydrophobic and cationic residues. Usually the ratio between 
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the number of hydrophobic and charged residues varies from 1:1 to 2:1 [29]. At 
physiological pH, lysine and arginine residues are positively charge which render 
AMPs cationic leading to the class of cationic antimicrobial peptides (cAMPs). 
There are also anionic AMPs [30] which represent a small fraction of known AMPs 
[8] and will not be discussed here. Although there is a low sequence homology 
among AMPs, two features are frequently observed. The first one regards the 
presence of a glycine residue at the N-terminus, that is highly conserved. The glycine 
serves as capping residue providing resistance to aminopeptidases [31]. The second 
one is the amidation (a post-translational modification) at the C-terminus which 
provides resistance to carboxypeptidases [31].  
Finally, the presence of aromatic residues such as tryptophan and tyrosine could 
favor the localization of peptide at the membrane-water interface [32] due to the 
contemporary presence of polar groups (amide in Trp and OH in Tyr) and 
hydrophobic aromatic rings in the side chains which render the residues nor too much 
hydrophilic nor too much hydrophobic. 
 
Conformation. Despite the low sequence homology and the wide variety of primary 
structures, AMPs tend to adopt similar conformation upon interaction with 
membranes. AMPs can adopt three different conformations: α-helix, β-sheet and 
random structure. 
The most common secondary structure is the α-helix. Usually, AMPs have a random 
structure in solution and adopt an α-helix structure upon interaction with membrane. 
An example of helical peptide is represented by magainin [33]. The conformational 
change has a profound impact on the peptides’ activity. In fact, the peptides’ ability 
to adopt a helical structure is related to its ability to perturb the membrane integrity. 
Moreover, the lack of the secondary structure upon binding to eukaryotic membrane 
represents a way through which the peptides’ cytotoxicity could be minimized [34]. 
Peptides that adopt β-sheet conformation are quite different from α-helical ones. 
Usually, they adopt a more ordered structure in solution due to presence of cysteine 
residues that can form disulfide bridges thus stabilizing the three-dimensional 
structure. Upon interaction with the membrane, their conformation does not change. 
A good example is tachyplesin that possess two disulfide bonds [35]. In Fig. 1.1 are 
reported the structures of magainin 2 [36] and tachyplesin I [37] as examples of α-






Fig. 1.1 Cartoon representations of (left) magainin 2 (pdb: 2MAG) and (right) tachyplesin I (pdb: 
1MA2). In tachyplesin I the two disulfide bridges are represented as yellow spheres. The picture was 
made with VMD (Visual Molecular Dynamics) software. 
 
Amphipathicity. This property is directly linked to the conformation of AMPs. The 
α-helix or β-sheet structure adopted by AMPs are amphipathic structures. This means 
that they have a hydrophobic face on one side and a polar face on the other side (Fig. 
1.2) where the respective residues are clustered. 
 
 
Fig. 1.2 Schematic representations of amphipathic structures. (Left) β-sheet and (right) α-helix. Blue 
and red circles correspond to polar and non-polar residues, respectively. Adapted from [29]. 
 
This structure facilitates the peptide interaction with the membrane: the hydrophilic 
side interacts with the polar head groups of lipids and, at the same time, the 
hydrophobic side interact with the hydrophobic acyl chains. Thus, it plays an 
important role in the interaction with microbial membrane [38]. 
The peptides’ amphipathicity is quantitatively measured by the mean helical 
hydrophobic moment (<μH>) [39]. It is defined as the vector sum of the single amino 
acids hydrophobicities, normalized to that of an ideal α-helix. High values of the 
hydrophobic moment mean high amphipathicity. It is possible to calculate the 
hydrophobic moment by using online tools, such as Heliquest at 
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http://heliquest.ipmc.cnrs.fr/cgi-bin/ComputParams.py [40]. The best way to 
represent the amphipathicity is by means of the helical wheel projections. An 
example is reported in Fig 1.3 for the designed AMP “peptide 8” [41]. From this 
projection, the peptide amphipathic structure is quite clear.  
 
 
Fig. 1.3 The helical wheel projection of the AMP named peptide 8. Yellow circles are hydrophobic 
residues. Blue circles represent hydrophilic residues. The arrow represents the calculated 
hydrophobic moment (0.741). Adapted from [41]. 
 
The effect of amphipathicity on the AMPs activity is not completely clear. For 
example, it was reported no correlation between amphipathicity and biological 
activity in a series of L-V13K analogs antimicrobial peptides [42]. Another study on 
a series of 20 synthetic peptides demonstrated that the increase of amphipathicity is 
correlated with hemolytic activity but in a minor extent with antimicrobial activity 
[43]. On the other hand, a study with magainin 2 analogs demonstrated that both 
bacterial and hemolytic activities increase with an increase of amphipathicity [44]. 
Thus, it seems that the amphipathicity plays a role in determining the antibacterial 
and hemolytic activities and it is peculiar of the peptide sequence. 
 
Hydrophobicity. Peptide hydrophobicity is related to the primary structure and is 
defined as the percentage of hydrophobic residues within a peptide [12]. For most 
antimicrobial peptides it reaches 50%, meaning that half of the residues in the 
sequence are hydrophobic [31]. Hydrophobicity is an important parameter for the 
peptides’ biology activity since it determines the degree of partition inside the 
hydrophobic core of the membrane [45]. Several studies evidenced that an increase 
of hydrophobicity is related to a hemolytic activity increase but a decrease of 
selectivity against bacterial strains [12]. For example, a study on the peptide L-V13 
K showed that the substitution of Ala with the more hydrophobic Leu residue, 
increases the hemolytic activity of about 62 times. At the same time, the 
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antimicrobial activity against Pseudomonas aeruginosa does not change [46]. In 
another study (in which the effects of different parameters on a series of 20 AMPs 
were explored) is reported that an increase of hydrophobicity increases the hemolytic 
activity slighting affecting the antimicrobial activity [43]. 
 
Charge. Antimicrobial peptides exhibit a selective interaction towards the bacterial 
membrane. It is believed that electrostatic interaction between the positively charged 
peptide and negatively charged membrane is the first step in the interaction process 
and it is responsible for the selectivity. For this reason, the global charge on the 
peptide plays an important role in the antimicrobial activity [12]. 
Most cationic antimicrobial peptides possess a net positive charge ranging from +2 
to +9. They are enriched of lysine and arginine residues positively charged at 
physiological pH. At acidic conditions histidine residues can be positively charged 
contributing to the overall charge. 
There is a relation between charge and biological activity. As general rule, an 
increase of the net positive charge causes an increase of the antimicrobial activity 
[29]. In fact, a study on a series of peptides demonstrated that an increase of the 
positive charge increases the peptide potency against bacteria [47]. However, it 
seems that the charge cannot be increased indiscriminately. In fact, for some peptides 
there is a threshold value above which a decrease of the antimicrobial activity was 
observed. For example, in a study carried out on a series on magainin 2 analogs it 
was shown that an increase of the charge above the threshold value of +5 leads to a 
decrease of antimicrobial activity [48]. The observed decrease could be due to the 
strong electrostatic repulsions in the packed structure of the peptide upon interaction 
with the membrane. Even if the increase of positive charge seems a straightforward 
way to improve the antimicrobial activity, the possible rise of the hemolytic activity 
should be considered. In fact, the hemolytic activity also depends on the net charge. 
There is a threshold charge value (depending on the peptide sequence), above which 
the undesirable hemolytic activity increases [29]. This aspect was well demonstrated 
in a study carried out on series of peptides analogs where the positive charge of a 
peptide was varied holding constant the other peptide features [47]. 
 
Polar angle. This parameter measures the relative spatial proportion of polar and 
apolar face in amphipathic peptides [49]. In a perfect amphipathic α-helix, where one 
face is composed by hydrophobic residues and one face by only polar residues, the 
polar angle is 180°. An increase of the hydrophobic side will reduce the polar side 
leading to a decrease of the polar angle and vice versa. Changes in the primary 
sequence can alter the polar angle. Several studies have found a correlation between 
the polar angle and the permeabilization of the membrane. It seems that a decrease 
of the polar angle leads to an increase of the membrane permeabilization [49]. In a 
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study on two model peptides which only have different polar angle (100° and 180°), 
it was shown that the peptide with the lower polar angle induces greater 
permeabilization, translocation and rate of pores formation [50]. 
 
Even just from this brief description of antimicrobial peptides general features, it 
becomes clear that the fine interplay among these parameters defines the peptides’ 
activity. Moreover, they are not independent to each other. A modification of one 
parameter can change others. This demonstrates that the inter-relationships among 
these parameters are the key factors in determining the biological activity of 
antimicrobial peptides. 
 
1.3 Classification of AMPs 
 
Antimicrobial peptides are a heterogeneous class of molecules. It’s very hard to 
categorize them in specific classes. However, a possible classification can be 
attempted according to their secondary structures (adopted upon interaction with the 
membrane) and amino acids composition [8,51,52]: 
 
 Linear α-helical peptides; 
 β-sheet peptides; 
 mixed α/β peptides 
 peptides enriched of a specific amino acid. 
 
Linear α-helical peptides represent the most characterized group. These peptides 
adopt a random structure in solution but an amphipathic α-helix structure when 
interact with the membrane. Examples of AMPs belonging to this class are: 
magainins (Fig. 1.1), pexiganan and cecropins [53,54]. 
The second class is composed by peptides with a β-sheet structure. These peptides 
are usually enriched of cysteine residues. In solution, they can adopt a β-sheet 
conformation stabilized by disulfide bridges. Upon interaction with membranes, the 
conformation only slightly changes. β-sheet peptides can contain two or more 
cysteine residues. An example of AMPs with two Cys residues is tachyplesin 
(reported above, in Fig. 1.1). Another good example is represented by human 
defensins (both α- and β-defensins) which are characterized by the presence of three 
disulfide bridges [55]. 
Peptides with a mixed structure of α and β are also described. As an example, the 
drosomycin from the insect Phormia terranovae has a β-sheet composed by three 
strands and a small segment which adopts a α-helical structure. The whole structure 
is stabilized by the presence of four disulfide bridges [56]. From the same insect, it 
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was isolated the peptide defensin A with a β-sheet formed by two antiparallel strands 
and a segment in α-helix. The structure is stabilized by two disulfide bridges [56]. 
Finally, there are some AMPs in which a specific amino acid is overrepresented. 
These peptides can adopt different structures apart from the ones reported above. 
They can be enriched of proline, glycine, arginine, tryptophan and histidine residues. 
The peptide formaecin from the ant Myrmecia gulosa is a proline-rich peptide. It is 
composed by 16 residues: 5 of which are proline residues [57]. Plasticins are 
examples of glycine-enriched AMPs which adopt a β structure in solution [58]. PR-
39 is an arginine enriched AMPs of 39 residues, 11 of which are arginines [59]. It is 
effective against both gram -negative and -positive bacteria and even cancer cells. 
Its action mechanism probably involves a direct bind to DNA [60] rather than the 
common membrane destabilization. In fact, it is thought that arginine-enriched 
peptides can translocate across the membrane interacting with intracellular 
components. This class of AMPs are called cell penetrating peptides (CCPs) and will 
not be considered here [61,62]. As an example of Trp enriched AMPs it should be 
cited indolicidin [63]. This 13-residues peptide with 5 Trp adopts a unique extended 
structure with two half turns in the presence of dodecylphosphocholine micelles [64]. 
Finally, the antimicrobial peptide clavanin A is an example of histidine-enriched 
peptide [65]. It is composed by 23 amino acids, 4 of which are histidine residues. 
Upon interaction with liposomes mimicking bacterial membrane, it adopts a curved 
helical structure [66]. 
 
1.4 AMPs Action Mechanisms  
 
Antimicrobial peptides are a class of active molecules. They are involved in a wide 
variety of functions such as epithelial cell proliferation, wound healing and 
stimulation of the production of chemokines [52]. However, they are best known for 
their antimicrobial activity, which is the subject of this thesis. How do they carry out 
this important biological activity? It is widely accepted that the final target of AMPs 
is the lipid matrix of the membrane [6,12,28]. In fact, AMPs can interact with the 
cytoplasmic membrane of bacteria leading to its permeabilization and, finally, cell 
death. It is important to note that this interaction is non-specific with no receptor 
involved. In fact, it has been reported that the replacement of all L- amino acids in 
the sequence with the corresponding D- enantiomers does not affect antimicrobial 
activity [67]. The first step of the interaction process between peptides and the 
pathogens’ cell is represented by electrostatic interactions. At physiological pH, 
AMPs are positively charged (section 1.2) and bacterial membranes are enriched of 
negatively charged lipids (section 2.4) [68]. Once peptides are in contact with the 
cell surface, they must cross the cell wall for gram-positive bacteria, and outer 
(cytosolic) membrane and cell wall for gram-negative bacteria before to interact with 
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the cytoplasmic membrane, the target of AMPs [69]. For gram-negative bacteria, it 
was proposed that peptides displace divalent ions associated with 
lipopolysaccharides (LPS) in the cytosolic membrane [70]. In this way, a 
destabilization of the membrane occurs, and peptides can gain access to the inner 
membrane. The way through which AMPs cross the thick cell wall of gram-positive 
bacteria is not fully understood. It seems that the presence of peptidoglycan is not 
important in gaining the access to the cytoplasmic membrane. On the contrary, 
teichoic acids are involved in the translocation across the cell wall, since they could 
limit peptides’ availability at the surface of the cytoplasmic membrane [71,72]. 
Moreover, the peptides’ ability to cross the cell wall seems to depend on their 
secondary structures and oligomerization state. In some way, peptides reach the 
cytoplasmic membrane of bacteria and are adsorbed on the membrane surface where 
they change the conformation. The most common conformational change is from 
random-coil to α-helix (for linear AMPs). Together, these three steps constitute “the 
binding steps” of peptides to the membrane (Fig. 1.4) and is common to all AMPs.  
 
 
Fig. 1.4 The three steps involved in the binding of linear AMPs to the negatively charged membrane. 
Adapted from [73]. 
 
After this stage, the peptide molecules remain associated on the surface of the 
negatively charged membrane. To exert their activity, peptides must be locally 
concentrated. Thus, they must reach a critical concentration called the threshold 
concentration [28]. This parameter is defined as the minimum peptide concentration 
(or lipid-to-peptide ratio, L/P, in an experiment) required to exert the biological 
effect [28]. Melo et al. [28] established that to observe a biological effect a very high 
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membrane coverage, close to the membrane saturation, is required [12]. Thus, it 
appears clear that the binding affinity of a peptide for a membrane with a specific 
composition is fundamental in determining how much peptide is required to kill the 
bacteria. A correlation between Minimum Inhibitory Concentration (MIC), the lipid 
to peptide ratio, L/P at saturation and the partition constants exists. The minimum 
inhibitory concentration is the microbiological parameter indicating the minimum 
peptide concentration at which bacterial growth is inhibited). As an example, in the 
case of melittin a partition constant of 6∙104 was determined for the interaction with 
liposomes composed by phosphatidylcholines (PCs) and phosphatidylglycerols 
(PGs) [74]. From this partition constant a lipid-to-peptide ratio at saturation of about 
2.5/1 is estimated. From these two parameters, the MIC value can be determined 
which reproduce the experimental value for E. coli. Thus, there is a link between 
membrane coverage (threshold) and effect in vivo [28]. 
As a consequence of membrane coverage (threshold concentration), the peptide can 
destabilize the membrane, but how does it take place? This is a very difficult task to 
address. The mechanism by which a peptide destabilizes a membrane depends on 
several parameters, such as lipid composition and all the physico-chemical properties 
of both the membrane (e.g. physical state) and peptide (charge, length, 
amphipathicity, hydrophobicity, conformation). However, to explain the AMPs 
action mechanism, different models have been proposed. Three of them are the most 
common invoked and are schematically represented in Fig. 1.5: 
 
 barrel-stave model; 
 toroidal model; 






Fig. 1.5 The three most common invoked AMPs action mechanisms. (A) Barrel-stave model; (B) 
Carpet model; (C) Toroidal model. The amphipathic peptides are represented as cylinders: the red 
portion are polar residues, the blue one represents hydrophobic residues. Adapted from [12]. 
 
In the so-called barrel-stave model (Fig. 1.5, A), AMPs induce the permeabilization 
by forming pores in the membrane. These pores are formed by interacting trans-
membrane peptides that face their apolar residues toward the hydrophobic core of 
the membrane and polar residues toward the center of the pores which are filled with 
water. In the initial step, peptides bind in their monomeric form to the surface, 
interacting with the polar head groups of lipids leading to a local membrane thinning. 
This favors the peptides insertion in the hydrophobic part of the outer leaflet of the 
membrane, since most of them are too short to span the membrane completely. At 
the threshold concentration, the peptides’ monomers self-assemble and insert deep 
in the membrane forming pores. This mechanism is characteristic of hydrophobic 
peptide with a low charge density. An example of peptide which it is believed to act 
through this mechanism is alamethicin [75]. This peptide forms a helix bundle 
composed by 6 peptides which lines the pore. Its orientation respect to the bilayer 
depends on the membrane hydration state and the lipid-to-peptide ratios underlying 
the importance of threshold concentration concept [76,77]. 
The second mechanism is called toroidal model. As in the barrel-stave, also this 
model predicts the formation of pores. The main difference is that in the toroidal 
model, peptides are always associated with the lipid polar head groups.  
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In this model, peptides partition into the membrane (assuming a trans-membrane 
orientation) and induce a bending in the membrane leaflets which connect to each 
other (Fig. 1.5, B). Thus, the pore is lined by peptides and lipid head groups and 
filled with water. Peptides with high charge density and not particularly hydrophobic 
act through this mechanism. The bending of the membrane and the association of 
lipid polar heads with peptides stabilizes the pore. In fact, without it, the electrostatic 
repulsion among peptides will be too high that a pore cannot be formed. An example 
of peptide that acts through this mechanism is magainin [78,79]. 
In the carpet mechanism (Fig. 1.5, C), proposed by Shai in 1996 [80] peptides cover 
the membrane like a carpet. At the threshold concentration, peptides produce a 
detergent-like effect which solubilize the membrane. Thus, the permeabilization 
does not occur through the formation of pores. In this mechanism, the peptide is not 
necessarily inserted in the hydrophobic core, but it can remain attached to the lipid 
polar head groups. In addition, peptides might form transient pores that allow to 
peptides to translocate to the inner leaflet of the membrane favoring the 
solubilization process. Examples of peptides which it is believed to act through this 
mechanism are ovispirin [81] and cecropin [80]. Both these peptides don’t penetrate 
inside the membrane hydrophobic core and remains attached to the lipid head groups 
with their helical axes perpendicular to the bilayer normal. 
The three models described above are membranolytic mechanisms. It means that 
they predict the membrane permeabilization through its disruption (with stable pores 
or with a detergent-like effect). 
Other mechanisms have been proposed in which a membrane disruption does not 
occurs [12]. The development of these models was necessary from the observation 
that some peptides are effective against bacteria, but they are not able to perturb the 
membrane [82,83]. 
One of these models is the aggregate channel model [84,85]. In this model, peptides 
insert into the membrane in form of unstructured aggregates. These aggregates are 
only transient and allow to the peptides to cross the membrane without causing a 
significant membrane disruption. Once inside, the peptides can interact with 
intracellular targets as DNA, RNA and proteins [68]. 
Another one is the molecular electroporation model, proposed for the peptide 
annexin V [12]. In this model, peptides with a high charge density generate an 
electric field. The electric field promotes the formation of transient pores which 
increase the membrane permeability without causing it any kind of damage. 
Some peptides can perturb the membrane by promoting the formation of specific 
lipid-peptide domains [86]. In this mechanism, the preferential interaction of 
peptides with the negatively charged lipids (phosphatidylglycerols, cardiolipins) 
leads to a lateral phase segregation of anionic lipids from the zwitterionic ones. The 
formation of discrete domains induces a destabilization of the membrane since the 
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interface among domains act as defects which increase membrane permeability [87]. 
For example, it was demonstrated by means of calorimetric measurements that the 
small peptide Ac-RW [88] is able to induce the formation of a PE 
(phosphatidylethanolamine) and PG (phosphatidylglycerols) enriched domains in 
model membrane composed by a mixture of both lipids. It is known that PEs and 
PGs, in their pure forms, prefer to adopt different phases: inverted hexagonal and 
lamellar, respectively (see section 2.6). The interface among domains of different 
phases destabilizes the membrane without disrupting it. The formation of domains 
can have a deep impact also on the biological activity of the cell [12]. For example, 
it can alter the diffusion rates of lipids and membrane proteins. Moreover, the 
membrane curvature is also affected by the lipid segregation process. It is known that 
a correct curvature is required for some process such as cell division [89]. 
 
In conclusion, several peptides and membranes properties dictate the action 
mechanism. Often, a peptide doesn’t act through a single, well defined mechanism. 
Sometimes, its mechanism is unique. Find a relation between peptides’ structural 
properties and mechanism is a very difficult task. 
 
1.5 AMPs in Clinical Trials 
 
The efforts of the scientific community in studying AMPs are all devoted to a 
common final goal: the application of AMPs as drugs. These studies are important 
in revealing the relation between peptides’ properties and biological activity. In this 
way the design of new AMPs with high antimicrobial activity and low cytotoxicity 
is possible.  
AMPs as drugs offer a series of advantages [90,91] among which it is possible to 
cite: safety, tolerability, efficacy and selectivity. A lot of peptides are characterized 
by low MIC values and low hemolytic activity. This automatically means that human 
body well tolerates them because AMPs are selective and interact preferentially with 
pathogens. Unfortunately, peptides are not chemically e physically stable. They are 
prone to hydrolysis and oxidation reactions which can modify the biological activity. 
Moreover, the plasma half-life is short. In fact, once inside the human body, they are 
subjected to the proteases action [92] that cleave the peptide at specific residue or 
directly at one of the two termini. This inevitably leads to an unfavorable 
pharmacological profile. Thus, there are some limitations in the application as drugs 
and several strategies have been developed to face these problems. The introduction 
of unnatural amino acids, β-amino acids or D- enantiomers as well as protection of 
both N- and C- termini contribute increasing the peptide half-life [91,93]. The 
attachment of fatty acids (lipopeptides) or PEG (polyethylene glycol) can also 
enhance serum stability [90]. 
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Apart from the “scientific problems”, financial problems should be considered, as 
the high production cost which limit AMPs applications in medicine [94]. From this 
very brief description, it appears clear that the development of a peptide-based drug 
is not simple. However, due to selectivity, low cytotoxicity, broad spectrum of 
activity and no resistance development, AMPs have attracted the attention of several 
pharmaceutical companies [95]. 
Today, about 60 peptide-based drugs are available on the market and many others 
are at different stages of clinical trials [90,91]. Examples of AMPs in clinical trials 
are reported. 
Pexiganan is a peptide derived from magainins and is at phase III of clinical trials. It 
is composed by 22 amino acid and it has a broad spectrum of activity against bacteria 
(both gram-positive and negative) and fungi [54]. The final goal is to obtain a 
pexiganan-containing formulation for topical application in the treatment of infected 
diabetic foot [91,96]. Omiganan, is an antimicrobial peptides derived from 
indolicidin, a Trp-rich peptide [97]. It is in phase III of clinical trials for the 
evaluation of safety and efficacy in the topical treatment of rosacea. Omiganan is 
also in phase II for the development of a gel against acne vulgaris. Finally, another 
example of AMP in development is represented by PAC-113, a peptide derived from 
histatin 5, enriched in histidine residues. It has shown activity against the fungus 
Candida albicans [98]. It is in phase III clinical trials aimed in finding the optimal 
dose for the treatment of candidiasis of oral cavity [91]. 
These examples show that application of AMPs as drugs is possible. So, AMPs have 

























Biological membranes are fluid structures composed by lipids, proteins and 
carbohydrates [99]. Membranes are fundamental components of every kind of cells, 
from simpler prokaryotes like bacteria to the more complex higher organisms as 
animals [100]. Biological membranes separate the inner part (intracellular space) of 
a cell from the external part (extracellular space) or delimit organelles inside a cell 
(e.g. membrane of mitochondria). More specifically, in the first case we will refer to 
the membrane as “the plasma membrane” which constitute the cell boundaries. In 
Fig. 2.1 is reported a schematic representation of a plasma membrane highlighting 
its major components. 
 
 
Fig. 2.1 A schematic representation of a plasma membrane. Their main constituents are lipids, 
proteins and carbohydrates. Adapted from [99]. 
 
The fluid mosaic model developed by Singer and Nicolson [101] is the common 
representation used to describe cell membrane structure and dynamics. In this model 
and in its update version [102] the membrane components, lipids and proteins are 
distributed inhomogeneously like a mosaic. But differently from a Roman mosaic in 
which the tesserae are fixed, the membrane tesserae (its components) are in constant 
motion. They can diffuse along the plane of the membrane (translational diffusion) 
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or can rotate around an axis perpendicular to the membrane plane. Occasionally, 
lipids can go from the inner leaflet to the outer and vice versa (transbilayer diffusion 
or flip-flop) [103]. Following, the general features of a membrane are reported: 
 
 A membrane is composed by a lipid double layer (two leaflets) with a 
thickness of 5-6 nm. Lipids are amphipathic molecules (Fig. 2.2A). They 
present a polar head group (hydrophilic) and two lipid chains (hydrophobic). 
When exposed to aqueous environment, they organize themselves 
spontaneously by forming a structure (the bilayer) in which the hydrophobic 
portion of each lipids is hidden to the water, whereas the hydrophilic portion 
is exposed to the water (Fig. 2.2B); 
 
 
Fig. 2.2 (A) Simplified representation of a lipid molecule. The hydrophilic and hydrophobic portion 
of the molecule are indicated by arrows. (B) The lipid bilayer: it is formed by two lipid monolayers 
(or leaflets) facing their hydrophobic portions. The hydrophilic head groups are surrounded by water 
molecules.  
  
 Membranes are enriched in proteins. Proteins associated with the polar head 
groups are called peripheral proteins. They can be found on both side of the 
membrane. Proteins which interact with the hydrophobic matrix of the 
membrane are called integral proteins. Usually, not the entire protein is 
embedded in the membrane, but some regions come out of the membrane 
(Fig. 2.1); 
 All membranes contain carbohydrates. Carbohydrates do not possess a 
hydrophobic moiety. Consequently, they are never localized in the membrane 
interior. Interestingly, sugars are only found on the outer surface of the 
plasma membrane. Carbohydrates are always associated with lipids 
(glycolipids) and proteins (glycoproteins); 
 The membrane is an asymmetric structure [104]. It means that the 
composition of the inner, cytosolic leaflet is different from the outer leaflet. 
For example, in the eukaryotic plasma membrane the lipid 
phosphatidylserine is almost found in the inner leaflet. The same holds for 
proteins: a peripheral protein which interact, for example, on the surface of 
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the outer leaflet will be found always there and never in the inner leaflet 
[102]; 
 The membrane is characterized by later heterogeneity. This means that the 
constituents’ composition is not the same everywhere. There are small (0.1 – 
1 µm in diameter) patches called “domains”, enriched of specific lipids and 
proteins, which exhibit characteristic functional properties. The so called 
“lipid rafts” are a good example of domains. The rafts are enriched of 
sphingolipids and cholesterol. It is believed that rafts domains are the house 
of a series of membrane proteins involved in the cell signaling [105].  
 
2.2 Membrane Functions: a Brief Overview 
 
The most obvious function of a biological membrane is to separate two aqueous 
compartments. For a plasma membrane this involves separation between 
intracellular and extracellular space. Clearly the separation cannot be absolute. In 
fact, a cell must be able to uptake nutrients from the external environment and to 
remove molecules from its interior. In other words, a cell must communicate with 
the external environment. Thus, it acts as a selective permeable barrier which 
regulates the enormous traffic of molecules in and out of the cell. Essentially, 
molecule movements across the membrane can be divided in two big groups: passive 
diffusion and active transport [103,106]. In Fig. 2.3 are summarized these basic types 
of membrane transport. 
 
 
Fig. 2.3 The basic types of membrane transport: passive transport (which includes also simple 
diffusion) does not require energy. In contrast, active transport requires energy in form of ATP. 




Passive diffusion does not require energy, but it is driven by only solutes 
concentration gradient. Passive diffusion can be either simple diffusion across the 
membrane or “assisted” diffusion, where some carriers (proteins) are involved in the 
process. Potassium and Sodium Channels are examples of integral membrane 
proteins which facilitate the diffusion of K+ and Na+ across the membrane. In 
contrast, active transport requires energy, usually in form of ATP, and it is always 
performed by membrane proteins. An important example of active transport is 
represented by Na+/K+ ATPase which uses ATP to pump Na+ out of the cell and to 
pump in K+ both against their concentration gradients. These mechanisms are mainly 
involved in the transportation of small molecules. For larger molecules (e.g. 
macromolecules) other ways are required. These ways include: 1) receptor mediated 
endocytosis (RME) also known as clathrin-dependent endocytosis where a 
membrane protein named clathrin favors the internalization of molecules by forming 
a small lipid vesicle; 2) pinocytosis, in which an invagination of the plasma 
membrane encapsulates external fluid materials. This leads to the formation of a 
vesicle which it is released inside the cell. Every kinds of fluid can be incorporated; 
thus, this mechanism is completely non-specific; 3) phagocytosis involves the uptake 
of large solid particles of macromolecules, parts of cell or even a whole 
microorganism. The solid particle is recognized by receptors on the membrane 
surface. Then, the formation of vesicles called phagosomes take place which 
internalize the solid particle. Finally, the particle will be transported to the lysosome 
for digestion.  
In addition, the plasma membrane carries out other important functions: 
 
 It contributes in protecting the structural integrity of the interior of the cell, 
e.g. maintaining the cytosol pH and the right osmotic pressure; 
 It constitutes the point of attachment to the cytoskeleton: this helps in 
maintaining the cell shape; 
 It is involved in the cell recognition thanks to the presence of glycolipids on 
its surface; 
 It is involved in a series of biochemical and physiological functions: inter-
cellular communication, cell adhesion [107] and energy transduction events, 
just to cite a few. 
 
From this description it appears clear that membranes are involved in a great number 






2.3 The Membrane Composition 
 
The basic components of all biological membranes are lipids, proteins and 
carbohydrates. The composition of a plasma membrane can vary from cell to cell, 
depending primary on the cell function [108]. 
Even in a cell, the composition of plasma membrane differs from that one of 
organelles. For example, the myelin sheath (the plasma membrane of nervous fiber) 
is enriched of sphingomyelin and cholesterol and it contains only 20% by weight of 
proteins [109]. In contrast, the mitochondrial membrane is enriched in proteins, up 
to 75% by weight. This difference is primary due to the function of the membranes: 
the role of the myelin sheath is to insulate nerve cells (structural role), instead the 





Lipids are fundamental components of the membrane. The principal classes of lipids 
found in membranes are essentially three: glycerophospholipids, sphingolipids and 
sterols. 
For sure, glycerophospholipids are the main components of a membrane. They are 
composed of one glycerol molecule, a phosphate, two fatty acid chains and an 
alcohol.  A phospholipid is an amphipathic molecule: it has a polar head group 
formed by glycerol, phosphate and alcohol, and a hydrophobic portion formed by the 
two fatty acid chains. In Fig. 2.4 is reported a representation of a 
glycerophospholipid. 
 
Fig. 2.4 Chemical structure of a glycerophospholipids. 
 
The fatty acids are esterified at C1 (sn-1 position) and C2 (sn-2 position) of the 
glycerol. Usually the acyl chain in position sn-1 is saturated, instead that one in 
position sn-2 is unsaturated. Clearly this is not a rule. Both chains can be saturated 
or even both with multiple unsaturations. Their length can vary from 14 to 22 carbon 
25 
 
atoms. At the C3 of the glycerol, a phosphate group is esterified. Attached to 
phosphate, there is an alcohol. Based on the type of alcohol, it is possible to obtain 
different kinds of phospholipids (Fig.2.5): phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol (PI) 
and phosphatidylglycerol (PG). There are also phosphatidic acids (PA) in which 




Fig. 2.5 Chemical structures of the polar head groups of glycerophospholipids. The pKa values of the 
chemical groups forming the polar heads are also reported. Adapted from [99]. 
 
A particular lipid found both in eukaryotic and prokaryotic membrane [99,110] is 
the cardiolipin (CL). It is formed by two PAs linked together by a glycerol (Fig. 2.6). 
Thus, it differs from other lipids having four fatty acid chains. 
 
 
Fig. 2.6 Chemical structure of cardiolipin (CL). Adapted from [99]. 
 
All the subclasses of glycerophospholipids (Fig. 2.5 and 2.6) are amphipathic 
molecules. At physiological pH of 7.4 some of them are zwitterionic, and some are 
negatively charged. Due to the acidic character of the phosphate group, at 
physiological pH, it brings always a net negative charge. Thus, the net charge of a 
particular lipid is determined by the phosphorylated alcohol. For example, PCs have 
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not ionizable groups and a positive charge on the nitrogen atom. Thus, it is 
zwitterionic with no net charge. PEs instead, are slightly negative charged. This is 
because the amine group of PE has a pKa around 8.5. CLs, instead, have a negative 
charge of about 2 dues to the presence of two phosphate groups which are not fully 
ionized [111]. 
Each subclass of phospholipids has a role in the membrane. PCs are the most 
abundant phospholipids in all the eukaryotic membranes. Basically, they have a 
structural role, determining many properties of the membrane, for example the 
fluidity. Another structural lipid is the PE. It is the second most abundant lipid in 
eukaryotic organisms, but it is the main lipid in the membrane of bacteria. This is 
because, in eukaryotes PEs are converted into PCs. This process is not possible in 
bacteria. PSs are negatively charged lipids which have a different role. In fact, they 
are involved in activating and anchoring proteins to the membrane. It is interesting 
to note that PSs are found almost exclusively in the inner leaflet of the membrane 
(bilayer asymmetry). This is accomplished by proteins named flipases [112]. With 
the ageing of the cell, PSs accumulate in the outer leaflet of the membrane and this 
is a signal that the cell should be recycled. PIs, another negatively charged lipids, 
play a central role in cell signaling and regulation [113]. PIs are present, more or 
less, in every cell type but they are particularly abundant in the cells of the brain. 
PGs, anionic lipids, are found in low abundance in the membrane of eukaryotes. An 
exception is represented by lung surfactant in which PGs constitute up to 10% of all 
lipids [114]. Moreover, PGs are among the main components of the bacterial 
membrane [115]. PAs are unique lipids involved in different processes such as 
membrane fission and fusion events. At physiological pH, they are negatively 
charged. Finally, CLs are abundant in the mitochondrial membrane where they are 
involved in electron transport stabilizing some electron transport proteins. CLs are 
also present in the bacterial membrane. They take part in some processes such as cell 
division, membrane transport and energy metabolism [116]. 
The second important class of lipids is represented by sphingolipids. All the 
sphingolipids are based on the sphingosine, an amino alcohol with a hydrophobic tail 






Fig. 2.7 The chemical structure of sphingosine, the precursor of all sphingolipids. 
 
All the sphingolipids derive from the sphingosine by attaching an alcohol to the C1 
and a fatty acid chain (saturated or not) to the its unique nitrogen atom. Depending 
on the alcohol on the C1 we can identify five different subclasses: 
 
 Ceramide, where the attached group is a simple hydrogen atom; 
 Sphingomyelin, where the attached group is a phosphatidylcholine or a 
phosphatidylethanolamine; 
 Cerebroside, with a sugar such as glucose or galactose; 
 Globoside, with up to four sugar molecules; 
 Ganglioside where the attached group is a complex oligosaccharide. 
 
The most abundant sphingolipid in humans is sphingomyelin (SM). In this lipid, the 
head group is a phosphocholine. Thus, like PCs, at physiological pH it is 
zwitterionic. The fatty acid chain can vary in length (up to 24 C atoms) and usually 
it is longer and more saturated respect to the hydrocarbon chains in PCs. In Fig. 2.8 
is reported a chemical structure of a sphingomyelin, where the attached fatty acid has 
16 C atoms and it is saturated.  
 
 
Fig. 2.8 The chemical structure of palmitoyl-sphingomyelin. Taken from https://avantilipids.com/. 
 
Sphingomyelin is present in many mammalian cells, but it is particularly abundant 
in the plasma membranes of the nervous cells [117]. It has a higher affinity for 
cholesterol, with which forms organized microdomains termed “lipid rafts” 
[118,119]. These microdomains can function as signaling platforms that regulate the 
localization of proteins [120]. Other sphingolipids are involved in different 
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functions. For example, gangliosides are found in the outer leaflet of the membranes 
where are involved in cell-cell recognition [121]. 
The third class of lipids commonly found in the membranes are sterols [122]. They 
are components of the membrane of animals, plant and fungi but it is completely 
absent in prokaryotes. Sterols are very water insoluble and readily partition inside 
the hydrophobic core of the membrane. The basic structure is formed by four rigid 
rings (Fig. 2.9) where at C3 an OH group is attached which form the polar head group 
of this lipid. 
 
 
Fig. 2.9 The chemical structure of sterol which constitutes the basic structure of all sterols. 
 
Some carbons in the rings could be also unsaturated. At the C16, a hydrocarbon tail 
is found. Depending on the structure of the tail, we will have different kinds of 
sterols. In Fig. 2.10 are reported the three main sterols found in animals (cholesterol), 
fungi (ergosterol) and plants (β-sitosterol). 
 
 




Cholesterol (Chol) is found in many cell membranes. It constitutes up to 50% by 
weight of all lipids in the plasma membrane and it is particularly abundant in the 
brain. The main role of cholesterol in membranes is to regulate their fluidity [122] 
controlling the phase behavior of the bilayer (see section 2.7). This is accomplished 
thanks to its unique flat structure which permits its intercalation among phospholipid 
chains. Thus, cholesterol is important in supporting membrane lateral organization, 
stability and preventing the leakiness of solutes across the membrane. Moreover, 
cholesterol is a precursor of a series of steroid hormones (e.g. testosterone), vitamin 
D and bile salts. In conclusion, cholesterol has two functions: it has a structural role 
and a biochemical role as a precursor of important molecules. 
 
2.3.2 Membrane Proteins 
 
Proteins are an important component of the membrane. Differently from lipids, all 
proteins have an active role. They can serve as enzymes which catalyze some 
reaction at the water/membrane interface, they are involved in the active transport of 
solutes and they can function as receptor in the surface of the membrane. Basically, 
all the membranes have proteins. Their percentage by weight can vary from 20% up 
to 75%, depending on the function of the membrane. If the membrane has only a 
structural role, the % of proteins will be very low. Conversely, if a membrane must 
catalyze a series of reactions, its protein content will be very high. 
Membrane proteins can be classified in two big groups: peripheral and integral 
proteins [123]. 
Essentially, a peripheral protein is a water-soluble protein which interact with the 
membrane surface through electrostatic interaction or hydrogen bonds. Some of 
them interact directly with the anionic lipids, others interact on the surface of integral 
proteins. Since the weak forces involved in this interaction, peripheral proteins can 






Fig. 2.11 A schematic representation of the two kinds of peripheral proteins found in membranes. 
Adapted from [99]. 
 
A good example of peripheral protein which interact directly with lipid head groups 
is myelin basic protein [124] whose malfunctions are involved in multiple sclerosis. 
Cytochrome c, instead, is an example of peripheral protein which interacts with an 
integral protein. In fact, cytochrome c is weakly bound to cyctchrome c oxidase that 
is localized in the inner membrane of mitochondria [125]. 
Integral proteins penetrate inside the membrane and interact directly with the 
hydrophobic core. Usually, these proteins span the entire membrane (they are trans-
membrane protein) with some segments exposed on both side of the membrane (as 
well represented in Fig. 2.1). The residues which interact with the lipid chains are 
clearly hydrophobic. Instead, the portions out of the membrane are enriched in polar 
amino acids. A general feature of integral proteins is that they have aromatic residues 
as tryptophan and tyrosine localized at membrane/water interface [32,126]. The 
portion of integral protein, which is embedded in the membrane hydrophobic core, 
adopts a specific motif. On this basis we can divide integral proteins in several 
classes (Fig. 2.12): 
 
1. Single trans-membrane α-helix proteins; 
2. Multiple trans-membrane α-helices proteins; 





Fig. 2.12 The three kinds of integral proteins. From left to right: single trans-membrane α-helix, 
multiple trans-membrane α-helices proteins and β-barrel. 
 
Single trans-membrane α-helix proteins have a single helix which span the entire 
membrane. Since the average thickness of a membrane is about 5-6 nm, a trans-
membrane α-helix should have 20 amino acids. An example of this kind of integral 
protein is represented by glycophorin [127]. Multiple trans-membrane α-helices 
proteins, instead, are composed by several helical structures embedded in the 
membrane. An example is represented by the 7 α-helix trans membrane protein 
bacteriorhodopsin [128]. The last type of structure adopted by integral proteins is the 
β-barrel. It is composed by 16 or more anti-parallel β-strands arranged like a cylinder 
(the barrel) inside the membrane. β-barrels are very common in the outer membrane 
of gram-negative bacteria. The bacterial porins are an example [129]. They are 
composed by 18 strands connected by turns on cytoplasmic side and loops on the 
extracellular side. 
Many integral proteins are also attached to the membrane through lipid anchors. The 
most important lipid chains involved are: myristic acid, palmitic acid, prenylated 
hydrophobic chains and glycosylphosphatidylinositol (GPI). 
 
2.3.3 Membrane Carbohydrates 
 
Carbohydrates (or sugars) are the third component found in biological membranes. 
Being water-soluble molecules, they do not partition inside the hydrophobic core of 
the membrane. Sugars are exclusively found on the outer surface of the membrane 
and always attached to lipids (glycolipids) or proteins (glycoproteins). This aspect 
suggest that sugars are involved in the interaction of the cell with the external 
environment. Among carbohydrates diverse function, it is possible to mention: cell-
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cell recognition, membrane receptors, membrane proteins protection from 
degradation, chaperones, proteins stability [99]. Carbohydrates have also a 
protecting role in protein-derived antimicrobial peptides. Moreover, sugars are 
fundamentals for the activity of some AMPs [130]. Carbohydrates can also 
contribute to the membrane physical state, modulating its fluidity [131]. Commonly, 
in membranes are found about nine different sugars: α-D-glucose, α-D-mannose, α-
D-galactose, α-L-fucose, α-D-xylose, α-L-arabinose, N-acetylglucosamine, N-
acetylgalactosamine and sialic acid. It is possible to find attached to proteins and/or 
lipids a single sugar molecule or more, up to 15. 
In glycolipids, carbohydrates can be covalently linked (through a glycosidic bond) 
directly to a fatty acid (simple glycolipids) or to the glycerol of the lipid head group 
of glycerolipids, forming the class of glycerol-glycolipids. On the other hand, 
carbohydrates linked to the oxygen atom on C1 of sphingolipids form the class of 
sphingo-glycolipids (Fig. 2.13). 
 
 
Fig. 2.13 The chemical structure of glycolipids (left), glycero-glycolipids (middle) and sphingo-
glycolipids (right). Adapted from https://en.wikipedia.org/wiki/Glycolipid. 
 
In animals, the major glycolipids are sphingo-glycolipids. They can accumulate into 
lipid rafts where they are involved in the cell signaling. Cerebrosides are sphingo-
glycolipids with only one sugar molecules (usually a glucose or a galactose). 
Globosides can have two, three or four sugar molecules (in the form of di-, tri- or 
tetra-saccharide) linked to the sphingolipid. Finally, gangliosides have a complex 
oligosaccharide. A special mention merits a class of glycolipid localized in the outer 
membrane of gram-negative bacteria: the lipopolysaccharide (LPS) [132]. Briefly, it 
is composed by a disaccharide of N-acetylglucosaimne with multiple fatty acid 
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chains. The hydrophobic tails can be linked to the disaccharide free OH group or to 
the acetyl group. Attached to the disaccharide moiety, there is a complex 
polysaccharide whose composition varies from bacterium to bacterium. 
Carbohydrates can also be found attached to membrane proteins. The combination 
of proteins and sugars forms glycoproteins. The process through which sugars are 
added to proteins is known as glycosylation.  There are two types of glycoproteins: 
N-glycosylated and O-glycosylated (Fig. 2.14). Intuitively, in the case of N-
glycosylated proteins, the glycosylation occurs at the nitrogen atom of asparagine. 
The first sugar attached is always a N-acetylglucosamine. From this unit, other 
sugars can be attached. In O-glycosylated proteins, carbohydrates are linked to the 
oxygen atom of serine and threonine residues. 
 
 
Fig. 2.14 The two types of proteins glycosylation. (Left) N-glycosylation always starts with a N-
acetylglucosamine. (Right) O-glycosylation involving a residue of serine. Adapted from [99]. 
 
Usually, the sugar chain of O-glycosylated proteins is shorter respect to N-
glycosylated proteins. Moreover, the N-glycosylation is common for all the 
membrane proteins which have an active role (enzymatic), whereas O-sugars are 
predominant in structural proteins. For example, in the plasma membrane (a very 
active membrane) about 90% of protein are glycosylated. The number of N-linked 
sugars is more than the O-linked ones [99]. 
 
2.4 A Comparison between Eukaryotic and Prokaryotic (Bacterial) Membranes 
 
All the living organisms are formed by cells [100]. Essentially, there are two cell 
types:  prokaryotic cells and the more complex eukaryotic ones. They differ in a wide 
variety of aspects which can be found in every biology text. Here we focus our 
attention to a specific part of the cell: the membrane. Eukaryotic and prokaryotic 
membranes are both formed by a lipid bilayer. However, there are some important 
differences between them, both structurally and compositionally. 
34 
 
The main constituent of the eukaryotic plasma membrane is represented by 
phosphatidylcholines (PCs). Other constituents are phosphatidylethanolamines 
(PEs), sphingomyelins (SMs), cholesterol (Chol), phosphatidylinositols (PIs) and 
phosphatitdyserines (PSs) [108]. As example, the average lipid composition of 
mammalian liver cells is (in mol %): 45-55% PCs, 15-25% PEs, 10-15% PIs, 5-10% 
PSs, 5-10% SMs and 10-20% Chol. Clearly, the abundance of these lipids varies 
from cell to cell [133]. Moreover, the lipid composition of the inner leaflet is 
different from that one of the outer leaflet [134]. The zwitterion lipids, PCs and SMs, 
are mainly found in the outer leaflet. On the contrary, PEs and anionic lipids (PSs 
and PIs) are localized in the inner leaflet. Thus, from the point of view of an external 
observer, the plasma membrane of a eukaryotic cell appears with no net charge.  
Bacterial membranes are enriched of the zwitterionic lipids as PEs, and anionic lipids 
PGs and CLs [87,135]. The exact composition and the ratio between zwitterionic and 
anionic lipids depend on the type of bacterium and even on the environment 
surrounding the microorganism [136]. 
Bacterial cells do not have only membranes, but they have also a cell wall formed 
by sugars [137]. Together, cell wall and membrane form a complex structure which 
separate the cytosolic space from the external environment. There are two classes of 
bacteria: gram-negative and gram-positive (Fig. 2.15). 
 
 
Fig. 2.15 Schematic representations of the gram-positive (left) and gram-negative (right) bacterial 
membranes. Taken from [87]. 
 
Gram-positive bacteria have a lipid double composed by PEs, PGs and CLs. The 
bilayer is surrounded by a thick cell wall of about 40-80 nm [138] composed by a 
polymer of N-acetylglucosamine and N-acetylmuramic acid linked through a β-(1,4) 
glycosidic bond, i.e. peptidoglycan. In addition, peptidoglycan is cross-linked by a 
pentapeptide which links together the sugar layers. Attached to the peptidoglycan, 
there are polyanionic molecules named teichoic acids (TAs). TAs can also be directly 
embedded in the membrane through a lipid anchor, forming lipoteichoic acids 
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(LTAs) [71]. In contrast, gram-negative bacteria possess two distinct membranes 
(the outer and the inner or cytoplasmic membrane) separated by a thin layer of 
peptidoglycan of about 7-8 nm  [138] without TAs.  
Both the leaflets of the cytoplasmic membrane and the inner monolayer of the outer 
membrane in gram-negative bacteria are composed by zwitterionic lipids PEs and 
anionic ones, PGs and CLs. Instead, the external leaflet of the outer membrane is 
enriched by lipopolysaccharides (LPS), briefly described in the section 2.3.3. 
Clearly, attached to the membranes, there are also proteins, both peripherals and 
integrals involved in numerous functions. 
In bacterial membranes, the anionic lipids are not only localized in the inner leaflet 
but are exposed to the surface. This confer to the membrane a net negative charge. 
This is the main difference with the eukaryotic membrane which is fundamental in 
the interaction with antimicrobial peptides, described in chapter 1. 
 
2.5 Lipids Self-Assembly 
 
Lipids are amphipathic molecules. When exposed to the aqueous medium, they tend 
to self-assemble into aggregates. The main force which drives the aggregation of 
lipid molecules, and the formation of membranes and model membranes as 
liposomes (see section 2.8), is the hydrophobic effect [139,140]. In aqueous medium, 
a lipid molecule is surrounded by water molecules. Water does not interact in the 
same way with all the portions of the lipid molecules. There are some favorable 
interactions with the polar head group. There are also unfavorable interactions of 
waters with the lipid hydrocarbon chains. This brings to the formation of an ice-like 
structure (the water cage) around the acyl chains because water molecules prefer to 
interact to each other through hydrogen bonds. In this cage, water molecules are not 
free to move: their motion is restricted. From a thermodynamic point of view, we 
will say that water molecules around hydrocarbon chains are characterized by low 
entropy. When a second lipid molecule is added, it immediately interacts with the 
first lipid molecule. This leads to the release of water molecules from the cage. Now 
the water molecules are free to move in the bulk. This release increases the entropy 
of water. It is this increase of entropy that is the main responsible for the aggregation 
of lipids. 
In addition, there are other minor forces that contribute to the bilayer stability: head 
group-water interactions, head group-head group interactions, entropy of caged lipid 
chains and van der Waals interactions [99]. 
Lipids have a polar head group (often charged) which can interact favorably with 
water molecules, contributing to the stabilization of the membrane. For example, 
water molecule can from a hydrogen bond with the oxygen atom of the phosphate 
group. Additional stabilizing forces come from head group-head group interactions 
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between neighbouring lipids. These interactions are mainly ionic in nature. Another 
stabilizing force comes from the increase in entropy of lipid chains when are buried 
to the water. In fact, the formation of the water cage around hydrocarbon chains 
restrict their motion (low entropy). When the aggregate is formed, the acyl chains 
are segregated in the bilayer hydrophobic core which results in an increase of chains 
motion (high entropy). The last forces involved in the stabilization of the membrane 
are the van der Waals interactions. These are very weak forces which involve the 
hydrocarbon chains. van der Waals interactions are the result of the interaction 
among induced dipoles that form instantaneously between two close acyl chains. 
In Fig. 2.16 are summarized all the forces involved in the bilayer formation, keeping 
in mind that the main responsible is the hydrophobic effect. 
 
 
Fig. 2.16 The main forces involved in membranes’ formation. (A) Hydrophobic effect and entropy of 
caged lipid chains; (B) head group-water interactions; (C) head group-head group and van der Waals 
interactions. 
 
The tendency to aggregate depends on several factors. It depends on the lipid 
concentration in solution, their chemical structure and the ionic strength of the 
medium [141]. The concentration at which amphipathic molecules start to aggregate 
is defined critical micellar concentration (cmc). In solution, the cmc for bilayer-
forming lipids is in the range 10-10-10-6 M [142]. For example, the cmc value in water 
for dimyristoylphosphatidylcholine (DMPC) is 6 nM, and for 
dipalmitoylphosphatidylcholine (DPPC) is about 0.4 nM. Thus, the cmc value 
decreases as the acyl chains length increases. The effect of the ionic strength is 
important in lipids with a net charge. The cmc value of dioctanoyl-
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phosphatidylserine in water is about 2.2 mM. In the presence of 5 mM Ca2+, the cmc 
decreases to 0.4 mM. 
 
2.6 Lipid Structures: Lamellar and Non-Lamellar Structures (Phases)  
 
In the previous section, we stated that lipids tend to interact to each other forming an 
aggregate. But, which kind of structure do they form? Looking at the biological 
membrane, we can think that all lipids form a bilayer having a flat structure, named 
lamellar phase. Depending on the lipid chemical structure and the environmental 
conditions (pH, temperature, ionic strength, water content), lipids can self-assemble 




 Inverted Hexagonal; 
 Cubic. 
 
It is possible to predict in which kind of structure a lipid self-assembles by 
considering the lipid shape. Membrane lipids can be divided into three basic 
geometrical shapes: truncated cone, cylinder and inverted cone (Fig. 2.17). 
 
 
Fig. 2.17 Membrane lipids shapes: (a) truncated cone, (b) cylinder and (c) inverted cone. Adapted 
from [99]. 
 
Bringing close to each other these geometrical shapes, we can have an idea on which 
kind of structure will be formed. For example, if we put together all cylindrical shape 
lipids, we will obtain a lamellar structure. It is more convenient to define a 
geometrical parameter, the packing parameter S, through which is possible to predict 
the final form of the assembly. The packing parameter is defined as S = v/a0l where 
v is the hydrocarbon volume, a0 is the optimal head group area and l is the length of 
fully extended lipid chain [143]. When S < 1, the lipid shape is inverted cone. These 
lipids will self-assemble forming spherical or non-spherical micelles with a positive 
curvature. A good example is represented by the class of Lyso PCs (e.g. 1-palmitoyl-
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2-hydroxy-sn-glycero-3-phosphocholine) that form micellar structures. For 
cylindrical lipids, S = 1 and they will form lamellar structures (the bilayer). PCs are 
cylindrical lipids and they prefer to adopt lamellar phase with no curvature. When S 
> 1, the lipid shape is truncated cone. In this case, lipids can form inverted, non-
lamellar structures with a negative curvature. PEs and Chol are truncated cone 
shaped and they adopt non-lamellar phase (e.g. hexagonal) [144]. Unfortunately, this 
scheme works only for one-component aggregate. When two or more lipids form the 
aggregate, other factors (as electrostatic and van der Waals interactions, hydrogen 
bonds) should be considered which render the prediction impossible. 
The lamellar phase is the most common structure. The lipid bilayer as described by 
the fluid mosaic model is a lamellar structure. The lamellar phase can exist in a 
variety of states, depending on how the lipid molecules interact to each other (see 
section 2.7 for a detailed description). The second most important structure is the 
non-lamellar phase named inverted hexagonal (HII). It is composed by six parallel 
lipid tubes of indefinite length. Each tube is formed by truncated cone lipids: the 
polar head groups point towards the tube cores (which are filled with water), instead 
lipid chains outside. The tubes are taken together by means of hydrophobic 
interactions and are arranged like a hexagon (Fig. 2.18). 
 
 
Fig. 2.18 A representation of the inverted hexagonal (HII) phase. 
 
Lipids as PEs can adopt this phase. Since a great amount of truncated cone lipids are 
required to have a full hexagonal phase, their existence in membranes is still under 
debate. However, PEs propensity to adopt HII phase may have a role in membrane 
fusion. In fact, PEs can help in achieving highly curved intermediate structures 
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during fusion [145]. The last category of possible phases is represented by cubic 
phases [146,147]. It is composed by a single continuous or discontinuous curved 
bilayer which is folded in a three-dimensional structure. The cubic phases can exist 
in three different morphology, reported in Fig. 2.19. 
 
 
Fig. 2.19 Schematic representations of three different morphologies of the cubic phases. Taken from 
[146]. 
 
Without entering in the details of these quite complex structures, it seems that they 
exist in the membrane. For example, cubic phase was observed in the plasma 
membrane of archaebacteria and in the membranes of mitochondria of mammals 
[141]. 
It is important to note that these “exotic” structures are rarely observed in 
membranes. They are reported in model membranes (liposomes) composed by one 
or two components. Usually, real membranes adopt the lamellar phase. This is a very 
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important point because the majority of lipids are not cylindrical. Thus, it seems that 
cylindrical lipids have a strong influence on the final structure adopted by 
membranes. A clear example is the inner membrane of bacteria. As stated in the 
section 2.4, it is composed by PEs, PGs and CLs [12]. The major component (up to 
80%) is the truncated cone PE, instead the cylindrical lipid PG is the minor 
constituent. Despite of this, the membrane of bacteria adopts a lamellar structure. 
 
2.7 Lamellar States and Phase Transitions 
 
As stated in the previous section, membranes exist in the so-called lamellar phase. 
Inside this phase, different physical states can be adopted depending on the chemical 
structure, temperature and medium conditions (pH and ionic strength). These 
parameters determine how lipids interact to each other. 
Basically, the membrane can exist in two distinct lamellar phases: the gel phase and 
the liquid crystalline phase (Lα). In the gel phase, the hydrocarbon chains are in their 
extended conformation (all-trans). The acyl chains can be tilted (Lβ’) or not (Lβ) 
respect to the bilayer plane. In this way they tightly interact to each other forming a 
compact bilayer. The gel phase is characterized by: 
 
 Low fluidity; 
 High degree of order; 
 Relative impermeability; 
 High bilayer thickness. 
 
In the Lα phase, the hydrocarbon chains are not in the all-trans conformation, but 
they assume a gauche conformation. This leads to a less packed bilayer. Thus, the 
liquid phase is characterized by: 
 
 High fluidity; 
 Low degree of order; 
 Relative permeability; 
 Low bilayer thickness. 
 
It is important to give an exact definition of terms fluidity and order. The term 
“fluidity” refers to the motion of lipid in the bilayer plane. The term “order” refers 
to the relative amount of trans/gauche conformers in the acyl chains [102]. The 
amount of trans conformers is higher in an ordered bilayer. In Fig. 2.20 are reported 





Fig. 2.20 Schematic representation of a lipid bilayer in the gel phase with tilted hydrocarbon chains 
(Lβ’), gel phase with no tilted chains (Lβ) and liquid crystalline phase (Lα). Adapted from [102]. 
 
Other phases are possible. One of these is the rippled gel phase (Pβ’) in which the 
bilayer surface is not flat, but it is undulated [148]. The lipid chains are in the all-
trans conformation, as in the gel phase. The Pβ’ does not exist for all lipids, but it is 
characteristic of some saturated lipids, as DPPC and DMPC [148]. A schematic 
representation of the rippled gel phase is reported in Fig. 2.21. 
 
 
Fig. 2.21 The rippled gel phase (Pβ’). Adapted from [102]. 
 
It is not known if Pβ’ phase has a biological role. This is because the addition of other 
lipids eliminates it. Thus, it is difficult to detect in real membranes. Another 
important lamellar phase is represented by the liquid ordered phase (Lo) [149,150]. 
This phase is observed in the presence of Chol (e.g. lipid rafts). The Lo phase has 
property in between the gel and liquid crystalline phases. In particular, it is 
characterized by: 
 
 A bilayer thicker than the Lα and thinner than the Lβ phases; 
 Higher degree of order compared to Lα, and lower degree or order compared 
to Lβ; 
 Higher mobility (fluidity) of lipids respect to the Lβ and lower mobility 
respect to the Lα; 
 Less permeable and more permeable than the Lα and Lβ, respectively. 
 
All lipid bilayers are characterized by definite melting temperatures at which the 
transition to one phase to another one occurs. The most important melting 
temperature is the temperature at which a bilayer goes from the gel to liquid phase 
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(Tm). As an example, we can consider the thermotropic behavior of liposomes 
composed by only DPPC [102,151]. In Fig. 2.22 are reported the phase transitions 
for this lipid bilayer. 
 
 
Fig. 2.22 The phase transitions in model membranes composed by only DPPC. Lβ’: gel phase with 
tilted hydrocarbon chains, Pβ’: rippled gel phase, Lα: liquid crystalline phase. 
 
In DPPC liposomes, there are two transitions. The first one from the Lβ’ to Pβ’, named 
pre-transition, occurs at about 36 °C. We indicate this temperature as Tp (pre-
transition temperature). As represented in the Fig. 2.22 it is mainly due to the 
rearrangement of polar head groups of lipids. A second transition, from the Pβ’ to Lα, 
occurs in between 41 and 42 °C and it is termed main-transition. This transition is 
the gel-to-liquid phase transition and occurs at the main-transition temperature (Tm). 
It is due to acyl chains melting which go from an all-trans conformation to a gauche 
conformation. 
The temperature at which a bilayer transits from one phase to another is strictly 
dependent on the lipids chemical structure. To be more precisely, it depends on 
length of acyl chains, the nature of polar head group and the presence of unsaturation. 
The melting temperature increases as the acyl chains length increases. This is 
because as the number of C atoms increases, the number of van der Waals 
interactions also increases. For example, DPPC with two acyl chains of 16 C atoms 
has a Tm around 42°C, instead DMPC with two acyl chains of 14 C atoms has a Tm 
about 23 °C [152,153]. 
The melting temperature is inversely related to the number of unsaturation in the 
hydrocarbon chains. More unsaturated a lipid is, lower the Tm is. For example, the 
lipid DSPC (distearoylphosphatidylcholine) with two saturated chains of 18 C atoms 
has a Tm around 58 °C. Conversely, its analog DOPC (dioleoylphosphatidylcholine) 
with two mono unsaturated chains of the same length has a Tm of -22 °C [152,153]. 
This strong temperature decrease is due to the fact that in natural lipids all the 
unsaturations are cis [154]. The cis unsaturation bends the lipid chains that cannot 
pack efficiently. 
Finally, the head group has also an influence on the Tm. As reported above, model 
membranes composed by DPPC have a transition temperature about 42 °C. DPPE 
(dipalmitoylphosphatidylethanolamine), with the same two saturated lipid chains, 
has a transition temperature (for the lamellar gel-to-liquid transition) at 62 °C [155]. 
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Probably this is due to the ability of phosphatidylethanolamine to form 
intermolecular hydrogen bonds that are not possible in cholines. 
It is important to note that transition between lamellar and non-lamellar phases are 
also possible. These can be induced by temperature, pH and ionic strength changes. 
An example of temperature-induced change is represented by saturated PEs (e.g. 
DPPE). Model membranes of DPPE adopt a lamellar gel phase (Lβ) at low 
temperature. On the contrary, at high temperature (about 120 °C) they adopt the 
inverted hexagonal phase (HII) [155]. 
PSs are cylindrical shaped lipids. At pH = 7 they tend to adopt a lamellar phase. 
When the pH is less than 4, they transit to the inverted hexagonal phase [99]. This 
phenomenon is due to the protonation of the carboxyl in the head group which 
reduces its apparent area without affecting the acyl chains. Thus, it seems that 
reducing the pH, PSs become truncated cone lipids. 
An example of ionic strength-induced transition is represented by the case of 
cardiolipins (CLs). When TOLC (1',3'-bis[1,2-dioleoyl-sn-glycero-3-phospho]-
glycerol) molecules are dispersed in water, they form a lamellar structure in the 
liquid crystalline phase. After the addition of NaCl at the concentration of about 3 
M, TOLCs transit to the inverted hexagonal phase [156]. 
 
2.8 Model Membranes: Liposomes 
 
As showed in the previous sections, biological membranes are very complex 
structures. For this reason, a variety of simple model membranes have been 
developed. There are many model membranes such as lipid monolayers [157], 
micelles, bicelles  [158] and supported bilayers [159]. One of the most common used 
models are liposomes.  Liposomes, or lipid vesicles, are colloidal particles formed 
by one or more sphere-shaped lipid bilayer [160]. The lipid bilayer surrounds an 





Fig. 2.23 A representation of a liposome formed by one sphere-shaped bilayer (unilamellar liposome). 
 
Alec Bangham discovered liposomes in 1964 and thus, he can be considered the 
“father of liposomes” [161]. To be more exact, Bangham reported the observation of 
what we call now multilamellar vesicles: liposomes formed by two or more 
concentric lipid bilayer (like an onion). 
Liposomes are multipurpose structures. The most obvious application is as model 
membrane systems. They are very useful in studying: 
 
 the general physical and chemical properties of a bilayer;  
 how two lipids interact to each other in the bilayer (lipids miscibility); 
 the interaction of proteins, peptides and drugs with membranes, highlighting 
the involvement of a particular lipid. 
 
During this PhD thesis, liposomes were employed as a model of eukaryotic and 
bacterial membrane. 
Another important application is as drug delivery systems. Liposomes can 
incapsulate drugs in their inner aqueous core. Moreover, insoluble drugs can be 
dissolved in the hydrophobic core of the membrane. In this way, drugs can reach a 
particular target in the body. The general properties of liposomes such as 
biodegradability, biocompatibility, small size, amphipathic character and low 
toxicity have permitted their application in medicine [162]. 
Liposomes are classified according to their dimensions and lamellarity. Basically, 
there are four different liposome types (Fig.2.24): 
 
 SUVs: Small Unilamellar Vesicles. These liposomes are formed by a single 
lipid bilayer with a diameter smaller than 100 nm; 
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 LUVs: Large Unilamellar Vesicles. Liposomes composed by a single bilayer 
with a diameter ranging from 100 nm to 200 nm; 
 GUVs: Giant Unilamellar Vesicles. Liposomes with a single bilayer of 1-100 
μm; 
 MLVs: MultiLamellar Vesicles. Liposomes composed by two or more 
concentric bilayer with a diameter up to 5000 nm. 
 
 
Fig. 2.24 The different kinds of liposomes. 
 
The preparation of liposomes is a very easy procedure. Lipids are dissolved in 
organic solvent (usually a mixture of chloroform and methanol) and placed in a 
round-bottom flask. The organic solvent is then evaporated under a gentle nitrogen 
gas (to avoid lipid oxidation). During this procedure a thin lipid film is produced. 
The flask is placed under vacuum over night to remove the final traces of organic 
solvent. Finally, the dried lipid film is hydrated with water or buffer at the 
temperature above the Tm. During the hydration, lipid molecules spontaneously 
assembly forming liposomes (see section 2.5 for a description of forces involved in 
lipid self-assembly). What it is produced by this simple protocol are MLVs. 
Unfortunately, MLVs have some disadvantages. They are not uniform in size and 
are formed by concentric bilayers which render them not a perfect membrane model. 
For these reasons, various methodologies were developed to obtain liposomes 
uniform in size and with a single lipid bilayer. 
Small unilamellar vesicles (SUVs) are produced by sonicating a suspension of MLVs 
with a tip sonicator. During this procedure multilamellar aggregates are broken. 
Lipids spontaneously re-assembly producing unilamellar vesicles of the smallest 
diameter (which depends on the lipid composition) [160]. 
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Large unilamellar vesicles (LUVs) are produced again starting from MLVs. But in 
this case, the lipid suspension is forced to pass thorough a polycarbonate filter with 
a specific cut-off (usually 100 nm and 200 nm). This technique is named extrusion 
[163]. 
Finally, giant unilamellar vesicles (GUVs) are produced in a wide variety of 
procedures. The most common one is the electroformation method [164]. In this 
method a deposit of lipids on a metallic plaque is rehydrated and exposed to an AC 
electric field. 
The choice of what kind of liposomes must be used depends on what we are looking 
for and the employed technique. For example, in differential scanning calorimetry 
measurements almost exclusively MLVs are used. This is because, MLVs ensure a 
better peak resolution compared to SUVs and LUVs. In confocal fluorescence 


























Chapter 3  
 
Synthesis, Biological and Biophysical Studies of Unnatural Amino 




The final goal in studying AMPs is their utilization as drugs to fight infections caused 
by bacteria.  To accomplish this issue, it is fundamental to develop a peptide with 
selective toxicity against bacteria, low toxicity towards mammalian cells and 
resistance to proteolysis to increase its half-life [92,165]. The design and synthesis 
on new AMPs could represent a way to overcome these problems. In this frame, the 
introduction of unnatural amino acids in the primary sequence of peptides represents 
a very good strategy rendering AMPs less prone to proteases action, enhancing their 
half-life in serum. Further, the physico-chemical properties of the unnatural amino 
acids can play an important role in determining the peptide selectivity. Usually, an 
optimization procedure is followed, where some residues are replaced by others in 
order to obtain a new selective and resistant peptide. In this context, the physico-
chemical characterization of the new AMPs with model membranes can help in 
revealing the key factors which modulate the antibacterial activity and the 
cytotoxicity. The knowledge of the main factors involved in these aspects represent 
important information which can be used in the peptide optimization process. 
Here, it is reported the design and synthesis of the P9Nal(SS) peptide, and two 
analogs, P9Trp(SS) and P9Nal(SR). Biological assays were performed in order to 
evaluate their antimicrobial activities on bacteria, cytotoxicity and resistance to 
proteolysis. Overall, these data show that the synthetic peptides have a broad 
spectrum of antibacterial activity and that the introduction of unnatural amino acids 
effectively increase their stability in serum. Moreover, low selectivity between 
bacterial and eukaryotic cells was observed. In order to explore the origin of the low 
selectivity, a detailed biophysical characterization of the interaction of P9Nal(SS) 
with liposomes mimicking eukaryotic and cytoplasmic bacterial membrane was also 
carried out. P9Nal(SS) was chosen, among the three peptides, as it possesses the 
broader spectrum of antibacterial activity, higher stability in serum but low 
selectivity.  
The results of biophysical studies on P9Nal(SS) reveal that there is a divergence in 
the action mechanism against the two cell types. In fact, using DPPC/DPPG vesicles 
as a simplified model of the bacterial membrane, P9Nal(SS) peptide interact 
superficially inducing domains formation. Above a threshold concentration, it is able 
to penetrate in the hydrophobic core of the membrane disrupting the lipid packing. 
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On the contrary, for DPPC liposomes mimicking the eukaryotic membrane, only 
surface binding was observed. Thus, the action mechanism responsible for the 
antimicrobial activity could be different to that for the undesired cytotoxicity. 
A further physico-chemical characterization of the interaction of P9Trp(SS) and 
P9Nal(SR) peptides with bacterial model membrane is reported in the chapter 4. A 
comparison among the results obtained for the three peptides revealed important 
differences in their membrane perturbation activities. 
 
3.2 Peptides’ Design 
 
The three new synthetic peptides were designed in collaboration with Prof. E. 
Notomista of the Department of Biology of the University of Naples Federico II and 
synthetized in collaboration with the research group of Prof. A. Lombardi and F. 
Nastri of the Department of Chemical Sciences, University of Naples Federico II. 
All of them contain cationic and hydrophobic residues. The sequence of the three 
peptides are: 
 
1. P9Nal(SS): H-εAhx-Cys(StBu)-Lys-(2Nal)2-Lys-Lys-Cys(StBu)-εAhx-NH2; 
2. P9Trp(SS): H-εAhx-Cys(StBu)-Lys-(Trp)2-Lys-Lys-Cys(StBu)-εAhx-NH2; 
3. P9Nal(SR): H-εAhx-Cys(tBu)-Lys-(2Nal)2-Lys-Lys-Cys(tBu)-εAhx-NH2. 
 
where εAhx is 6-aminohexanoic acid, Cys(StBu) is a cysteine with a disulphide and 
a tert-butyl group, Cys(tBu) is a cysteine with a tert-butyl moiety, 2Nal is 2-naphthyl-
L-alanine, Lys is a lysine and Trp is tryptophan residue. All the three peptides are 
composed by 9 residues and own a net positive charge of 4 at the physiological pH 
of 7.4. The molecular weights of the three peptides are 1405 g/mol, 1382 g/mol and 
1340 g/mol for P9Nal(SS), P9Trp(SS) and P9Nal(SR), respectively. The chemical 




Fig. 3.1 The chemical structure of (top) P9Nal(SS) peptide, (middle) P9Trp(SS) and (bottom) 
P9Nal(SR) peptides. Taken from [93]. 
 
At both the C- and N- termini, εAhx residues were introduced to protect the peptides 
from the action of exopeptidases. Moreover, due to their hydrophobic tail, εAhx 
residues contribute to the overall hydrophobicity. The residue at the C-terminus is 
amidated. Instead, the amino group of the N-terminus of εAhx is not modified and 
provides an additional positive charge. Thus, the three Lys residues and the N-
terminus εAhx account for the peptides’ positive charge. The aromatic residues 
(2Nal and Trp) were introduced to modulate the hydrophobicity. They are in the 
middle of the primary sequences, close to each other in position 4 and 5. It was shown 
that the introduction of these residues increases the antibacterial activity of several 
peptide sequences [166,167]. Finally, modified Cys residues were introduced as it 
was shown [168]. that some AMPs increase their antimicrobial activity upon 
disulphide reduction. To explore the eventual role of disulphide reduction, Cys(StBu) 
and Cys(tBu) residues were introduced in P9Nal(SS) and P9Nal(SR), respectively. 
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3.3 Materials and Methods 
 
Materials. Fmoc protected amino acid and coupling reagents were purchased from 
NovaBiochem and used without further purification. H-PAL Chemmatrix resin was 
from Sigma Aldrich. Peptide synthesis and purification solvents were from Romil 
(Biopure grade). Piperidine and N,N’-diisopropyl ethylamine were from 
NovaBiochem. The fluorescent probe DPH (1,6-Diphenyl-1,3,5-hexatriene) and 
acrylamide solution (40% w/v) were purchased from Sigma Aldrich Chemical. The 
lipids 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dipalmitoyl-sn-
glycero-3-phospho-1′-rac-glycerol (DPPG) and 1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-1′-rac-glycerol (POPG) were purchased from Avanti Polar Lipids Inc. 
(Alabaster, AL, USA) and used without further purifications. 
Deionized water was used for the phosphate buffer and all sample preparations. 
 
Peptide Synthesis. Peptides were synthesized by standard Fastmoc protocols on an 
ABI 433 A automatic peptide synthesizer. Dry H-PAL Chemmatrix resin (0.31 mmol 
g−1 substitution) was weighed to get a 0.25 mmol scale, and manually swelled in N-
Methyl-2-pyrrolidone (NMP). Double coupling steps were performed for the two 
bulky aromatic residues. After the final deprotection step, the resin was washed with 
2-propanol and with methanol and then dried. Cleavage and deprotection was 
performed with 25 mL of a 95:2.5:2.5 trifluoroacetic acid (TFA): tri-isopropyl silane 
(TIS):H2O solution. Cleavage reaction was performed for two hours, the first at 0 °C 
and the second at room temperature under gentle magnetic stirring. The exhaust resin 
was washed three times with fresh TFA and then discarded by filtration. The 
combined filtrates were concentrated in vacuo and the crude peptide precipitated 
with five volumes of diethyl ether. Crude peptide was washed three times with 
diethyl ether to remove the scavenged groups and then dried to get a 44% final yield. 
 
Peptide Purification. Crude peptides were purified by preparative HPLC on a 
Shimadzu LC-8A system. A Vydac C18 column (22 mm × 250 mm; 10 μm) was 
used, eluted with a H2O 0.1% TFA, (eluent A) and CH3CN 0.1% TFA (eluent B) 
linear gradient at 22 mL min−1 flow rate. Fractions were separated according to their 
absorbance at 210 nm by an online UV detector (Shimadzu). Peptide fractions were 
then checked for their purity by analytical LCMS. Peptide identities were confirmed 
by LCMS analysis on a Shimadzu 20ADxr coupled with a Shimadzu ESI-IT-TOF 
mass detector (probe voltage 4.5 kV; probe temperature 25 °C; desolvation 
temperature 250 °C; detector voltage 1.5 kV). All analyses were performed with a 
Vydac C18 column (2.1 mm × 100 mm; 5 μm), eluted with a H2O 0.05% TFA, 
(eluent A) and CH3CN 0.05% TFA (eluent B) linear gradient, from 5% to 95% 
(solvent B), over 30 minutes, at 0.2 ml min−1 flow rate. Pure fractions were pooled 
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and lyophilized as TFA salts (purity >95%). Peptide samples for biological assays 
were further subjected to counter ion exchange on a DEAE-Sephadex weak acidic 
resin. Briefly, peptide solutions in water were loaded on a 0.5 mL syringe column, 
and then eluted by decreasing the pH with an acetate buffer at pH 4.3 to obtain the 
desired peptide acetate salt. Further, the relative hydrophobicities of P9 peptides 
were evaluated through their retention in reverse phase HPLC. 
 
Biological Assays.  
Antimicrobial activity assay (standard condition). The antimicrobial activity of the 
three designed peptides was tested against Escherichia coli (ATCC® 25922™), 
Pseudomonas aeruginosa (ATCC® 27853™), Pseudomonas aeruginosa PAO1 wild 
type strain, Bacillus subtilis subsp. spizizenii (ATCC® 6633™), Staphylococcus 
aureus (ATCC® 6538 P™) and Staphylococcus aureus MRSA (methicillin-resistant 
Staphylococcus aureus) WKZ-2 (kindly provided by collection of Prof. Edwin 
Veldhuizen, University of Utrecht, Holland). MIC assays were performed by broth 
microdilution method [169] using Nutrient Broth (Becton Dickinson Difco, Franklin 
Lakes, NJ) as bacterial growth medium. Recombinant (P)GKY20 peptide [170] was 
used as control antimicrobial peptide. MIC values were measured as the lowest 
concentration at which no visible growth was observed at the end of the incubation 
time. Experiments were performed three times for each peptide. 
 
Antimicrobial activity of peptide pre-incubated in 10% serum. In addition to the 
antimicrobial activity assays, MIC values of the three designed peptides were 
determined against Escherichia coli ATCC 25922, also upon peptides incubation in 
10% serum (fetal bovine serum, Microgem Lab, Cat. S1860, Italy) for 1 hour or 16 
hours at 37 °C (water bath). Following the incubation time, MIC assays were carried 
out as previously described. Recombinant peptides (P)GKY20 and ApoE(133–150) 
and synthetic peptide Ac-ApoE(133–150)-NH2 with acetylated N-terminus and 
amidated C-terminus [170,171] were treated as the three designed peptides and used 
as control antimicrobial peptides. Experiments were performed five times for each 
peptide. 
 
Cytotoxicity Assay. Cytotoxic effects of the three peptides on human epithelial 
colorectal adenocarcinoma cells (CaCo-2) and on aneuploid immortal keratinocyte 
cells line from adult human skin (HaCaT) were assessed by performing the (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction inhibition 
assay [172]. Both human cell lines were obtained from the American Type Culture 
Collection (ATCC, Manassas, VA, USA) and grown at 37 °C in a humidified 
incubator containing 5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum, 4 mM glutamine, 400 units/mL 
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penicillin, and 0.1 mg mL−1 streptomycin. Cells were plated on 96-well plates at a 
density of 5 × 103 per well in 100 μL of medium and incubated at 37 °C with 5% 
CO2. Medium was then replaced with 100 μl of fresh media containing peptide 
solution to a final concentration ranging from 0.1–10 μM/well. After a time of 
incubation ranging from 18 to 48 hours at 37 °C, the peptide-containing medium was 
removed, and 10 μL of a 5 mg mL−1 MTT stock solution in DMEM without red 
phenol, corresponding to a final concentration of 0.5 mg L−1 in DMEM (final volume 
of 100 μL), was added to the cells. After 4 h of incubation, the MTT solution was 
removed and the MTT formazan salts were dissolved in 100 μL of 0.1 N HCl in 
anhydrous isopropanol. Cell survival was reported as the relative absorbance, with 
respect to control, of blue formazan measured at 570 nm with a Synergy Multi Plate 
Reader. Cytotoxicity experiments were performed at least three times independently. 
Standard deviations were always <10% for each experiment. 
 
Liposome Preparation. Lipids were weighted in a glass vial and dissolved in a 
chloroform/methanol mixture (2/1 v/v). A thin film was produced by evaporating the 
organic solvent by gentle dry nitrogen gas. The sample was placed in a vacuum for 
at least 3 h. The dried lipids were then hydrated, in the liquid-crystalline phase at the 
temperature of 50 °C, with an appropriate amount of 20 mM phosphate buffer pH 
7.4, and vigorously vortexed obtaining a suspension of multilamellar vesicles 
(MLVs). Small unilamellar vesicles (SUVs) were obtained using a Sonics VCX130 
tip sonicator until the suspension became transparent (about 20 min, at room 
temperature). Dynamic light scattering (DLS) measurements were used to check the 
size of lipid vesicles after sonication. The obtained average of the hydrodynamic 
radii of SUVs (∼90 nm) are consistent with the formation of unilamellar vesicles. 
SUVs containing the fluorescent probe DPH (1,6-Diphenyl- 1,3,5-hexatriene) were 
obtained by adding to the lipids dissolved in the organic mixture a definite amount 
of a solution of DPH in chloroform at the lipids/DPH mole ratio of 200. Liposomes 
with different composition were prepared: i) DPPC, as a model of eukaryotic 
membrane; ii) DPPC/DPPG (8/2 mol/mol) and DPPC/POPG (8/2 mol/mol) as 
simplified models of bacterial membrane. Samples of liposomes in the presence of 
peptide were prepared by mixing appropriate volumes of peptide in solution and 
liposomes suspension to get the desired lipid-to- peptide (L/P) ratio. 
 
Circular Dichroism (CD). CD spectra of P9Nal(SS) were recorded by using a 
JASCO J-715 spectropolarimeter, from Jasco Corporation (Tokyo, Japan), in a 0.1 
cm path length quartz cuvette as an average of 3 scans. In order to obtain CD spectra 
with the highest signal-to-noise ratio, the following instrument parameters were set 
as suggested in [173]: scan speed of 20 nm/min, 4 s response time and 2 nm 
bandwidth. The temperature was set to 25 °C. Peptide samples were prepared in 20 
53 
 
mM phosphate buffer pH 7.4 at the concentration of 35 μM in absence and in the 
presence of SUVs at total lipid concentration of 0.35 mM, 1.75 mM and 3.5 mM. 
For each sample, a background blank (buffer or lipid suspension alone) was 
subtracted. 
 
Differential Scanning Calorimetry (DSC). DSC measurements were performed 
using a nano-DSC from TA Instruments (New Castle, DE, USA). MLVs were used 
for all DSC experiments since they provide the better resolution of the peak [174]. 
A volume of 300 μL of 0.5 mM vesicles suspension (DPPC, DPPC/DPPG or 
DPPC/POPG) in the absence or in the presence of peptide was placed in the 
calorimetry vessel, and successive heating and cooling scans were performed at 1 
°C/min over the temperature range of 20–55 °C. The excess heat capacity function 
(<ΔCp>) was obtained after baseline subtraction. A buffer-buffer scan was 
subtracted from the sample scan. The samples composed by lipid suspension and 
peptide were prepared before the DSC experiments, by adding the appropriate 
amount of peptide to the lipid suspension and waiting at least 30 min to ensure that 
the equilibrium has been reached. The results presented here all refer to the second 
heating scan. The obtained data were analyzed by means of NanoAnalyze software 
supplied with the instrument and plotted using the Origin software package 
(OriginLab, Northampton, MA, USA). 
 
Steady-state Fluorescence. All the fluorescence experiments were performed using 
a Fluoromax-4 spectrofluorometer (Horiba, Edison, NJ, USA) operating in the 
steady-state mode at the temperature of 25 °C. 
 
Fluorescence anisotropy. Fluorescence anisotropy measurements were carried out 
for the probe DPH embedded into SUVs at total lipid concentration of 150 μM. The 
excitation wavelength was set to 355 nm and the emission was monitored at 427 nm. 
The slits were set to 4 nm for both the excitation and emission monochromators. The 
experiments were performed using a 1 cm path length quartz cuvette. Fluorescence 







where IVV is the fluorescence intensity obtained by setting both the excitation and 
emission polarizers vertically, IVH is the fluorescence intensity obtained by setting 
the excitation polarizer vertically and the emission polarizer horizontally and G is 
the instrument-specific correction factor, which accounts for the difference in the 
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polarizers transmission efficiency of vertically and horizontally polarized light 
[175,176]. 
 
Fluorescence Resonance Energy Transfer (FRET). In the FRET experiments, the 
P9Nal(SS) peptide in solution was excited in the presence of SUVs labeled with 
DPH. The excitation wavelength was set to 277 nm and emission spectra were 
recorded in the range 300–510 nm, using a 1 cm path length quartz cuvette. The slits 
for the excitation and emission monochromators were set to 3 nm and 6 nm, 
respectively. As references the spectra of peptide in buffer or in the presence of 
vesicles without DPH were also collected. From each sample, a blank (vesicles in 
the absence of the peptide or buffer solution) measurement was subtracted. The 
concentration of peptide was fixed at 5 μM and spectra at L/P ratio of 50 were 
recorded. 
 
Fluorescence quenching. For fluorescence quenching experiments, a 7 μM solution 
of peptide, in the absence or in the presence of SUVs at lipid-to-peptide mole ratio 
(L/P) of 100, was placed in a quartz cuvette with a path length of 1 cm and titrated 
with acrylamide solution (40% w/v). The titrations were performed at fixed peptide 
concentration in the absence and presence of acrylamide concentrations up to ~50 
mM. The excitation wavelength was set to 277 nm, and the emission spectra were 
collected from 290 nm to 500 nm. The obtained data were analyzed using the Stern-




= 1 + 𝐾ௌ௏[𝑄] 
 
where F0 is the fluorescence intensity in the absence of the quencher, F is the 
fluorescence intensity at each step of titration in the presence of the quencher, [Q] is 
the concentration of acrylamide. Due to acrylamide absorption at the excitation 
wavelength, the fluorescence intensities were corrected using the formula 𝐹௢௕௦ =
𝐹௖௢௥௥ ∙ 10
షಲ೐ೣ∙೏
మ  where Fobs is the observed intensity, Fcorr is the corrected intensity, 
Aex is the absorbance of acrylamide at the excitation wavelength and d is the cuvette 
path length [177]. 
 
3.4 Results: Biological Study 
 
In order to verify the antimicrobial activity, serum stability and toxicity towards 
eukaryotic cells of the three synthetic peptides, biological assays were performed. 
These experiments were carried out in collaboration with the research groups of Prof. 
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E. Notomista and Prof. E. Pizzo of the Department of Biology at the University of 
Naples Federico II. 
 
3.4.1 Evaluation of Antimicrobial Activity, Serum Stability and Cytotoxicity 
 
The antimicrobial activities were evaluated by determining the MIC values 
(minimum inhibitory concentration, a microbiological parameter that indicate the 
minimum peptide concentration at which bacterial growth is inhibited) against gram-
negative and gram-positive bacterial strains and are collected in Table 1.  
 
Table 1 The antibacterial activity of the three peptides against gram-negative and -positive bacteria. 
The activities are expressed as minimum inhibitory concentration (MIC, in µM). 
Peptide Gram-negative   Gram-positive   












(P)GKY20 10 20 20 20 80 5 
P9Nal(SS) 10 2.5 10 10 20 10 
P9Trp(SS) 10 2.5 10 40 40 20 
P9Nal(SR) 10 1.25 10 40 40 40 
 
As control, (P)GKY20 peptide, derived from the C-terminal region of human 
thrombin was used [178]. This peptide is composed only by natural amino acids and 
the termini are not protected. As demonstrated in Table 1, the three peptides are 
active against both kinds of bacteria, showing activities similar to those of the control 
peptide. The MIC values are in the range 1.25-10 µM for gram-negative bacteria, 
instead are in the range of 10-40 µM for gram-positive bacteria. Thus, the peptides 
are a little bit more effective against gram-negative bacteria. Among the three 
peptides, P9Nal(SS) has a broader spectrum of activity. In fact, for gram-positive 
bacteria, its MIC values are lower compared to those obtained for P9Trp(SS) and 
P9Nal(SR). 
In P9Nal(SS) and P9Nal(SR), the residues Cys(StBu) and Cys(tBu) were introduced, 
respectively, in order to explore the eventual role of disulphide reduction [168]. 
Since the two peptides exhibit the same activity against gram-negative bacteria, it 
seems that the disulphide reduction process does not play a significant role in 
determining their antimicrobial activity. 
In Table 2 are reported the MIC values obtained for peptides pre-incubated in 10% 





Table 2 The antibacterial activity of the three peptides against Escherichia coli ATCC 25922 after 
pre-incubation in 10% serum for 1 hour and 16 hours. The activities are expressed as minimum 
inhibitory concentration (MIC, in µM). 




(P)GKY20 10 10 >80 1 >8 
ApoE(133-150) 5 >80 >80 >16 >16 
Ac-ApoE(133-150)-NH2 5 20 >80 4 >16 
P9Nal(SS) 10 10 40 1 4 
P9Trp(SS) 10 10 80 1 8 
P9Nal(SR) 10 10 >80 1 >8 
a P.I. = pre-incubation; b,c the fold change is the ratio between the MIC value obtained after pre-
incubation for 1 hour (or 16 hours) and the MIC value for the not incubated peptide. 
 
As control, (P)GKY20 and ApoE(133-150) with free termini were used. In addition 
a version of ApoE(133-150), named Ac-ApoE(133-150)-NH2, with acetylated N-
terminus and amidated C-terminus was employed. ApoE(133-150) is a natural-
containing amino acids peptide derived from the receptor binding region of the 
human apolipoprotein E. The data reported in Table 2 indicated that the three 
synthetic peptide and (P)GKY20 did not change their potency after 1-hour 
incubation in 10% serum, i.e. no change in MICs. On the contrary, the unprotected 
termini ApoE peptide completely lost its antimicrobial activity (MIC > 80 µM) and 
the Ac-ApoE(133-150)-NH2 showed a fourfold increase in its MIC value. After 16 
hours of incubation in 10% serum, all the control peptides and P9Nal(SR) lost their 
antimicrobial activities. On the other hand, P9Nal(SS) and P9Trp(SS) showed a 
fourfold and eightfold increase in their MIC values, respectively. These important 
results revealed that the contemporary presence of 2Nal and Cys(StBu) contribute to 
the resistance to proteases present in the serum. 
In Fig. 3.2 are summarized the results obtained for the evaluation of toxicity of the 
three peptides towards two eukaryotic cell lines: human epithelial colorectal 
adenocarcinoma cells (CaCo-2) and aneuploid immortal keratinocyte cells (HaCaT). 
The experiments were performed by increasing peptides concentration from 0.1 µM 





Fig. 3.2 Toxicity MTT assay for the three synthetic peptides on HaCaT and CaCo-2 cells. Color 
legend: black = control, dark grey = 0.1 µM peptide, grey = 1 µM peptide, white = 10 µM peptide. 
 
The obtained results showed that both P9Nal(SS) and P9Trp(SS) have an effect on 
both cell lines and that this effect is dose-dependent. In fact, by increasing their 
concentration a higher cell mortality was observed. Moreover, it seems that 
P9Nal(SS) is slightly more toxic than P9Trp(SS). In contrast, P9Nal(SR) has no toxic 
effects on HaCaT cells at low doses (0.1 and 1 µM). On the contrary, its effect is 
slightly higher on CaCo-2 cells at the same doses. Its effect on CaCo-2 further 
increases at 10 µM. 
As described in the section 1.2, several factors modulate the AMPs biological 
activity. One of these parameters is represented by hydrophobicity [12]. Thus, the 
relative hydrophobicities of the three peptides were evaluated through their retention 




Fig. 3.3 Analytical RP-HPLC chromatograms collected at 280 nm upon injections of P9-Nal(SS) 
(black line), P9-Nal(SR) (pink line) and P9-Trp(SS) (blue line). 
 
As evidenced in Fig. 3.3, among the three peptides, P9Nal(SS) is the most 
hydrophobic. P9Nal(SR) seems a little bit more hydrophobic than P9Trp(SS). 
However, they have comparable hydrophobicities. These results well correlate with 
the observed higher cytotoxicity (section 1.2) and higher activity of P9Nal(SS) 
against gram-positive bacteria. In fact, it was demonstrated that an increase of 
hydrophobicity increases the activity against gram-positive bacteria but has only 
limited effect against gram-negative bacteria [179]. 
 
3.5 Results: Biophysical Study of the Interaction of the P9Nal(SS) Peptide with 
Model Membranes 
 
In order to clarify the action mechanism underlying the antimicrobial and cytotoxic 
activity of P9Nal(SS), a physico-chemical characterization of the interaction of this 
peptide with model membranes mimicking eukaryotic and bacterial membranes was 
carried out. Particularly, DPPC and DPPC/DPPG (8/2 mol/mol) vesicles were used 
as simplified models of eukaryotic and bacterial cytoplasmic membrane, 
respectively. P9Nal(SS) was chosen, among the three peptides, as it possesses the 
broader spectrum of antibacterial activity, higher stability in serum and it’s toxic to 
both eukaryotic cell lines. A further physico-chemical characterization of the 
interaction of the other two peptides (P9Trp(SS) and P9Nal(SS) peptides) with 
bacterial model membrane is reported in chapter 4. 
 
3.5.1 The Conformation of P9Nal(SS) Peptide 
 
Circular dichroism (CD) spectroscopy is a powerful technique that can give 
information about the secondary structure of peptide and proteins [173]. Thus, CD 
spectroscopy in the far-UV region of the spectrum was employed to characterize the 
conformational behavior of P9Nal(SS). In Fig. 3.4 are reported the CD spectra of 
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peptide in solution and in the presence of small unilamellar vesicles (SUVs) of DPPC 
and DPPC/DPPG at L/P of 10, 50 and 100. 
 
 
Fig. 3.4 CD spectra of P9Nal(SS) in 20 mM phosphate buffer, pH 7.4 (black line) and in the presence 
of (A) DPPC and (B) DPPC/DPPG small unilamellar vesicles at L/P of 10 (red), 50 (green) and 100 
(blue). 
 
In solution, the spectrum of peptide is characterized by the presence of a positive 
band at about 230 nm and a negative band at about 203 nm, indicating that P9Nal(SS) 
adopts a random structure. In the presence of SUVs, both DPPC and DPPC/DPPG, 
P9Nal(SS) changes significantly its conformation, demonstrating that the peptide can 
bind to both model membranes. In fact, it was observed an intensity increase of the 
positive band around 230 nm coupled with the appearance of two minima at about 
222 nm and 207 nm. Moreover, at L/P 50 and 100 a positive band at about 190 nm 
also appears. These observations suggest that the peptide approaches a helix-like 
conformation in the presence of both model membranes. 
It is known that in the region 220-240 nm, aromatic residues contribute to the 
recorded spectrum [180,181]. Thus, the positive band is probably due to contribution 
of aromatic residues (2Nal) in the primary sequence. This is confirmed by the 
comparison of CD spectra of P9Nal(SS) to those of P9Trp(SS) and P9Nal(SR) (Fig. 
3.5). In fact, the positive band is present in 2Nal containing peptides and it is absent 




Fig. 3.5 The CD spectra of (black line) P9Nal(SS), (red line) P9Trp(SS) and (green line) P9Nal(SR) 
in 20 mM phosphate buffer, pH 7.4. The temperature was set to 25 °C. 
 
The positive band at 230 nm and its increase in the presence of lipid vesicles could 
be attributed to the exciton effect. Since the 2Nal residues are very close to each 
other (position 4 and 5), an interaction between their excited states contribute to the 
observed spectrum [182,183]. Upon binding to lipid vesicles, the interaction between 
2Nal residues is stronger than in the absence of liposomes, which account for the 
observed intensity increase of the positive band. This effect leads to the splitting of 
the excited state in two components opposite in signs. In this case, a positive band at 
230 nm and a negative one at around 220 nm (positive couplet) was observed. Thus, 
upon the interaction with lipid vesicles, the peptide adopts a helical conformation 
where the negative band, typical of the α-helix at around 222 nm sums to negative 
band due to positive couplet. The result is that the minimum at around 220 nm is 
more intense than the minimum at 207 nm. 
 
3.5.2 The Effect of P9Nal(SS) on Bilayer Stability 
 
Since many AMPs carry out their activity through a destabilization of the lipid 
bilayer, differential scanning calorimetry (DSC) measurements on DPPC and 
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DPPC/DPPG multilamellar vesicles were performed. The DSC thermograms of 
DPPC and DPPC/DPPG (Fig. 3.6) vesicles in absence of peptide are very similar and 
characterized by two well defined transition [151,184]. The first one is the transition 
from the lamellar gel phase to rippled gel phase which occurs at about 36 °C. It is 
named pre-transition and it is due to a rearrangement of polar head groups. The 
second one is a transition from the rippled gel phase to liquid phase at about 42 °C. 
It is named main transition and it is due to the melting of hydrocarbon chains of 
lipids. Thus, DSC offers the opportunity to investigate the thermotropic properties 
of two distinct regions of lipid bilayer (surface and hydrophobic core) and the effect 
of peptide on them. In Fig. 3.6 are reported the DSC curves of DPPC and 
DPPC/DPPG vesicles on increasing peptide concentration. 
 
 
Fig. 3.6 The DSC thermograms of (A) DPPC and (B) DPPC/DPPG MLVs at the reported lipid-to-
peptide (L/P) ratio. The inserts show an enlargement of the pretransition peaks. 
 
As Fig. 3.6(A) shows, P9Nal(SS) has a very small effect on the thermotropic 
properties of DPPC liposomes suggesting that the peptide interacts with the DPPC 
bilayer only at the surface level and does not perturb significantly the lipid 
organization in the membrane. On the contrary, the peptide shows a strong effect on 
DPPC/DPPG liposomes, as indicated by modifications of both pre-transition and 
main transition peaks reported in Fig. 3.6(B). In particular, the peptide is able to 
modify the pre-transition peak even at low concentration (high L/P). By increasing 
peptide concentration, the enthalpy change for the pre-transition decreases and the 
peak is shifted at higher temperature. For the main transition, a different result was 
obtained. The peptide doesn’t affect this transition until L/P = 50, at L/P = 25 a slight 
a modification of the peak was observed and at L/P = 10 a drastic change occurred. 
These observations suggest that the P9Nal(SS) activity on DPPC/DPPG liposomes 
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depends on its concentration. In fact, at low peptide concentration, the interaction 
takes place at the membrane surface, as demonstrated by the perturbation of pre-
transition only. At high peptide concentration, the peptide penetrates inside the 
hydrophobic core disrupting the regular packing of lipid acyl chains (as 
demonstrated by the dramatic change in the main transition). At L/P = 10, the peptide 
is able also to perturb the lipid distribution inducing the formation of domains with 
different lipid compositions. This is well demonstrated by the multicomponent DSC 
thermogram [185] obtained at this lipid-to-peptide ratio (see section 3.5.3). 
To get further insight into the effect of peptide on the stability of lipid bilayer, 
fluorescence anisotropy measurements were performed on vesicles labeled with 
diphenylhexatriene (DPH) [186,187]. DPH is a very poor-soluble water fluorescent 
molecule that preferentially partitioning inside the hydrophobic core of lipid bilayer 
[175]. Measuring its anisotropy values can give information about the micro-
viscosity of the membrane (that in turn, depends on lipid acyl chains packing) and 
the effect of the peptide on it. In Fig. 3.7 the anisotropy values (r) of DPH embedded 
in DPPC and DPPC/DPPG SUVs are reported as function of peptide concentration. 
For DPPC liposomes, the anisotropy values do not change upon addition of peptide, 
even at high concentration. These results suggest that no penetration in the 
hydrophobic core occurs, in good agreement with DSC results. For DPPC/DPPG 
vesicles, the anisotropy remains roughly constant up to L/P = 50 and decreases by 
increasing peptide concentration (L/P < 50). These results support the idea that 
P9Nal(SS) is able to penetrate inside the membrane perturbing the lipid acyl chains 





Fig. 3.7 Fluorescence anisotropy for DPH embedded in DPPC (black squares) and DPPC/DPPG (red 
circles) unilamellar vesicles as a function of P9Nal(SS) concentration. The experiments were carried 
out in 20 mM phosphate buffer, pH 7.4 at the temperature of 25 °C. 
 
3.5.3 P9Nal(SS) Induces the Formation of Lipid Domains 
 
As stated in the previous section, the DSC thermogram of DPPC/DPPG vesicles at 
L/P = 10 is composed by a multicomponent peak which indicates a possible 
formation of domains promoted by the peptide. Most likely, the domain formation is 
triggered by the preferential interaction of positively charged peptide with the 
anionic (DPPG) component of the membrane. However, this preferential interaction 
cannot unambiguously proved by using DPPC/DPPG mixture. This is because, 
bilayer composed by pure DPPC and pure DPPG have similar transition 
temperatures [153]. Consequentially, to verify the domains formation hypothesis, a 
strategy which involves the utilization of two lipids with very different melting 
temperatures was followed [188]. Thus, the DSC experiment was repeated by 
replacing DPPG with POPG producing model membrane composed by DPPC/POPG 
(8/2 mol/mol). This replacement has several advantages: i) at the mole fraction used, 
the two lipids are completely miscible [189]; ii) the melting temperature of pure 
POPG vesicles is below 0 °C and, thus, it can affect the observed phase transition of 
DPPC indirectly, by changing its local distribution. If the added peptide 
preferentially interacts with the low-melting component of the membrane (POPG), 
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it will promote its segregation leaving the rest of the membrane enriched in the high-
melting component (DPPC), which melts at higher temperature. The DSC 
thermogram of DPPC/POPG multilamellar vesicles has the gel-to-liquid phase 
transition temperature centered at about 35.9 °C (Fig. 3.8). Upon the addition of 
P9Nal(SS) at L/P = 50, the DSC peak appears sharper than in the absence of the 
peptide (i.e. the transition is more cooperative) and the transition temperature shifts 
to higher values (at about 36.5 °C). This result strongly suggests that the peptide 
preferentially interacts with POPG molecules inducing a lipid segregation that leads 
to the formation of a more DPPC-rich domain, which melts at higher temperature. 
 
 
Fig. 3.8 The DSC thermogram of DPPC/POPG vesicles in the absence (black line) and in the presence 
of P9Nal(SS) (red line) at L/P = 50. 
 
3.5.4 P9Nal(SS) Inserts in the Hydrophobic Core of Bacterial-like Membranes 
but not in the Eukaryotic Model Membranes 
 
The fluorescence emission spectrum of P9Nal(SS) peptide, due to the two aromatic 
2-naphthyl-L-alanine residues, is superimposable to the absorption spectrum of DPH 
in the liposomes. Thus, peptide and DPH can act as donor-acceptor pair in a 
fluorescence resonance energy transfer (FRET) experiment and they can be used to 
further characterize the peptide-lipid interaction process [187]. FRET experiment 
was carried out by exciting the peptide at λex = 277 nm and recording the fluorescence 
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emission up to 510 nm, including the region of emission of DPH probe. In Fig. 3.9 
are reported the emission spectra of peptide and DPH embedded in DPPC and 
DPPC/DPPG vesicles, at the lipid-to-peptide ratio of 50. As a reference, the emission 
spectra of peptide in buffer and in the presence of vesicles without DPH have been 
reported. 
 
Fig. 3.9 Fluorescence emission spectra of P9Nal(SS) and DPH embedded in DPPC (black line) and 
DPPC/DPPG (blue line) SUVs at L/P = 50. As references, the emission spectra of the peptide in buffer 
(black dashed line) and in the presence of DPPC (red line) and DPPC/DPPG (green line) without 
DPH are also reported. 
 
The fluorescence emission spectrum of P9Nal(SS) peptide has a maximum centered 
at about 337 nm. Upon the addition of lipid vesicles without DPH, the fluorescence 
intensity increases, confirming that the peptide is able to interact with both the 
membranes. The fluorescence increase observed in the presence of DPPC/DPPG is 
about twofold higher respect to the increase observed with DPPC vesicles. Finally, 
the shift of the λmax observed for many fluorophores (e.g. Trp) going from to polar 
to a more apolar environment was not detected for 2Nal. This is because, being a 
apolar probe, its spectrum is insensitive to the environment polarity. Surprisingly, 
when DPH was added to lipid vesicles, FRET emission in the range 400-510 nm, 
coupled with a decrease of emission from the peptide, was observed only for 
DPPC/DPPG liposomes. These results can be rationalize considering the factors 
affecting FRET [175]. Briefly, the occurrence of FRET between a donor (D) and an 
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acceptor (A) depends on three parameters: i) the overlap integral, J(λ), i.e. 
superposition of the emission spectrum of D and absorption spectrum of A; ii) 
distance (d) between D and A and iii) the relative orientation (κ2) between them. For 
the two lipid systems, factors i) and ii) should be very similar. Thus, the observed 
difference could be mainly attributed to the relative orientation between peptide 
fluorophores and DPH. For DPPC, the lack of FRET suggests that the orientation 
factor approaches zero, indicating that the 2Nal residues are perpendicular to DPH. 
This view is consistent with a binding of the peptide on the membrane surface, 
resulting in the 2Nal residues parallel to the vesicles surface. For DPPC/DPPG, the 
orientation factor is not zero. This result is consistent for a peptide insertion into the 
bilayer where the 2Nal residues assume an orientation not perpendicular to the DPH 
molecules. 
To get further insight on the degree of insertion of peptide inside the lipid bilayer, 
fluorescence quenching experiment were performed. Fluorescence emission spectra 
of peptide in buffer or in the presence of DPPC or DPPC/DPPG at L/P = 100 were 
recorded at different acrylamide concentrations. According to the equation reported 
in “Fluorescence quenching” section, a plot of F0/F versus acrylamide concentration 
gives a straight line whose slope is the Stern-Volmer constant, indicated as KSV. The 
value of KSV is an index of the degree of exposure to the aqueous solvent of the two 
fluorophores in the primary sequence of the peptide [175,190]. A more exposed 
residue will be more quenched respect to a less exposed one. In the first case, the 
value of KSV will be greater than the value obtained in the second case. The Stern-
Volmer plots obtained from the acrylamide quenching of P9Nal(SS) peptide in 





Fig. 3.10 Stern-Volmer plots for acrylamide-induced fluorescence quenching of a solution of 
P9Nal(SS) peptide in buffer (black squares), in the presence of SUVs at L/P = 100 composed by 
DPPC (red circles) and DPPC/DPPG (blue triangles). The experiments were carried out in 20 mM 
phosphate buffer, pH 7.4 at the temperature of 25 °C. 
 
For the peptide in buffer, it was obtained the highest value of KSV (16.9±0.4 M-1). 
This is because of the complete exposure of 2Nal residues to the aqueous solvent. In 
the presence of DPPC liposomes, a value of KSV of 8.0±0.5 M-1 was obtained. This 
result suggests that a reduced exposure to the solvent occurred upon interaction with 
the membrane. Finally, in the presence of DPPC/DPPG liposomes, a further decrease 
of KSV was observed (3.1±0.4 M-1) suggesting that the peptide is inserted inside the 
membrane. These results are in good agreement with the FRET data, and support the 




Antimicrobial peptides are a class of peptide-based antibiotics. They are promising 
candidates as drugs of the future that can face the problem of antibiotic resistance in 
bacteria [191]. In order to obtain antimicrobial sequences suitable for medical 
applications, it’s mandatory to develop peptides with a selective toxicity and 
resistance to proteolysis [165]. In fact, AMPs applications are seriously limited by 
their sensitivity to proteases which leads to a reduced peptides’ half-life [92]. Several 
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strategies can be followed, as protecting the N- and C- termini or introducing D- and 
unnatural amino acids [179,192]. The three peptides, here reported, were designed 
in order to mimic the antibacterial activity of natural AMPs. Unnatural amino acids 
in the primary sequence were introduced to increase peptides stability towards 
proteases. In this way, pharmacologically improved drugs with increased activity 
and half-life can be obtained. 
The performed biological assays clearly showed that the synthetic peptides are more 
stable respect to the control peptides, which contain natural amino acids. Among the 
three P9 peptides, P9Nal(SR) lost completely its activity after 16 hours of incubation 
in serum. On the other hand, after 16 hours of incubation in serum, P9Nal(SS) and 
P9Trp(SS) were still active, with a MIC values of 40µM and 80 µM, respectively. 
These results suggest that the combination of 2Nal and Cys(StBu) residues are more 
effective in protecting against proteases respect to Trp and Cys(tBu). Several other 
factors as hydrophobicity modulate AMPs selectivity and consequentially toxicity 
[12,193]. For this reason, the relative hydrophobicities of the three peptides were 
evaluated (Fig. 3.3). Among the three peptides, P9Nal(SS) is the most hydrophobic. 
P9Nal(SR) seems a little bit more hydrophobic than P9Trp(SS). However, they have 
comparable hydrophobicities. These results well correlate with the observed higher 
activity of P9Nal(SS) against gram-positive bacteria (Table 1). In fact, previous 
studies [179] reported that an increase of hydrophobicity increases the activity 
against gram-positive bacteria but has only limited effect against gram-negative 
bacteria. Moreover, P9Nal(SS) showed the highest activity after 16 hours of 
incubation in serum (Table 2). Therefore, the higher antimicrobial activity of 
P9Nal(SS) could be related to its lower sensitivity to proteases action and higher 
hydrophobicity. The MTT assays, employed to evaluate the cytotoxic effect, showed 
that the three peptides exert significant dose dependent effects on two human cell 
lines (Fig. 3.2). In particular, P9Nal(SS) showed the highest toxicity. On the 
contrary, P9Nal(SR) showed a lower toxicity respect to the other two peptides, 
especially against HaCaT cells. The higher cytotoxicity of P9Nal(SS) could be 
attributed to its higher hydrophobicity and good resistance to proteases. The 
P9Nal(SR) is less toxic than the P9Trp(SS), despite the similar hydrophobicities. 
This observation could be attributed to the faster degradation of P9Nal(SR) respect 
to P9Trp(SS) when incubated in serum (Table 2). 
Collectively, the biological results indicated that the design of these new peptides 
have been partially successful. In fact, the peptides are effectively stable but, 
unfortunately, they are not selective. Hence, they are not suited for a pharmacological 
application. However, it remains open the possibility in the future to slightly modify 
the peptides to improve their selectivity. In the literature, there are several examples 
where cytotoxic peptides were converted in selective AMPs [194–196]. For example, 
it was demonstrated that the introduction of positively charged residues at 
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polar/apolar interface in piscidins may control the peptide insertion in the eukaryotic 
membrane and hence the cytotoxicity [197]. Thus, a toxic peptide can be a good 
starting point for a further design for obtaining a less cytotoxic sequence. To more 
rationally plan future modifications, biophysical studies on the peptide-lipid 
interaction mechanism were carried out. In particular, P9Nal(SS) peptide was 
chosen, since it possess the broader spectrum of activity, higher stability in serum 
and it’s toxic against both eukaryotic cell lines. The interaction process of this 
peptide was performed with DPPC and DPPC/DPPG (8/2 mol/mol) vesicles, as 
simplified models of eukaryotic and bacterial membrane, respectively. The final 
intent was to clarify the action mechanisms underlying its antimicrobial and 
cytotoxic activity. 
The CD spectra reported in Fig. 3.4 clearly indicate that P9Nal(SS) changes its 
conformation upon binding to both model membranes, approaching a helix-like 
conformation. It is known that the membrane perturbation activity of some AMPs is 
related to the ability to adopt a helical conformation [29]. In this regard, these results 
well correlate with the observed low selectivity. However, the effect of the 
P9Nal(SS) on the thermotropic properties of the two membranes, as measured by 
DSC, is completely different. Particularly, the P9Nal(SS) is not able to perturb the 
lipid packing of the DPPC bilayer and cannot penetrate in the membrane 
hydrophobic core. In contrast, DSC experiments reveal that P9Nal(SS) strongly 
perturbs DPPC/DPPG liposomes in a concentration dependent manner. In fact, at 
low L/P only the pre-transition is affected suggesting that the peptide binding at the 
lipid head groups/water interface. Increasing its concentration, the peptide is able to 
penetrate inside the membrane disrupting the regular lipids packing. Moreover, as 
evidenced by the multicomponent DSC peak at L/P = 10 (Fig. 3.6,B) P9Nal(SS) 
perturbs the lipid distribution in the membrane inducing the formation of domains of 
different lipid compositions. Most likely, the lipid segregation is due to the 
preferential interaction of the cationic peptide with negatively charged lipids. This 
phenomenon was already observed for other AMPs [12,86,88,198]. To strongly 
support this hypothesis, the DSC experiment was repeated by replacing DPPG with 
POPG in the mixed vesicles (Fig. 3.8). The obtained result supports the idea that the 
peptide prefers to interact with POPG lipids inducing a lipid segregation that leads 
to the formation of DPPC-rich domains that melts more cooperatively and at higher 
temperature. This aspect could be crucial since the interface among domains can act 
as defects destabilizing the bilayer [12,87,199,200] facilitating the peptide insertion 
in the membrane. 
The ability of peptide to penetrate in DPPC/DPPG membrane but not in DPPC 
membrane was further demonstrated by several experiments. The results obtained in 
FRET (Fig. 3.9) and quenching (Fig. 3.10) experiments are compatible with a peptide 
localization on the surface of DPPC vesicles and a penetration of the peptide inside 
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DPPC/DPPG vesicles. Fluorescence anisotropy is a powerful method to follow the 
lipid packing perturbation upon peptide insertion in the membrane hydrophobic core. 
The experiments reported in Fig. 3.7 clearly demonstrated that P9Nal(SS) doesn’t 
affect the anisotropy values for DPH embedded in DPPC vesicles. On the contrary, 
it drastically affects the anisotropy for DPH in DPPC/DPPG vesicles. It’s interesting 
to note that, as for DSC results, the P9Nal(SS) affects the anisotropy values only 
after a threshold concentration. A threshold concentration (see also section 1.4) is 
always required for membrane disruption, regardless of the action mechanism 
[28,201] and it seems a pre-requisite for all AMPs to exert their biological activity 
[12]. 
To conclude, overall the reported data are consistent with a concentration dependent 
membrane perturbation mechanism for P9Nal(SS) interacting with bacterial model 
membrane. In particular, the peptide interacts on the membrane surface inducing 
anionic lipid segregation. Above a threshold L/P value, the peptide penetrates deeply 
in the hydrophobic core perturbing the packing among lipid acyl chains. On the other 
hand, the binding of peptide with DPPC liposomes is only superficially. In fact, 
P9Nal(SS) is not able to perturb the membrane even at low L/P ratios. Thus, the 
mechanisms responsible for antimicrobial activity could be different to that 






























In this chapter, the biophysical characterization of the interaction of two P9Nal(SS)-
derived peptides, named P9Trp(SS) and P9Nal(SR), with liposomes composed by 
DPPC/DPPG (8/2 mol/mol) as simplified model of the cytoplasmic bacterial 
membrane is reported.  
In the previous chapter, it was shown that the P9Nal(SS) peptide is able to strongly 
perturb the bacterial model membrane inducing lipid domains formation and 
penetrating in the hydrophobic core of the membrane disrupting the regular lipid 
packing. As demonstrated by retention of peptides in reverse phase HPLC 
experiment (Fig. 3.3), the two peptides are less hydrophobic respect to P9Nal(SS) 
and they have comparable hydrophobicities. It is well known that the replacement of 
some residues with ones which decrease the total peptides’ hydrophobicity can affect 
the biological activities [12]. Thus, the final goal of these studies was to verify the 
effect of the overall hydrophobicity on the peptide membranotropic activity. 
Following, are reported the sequences of the three peptides, highlighting the changes 
compared to the parent peptide (i.e. P9Nal(SS)): 
 
1. P9Nal(SS): H-εAhx-Cys(StBu)-Lys-(2Nal)2-Lys-Lys-Cys(StBu)-εAhx-NH2; 
2. P9Trp(SS): H-εAhx-Cys(StBu)-Lys-(Trp)2-Lys-Lys-Cys(StBu)-εAhx-NH2; 
3. P9Nal(SR): H-εAhx-Cys(tBu)-Lys-(2Nal)2-Lys-Lys-Cys(tBu)-εAhx-NH2. 
 
P9Trp(SS) was obtained by replacing the two 2Nal residues with the less 
hydrophobic Trp residues. Instead, P9Nal(SR) was obtained from the substitution of 
the two Cys(StBu), in position 2 and 8, with Cys(tBu). Cys(StBu) residue is a cysteine 
with a disulphide and a tert-butyl group, while Cys(tBu) is a cysteine with a tert-butyl 
moiety without a disulphide.  
The obtained data reveals important similarities and differences on the interaction 
with cytoplasmic bacterial model membrane between the two peptides and with the 
parent peptide P9Nal(SS). The three peptides act through the same general action 
mechanism which involves peptides absorption on membrane surface, 
conformational changes and formation of lipid domains. Upon reaching a threshold 
L/P value, the peptides insert in the bilayer at different levels perturbing, or not, the 
regular lipid packing. The collected data suggest that the penetration abilities follow 
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the order: P9Nal(SS) >> P9Nal(SR) ≥ P9Trp(SS) which correlate with peptides’ 
hydrophobicity. It seems that the partition inside the membrane is not fundamental 
in destabilizing the membrane, since all the peptides have similar activities against 
gram-negative bacteria [93]. Rather, the formation of lipid domains is the key step 
in promoting membrane perturbation. Overall, these results could represent an 
important contribution in understanding the action mechanism of AMPs and for the 
development of new peptide-based drugs for biomedical application. 
 
4.2 Materials and Methods 
 
Materials. The lipids 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-
dipalmitoyl-sn-glycero-3-phospho-1′-rac-glycerol (DPPG) and 1-palmitoyl-2-
oleoyl-sn-glycero-3-phospho-1′-rac-glycerol (POPG) were purchased from Avanti 
Polar Lipids Inc. (Alabaster, AL, USA) and used without further purifications. The 
fluorescent probe DPH (1,6-Diphenyl-1,3,5-hexatriene) and acrylamide solution 
(40% w/v) were purchased from Sigma Aldrich Chemical. A 20 mM phosphate 
buffer, pH 7.4 prepared with deionized water was used for all the reported 
experiments.  
 
Liposome Preparation. Lipids were weighted in a glass vial and dissolved in a 
chloroform/methanol mixture (2/1 v/v). A thin film was produced by evaporating the 
organic solvent by gentle dry nitrogen gas. The sample was placed in a vacuum for 
at least 3 h. The dried lipids were then hydrated, in the liquid-crystalline phase at the 
temperature of 50 °C, with an appropriate amount of 20 mM phosphate buffer pH 
7.4, and vigorously vortexed obtaining a suspension of multilamellar vesicles 
(MLVs). Small unilamellar vesicles (SUVs) were obtained using Sonics VCX130 
tip sonicator until the suspension became transparent (about 20 min, at room 
temperature). Dynamic light scattering (DLS) measurements were used to check the 
size of lipid vesicles after sonication. The obtained average of the hydrodynamic 
radii of SUVs (∼90 nm) are consistent with the formation of unilamellar vesicles. 
SUVs containing the fluorescent probe DPH (1,6-Diphenyl- 1,3,5-hexatriene) were 
obtained by adding to the lipids dissolved in the organic mixture a definite amount 
of a solution of DPH in chloroform at the lipids/DPH mole ratio of 150. Liposomes 
composed by DPPC/DPPG (8/2 mol/mol) and DPPC/POPG (8/2 mol/mol) as 
simplified models of bacterial membrane were prepared. Samples of liposomes in 
the presence of peptides were prepared by mixing appropriate volumes of peptides’ 
concentrated stock solution and liposomes suspension to get the desired lipid-to-




Circular Dichroism (CD). CD spectra of P9Nal(SR) and P9Trp(SS) were recorded 
by using a JASCO J-715 spectropolarimeter, from Jasco Corporation (Tokyo, Japan), 
in a 0.1 cm path length quartz cuvette as an average of 3 scans. For the acquisition 
of spectra, the following instrument parameters were used: scan speed of 20 nm/min, 
4 s response time and 2 nm bandwidth. The temperature was set to 25 °C and 
controlled with a peltier system which ensures an accuracy of ±0.1 °C. Peptide 
samples were prepared in 20 mM phosphate buffer pH 7.4 at the concentration of 30 
μM in absence and in the presence of SUVs at total lipid concentration of 0.30 mM, 
1.5 mM and 3.0 mM. For each sample, a background blank (buffer or lipid 
suspension alone) was subtracted. 
 
Differential Scanning Calorimetry (DSC). DSC measurements were carried out 
by means of a nano-DSC from TA Instruments (New Castle, DE, USA). 
Multilamellar vesicles (MLVs) were used for all DSC experiments since they 
provide the better resolution of the peak [174]. A volume of 300 μL of 0.5 mM 
vesicles suspension (DPPC/DPPG or DPPC/POPG) in the absence or in the presence 
of peptides was placed in the calorimetry vessel, and successive heating and cooling 
scans were performed at 1 °C/min over the temperature range of 20–55 °C. The 
excess heat capacity function (<ΔCp>) was obtained after baseline subtraction. A 
buffer-buffer scan was subtracted from the sample scan. The samples composed by 
lipid suspension and peptide were prepared before the DSC experiments, by adding 
the appropriate amount of peptide to the lipid suspension and waiting at least 30 min 
to ensure that the equilibrium has been reached. The results presented here all refer 
to the second heating scan. The obtained data were analyzed by means of 
NanoAnalyze software supplied with the instrument and plotted using the Origin 8.0 
software package (OriginLab, Northampton, MA, USA). 
 
Steady-state Fluorescence. All the fluorescence experiments were performed using 
a Fluoromax-4 spectrofluorometer (Horiba, Edison, NJ, USA) operating in the 
steady-state mode at the temperature of 25 °C. 
Fluorescence anisotropy. Fluorescence anisotropy measurements were carried out 
for the probe DPH embedded into SUVs at total lipid concentration of 50 μM. The 
excitation wavelength was set to 355 nm and the emission was monitored at 426 nm. 
The slits were set to 6 nm and 10 nm for the excitation and emission 
monochromators, respectively. The experiments were performed using a 1 cm path 










where IVV is the fluorescence intensity obtained by setting both the excitation and 
emission polarizers vertically, IVH is the fluorescence intensity obtained by setting 
the excitation polarizer vertically and the emission polarizer horizontally and G is 
the instrument-specific correction factor, which accounts for the difference in the 
polarizers transmission efficiency of vertically and horizontally polarized light 
[175,176]. 
 
Fluorescence quenching. For fluorescence quenching experiments, a 5 μM solution 
of peptides, in the absence or in the presence of SUVs at lipid-to-peptide mole ratio 
(L/P) of 100, was placed in a quartz cuvette with a path length of 1 cm and titrated 
with acrylamide solution (40% w/v). The titrations were performed at fixed peptide 
concentration in the absence and presence of acrylamide concentrations up to ~80 
mM. The excitation wavelength was set to 277 nm for P9Nal(SR) and 280 nm for 
P9Trp(SS), and the emission spectra were collected from 290 nm to 500 nm. The 




= 1 + 𝐾ௌ௏[𝑄] 
 
where F0 is the fluorescence intensity in the absence of the quencher, F is the 
fluorescence intensity at each step of titration in the presence of the quencher, [Q] is 
the concentration of acrylamide. Due to acrylamide absorption at the excitation 
wavelength, the fluorescence intensities were corrected using the formula 𝐹௢௕௦ =
𝐹௖௢௥௥ ∙ 10
షಲ೐ೣ∙೏
మ  where Fobs is the observed intensity, Fcorr is the corrected intensity, 
Aex is the absorbance of acrylamide at the excitation wavelength and d is the cuvette 




4.3.1 The Conformational Behavior of P9Nal(SR) and P9Trp(SS) Peptides 
 
Circular dichroism (CD) spectroscopy experiments were carried out to check the 
ability of the two peptides to change their conformation upon binding to bacterial-
like liposomes composed by DPPC/DPPG (8/2 mol/mol). Thus, in Fig. 4.1, panel A 
are reported the CD spectra of P9Nal(SR) in phosphate buffer and in the presence of 
DPPC/DPPG unilamellar vesicles at lipid-to-peptide (L/P) ratios of 10, 50 and 100. 






Fig. 4.1 CD spectra of (A) P9Nal(SR) and (B) P9Trp(SS) in buffer (black line) and in the presence of 
DPPC/DPPG unilamellar vesicles at L/P = 10 (red line), 50 (blue line) and 100 (green line). All the 
experiments were carried out in 20 mM phosphate buffer, pH 7.4 at 25°C. 
 
Qualitatively, the acquired CD spectra of P9Nal(SR) are the same as the spectra 
obtained for the parent peptide P9Nal(SS) (section 3.5.1, Fig. 3.4). In solution, the 
spectrum is characterized by a positive band at about 230 nm and a negative one 
around 200 nm, suggesting that P9Nal(SR) adopts a random structure [173]. Upon 
the addition of unilamellar vesicles, the intensity of the positive band increases as 
the lipid concentration increases. Moreover, two minima centered at about 220 nm 
and 205 nm appear. At L/P = 50 and 100 a positive band rises at about 190 nm. These 
results indicate that P9Nal(SR) adopts a helix-like conformation in the presence of 
lipid vesicles. As for P9Nal(SS), the positive bands in the range 230-240 nm could 
be due to the excited state interactions of 2Nal residues which contribute to the 
observed spectra (exciton effect) [182,183]. The CD spectrum of P9Trp(SS) in 
phosphate buffer showed two negative bands at about 225 nm and 200 nm. The band 
at 225 nm could be attributed to the contribution of two Trp residues [180,181,183]. 
Instead, the band at about 200 nm is typical of small unstructured peptides. Thus, 
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P9Trp(SS) is essentially random coil in solution. In the presence of DPPC/DPPG 
vesicles, a band around 195 appears. Its intensity increases as the lipid concentration 
increases. Moreover, the band at 200 nm shifts towards longer wavelengths, reaching 
about 208 nm at L/P = 100. These results suggest that, as for the P9Nal(SR), also 
P9Trp(SS) approaches a more ordered structure in the presence of liposomes, most 
likely a helix-like conformation. The band at 225 nm also shifts towards longer 
wavelength, reaching about 230 nm at L/P = 100. The shift of this band could be 
attributed to changes in the local environment experienced by the two Trp residues. 
Similar observations are reported for others Trp-containing peptides [183,202,203].  
 
4.3.2 The Effects on the Lipid Bilayer Stability 
 
Differential scanning calorimetry is powerful technique to study the thermotropic 
properties of lipid vesicles and the effects of added peptides on them and it was 
successfully applied in several different studies [204–206]. Thus, in order to study 
the effects of P9Nal(SR) and P9Trp(SS) on bilayer stability, DSC measurements 
with liposomes composed by DPPC/DPPG were carried out. In Fig. 4.2 are reported 
the DSC thermograms of DPPC/DPPG multilamellar vesicles in the presence of 
P9Nal(SR) (panel A) and P9Trp(SS) (panel B) at L/P = 10, 5 and 1.  
 
 
Fig. 4.2 DSC thermograms of DPPC/DPPG multilamellar vesicles (black line) in the presence of (A) 
P9Nal(SR) and (B) P9Trp(SS) at lipid-to-peptide ratio of 10 (red line), 5 (blue line) and 1 (green line). 
All the experiments were carried out in 20 mM phosphate buffer, pH 7.4 
 
As described in the section 3.5.2, the DSC thermogram of liposomes composed by 
DPPC/DPPG (8/2 mol/mol) is characterized by the presence of two transitions 
[184,207]: the pre-transition, at about 35 °C, is due to the rearrangement of lipid 
77 
 
polar head groups; the main transition, at 42.4 °C, is due to the melting of acyl chains 
of lipids. Thus, the peptides’ effects on two distinct regions of the membrane, surface 
and hydrophobic core, can be followed. 
The addition of P9Nal(SR) or P9Trp(SS) completely abolish the DPPC/DPPG pre-
transition already at lowest peptide concentrations used (L/P = 10). These results 
clearly indicate that both peptides interact with lipid polar head groups perturbing 
their transitions from the lamellar gel phase to rippled gel phase. 
The most surprising result, which differs from that observed for the parent peptide 
P9Nal(SS), is that the main transition, i.e. lipid acyl chains packing, seems not 
significantly perturbed by the presence of peptides, up to L/P = 5 (high peptide 
concentrations). In fact, only a small increase of transition temperature coupled with 
a slightly broadening of transition peaks were observed, suggesting a binding at 
hydrophilic/hydrophobic interface [185]. In contrast, already at L/P = 10 P9Nal(SS) 
was able to penetrate inside the bilayer strongly perturbing the lipid packing (section 
3.5.2, Fig. 3.6). 
An evident perturbation of the main transition was observed only at very high peptide 
concentration (L/P = 1). At this ratio, in the presence of P9Nal(SR), the main 
transition temperature decreases from 42.3 °C to 38.8 °C. Moreover, the peak looks 
broader and composed by at least two peaks (with a shoulder centered at about 39.5 
°C) suggesting the formation of domains which differ in their lipid compositions and 
melt at different temperatures, as observed for P9Nal(SS). These results indicate that 
P9Nal(SR) is able to perturb the lipids packing inducing the formation of lipid 
domains and penetrating at some extent in the bilayer [185]. 
Similarly, also for P9Trp(SS) a very high peptide concentration is required to clearly 
perturb the main transition peak (Fig. 4.2, panel B). At this high peptide 
concentration, the DSC peak looks sharper respect to that in the absence of peptide 
and it does not appear as composed by the superposition of two or more peaks. This 
result suggest that P9Trp(SS) does not penetrate in the membrane hydrophobic core 
and is not able to perturb the lipid packing. Most likely, the preferential interaction 
of P9Trp(SS) with DPPG caused a demixing of DPPC and DPPG molecules leading 
to the formation of lipid domains. The formed domains (with acyl chains unperturbed 
by the presence of peptide) of DPPC and DPPG have similar transition temperatures. 
Their sharp transitions sum to each other leading to the formation of the observed 
DSC peak. The localization of the peptide at the hydrophilic/hydrophobic interface 
is also supported by the particular preference of Trp residues in localizing in this 
membrane region [32,208]. Thus, it seems that P9Nal(SR) and P9Trp(SS) have 
different penetration abilities inside the membrane. P9Trp(SS) doesn’t perturb 
strongly the lipid acyl chains packing, because it cannot distribute in the hydrophobic 




To better highlight the ability of P9Trp(SS) to induce the formation of lipid domains, 
the DSC experiment was repeated by replacing DPPG with POPG, producing 
multilamellar vesicles composed by DPPC/POPG (8/2 mol/mol). As stated in section 
3.5.3, POPG vesicles have a transition temperature below 0°C. Thus, POPG 
incorporation affects the observed transition of DPPC only indirectly, by changing 
its local distribution. This replacement has several advantages: i) at the mole fraction 
used, the two lipids are completely miscible [189]; ii) the melting temperature of 
pure POPG vesicles is below 0 °C and, thus, it can affect the observed phase 
transition of DPPC/POPG indirectly, by changing its local distribution. If the added 
peptide preferentially interacts with the low-melting component of the membrane 
(POPG), it will promote its segregation leaving the rest of the membrane enriched in 
the high-melting component (DPPC), which melts at higher temperature [209]. In 
Fig. 4.3 are reported the DSC thermograms of DPPC/POPG vesicles in the absence 
and in the presence of P9Trp(SS) at L/P = 50. 
 
Fig. 4.3 DSC thermograms of DPPC/POPG multilamellar vesicles in the absence (black line) and in 
the presence (red line) of P9Trp(SS) at L/P = 50. The experiments were carried out in 20 mM 
phosphate buffer, pH 7.4. 
 
The DSC thermogram of DPPC/POPG vesicles has a transition temperature at about 
35.6 °C. After the addition of P9Trp(SS) an increase of the transition temperature to 
36.1 °C was observed coupled with an increase of the transition cooperativity 
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(sharper peak). This result is consistent with a preferential interaction with negatively 
charged lipids leaving a DPPC enriched domain which melts more cooperatively and 
at higher temperature. 
 
4.3.3 Abilities of Peptides to Penetrate in the Membrane 
 
To better understand the effects of peptides insertion on the bilayer stability, 
fluorescence anisotropy measurements with the probe DPH were carried out. DPH 
is a very poor-soluble water fluorescent molecule that partitions inside the 
hydrophobic core of the lipid bilayer [175,210]. Since the DPH anisotropy values 
depend on the lipid acyl chains packing, this technique is an invaluable tool to study 
the peptides insertion in the membrane [211]. 
In Fig. 4.4 are reported the anisotropy values of DPH embedded in DPPC/DPPG 
unilamellar vesicles in the presence of increasing concentration of P9Nal(SR) and 
P9Trp(SS) peptides in panel A and B, respectively. 
 
 
Fig. 4.4 Fluorescence anisotropy for DPH embedded in DPPC/DPPG unilamellar vesicles in the 
presence of increasing concentration of (A) P9Nal(SR) and (B) P9Trp(SS). The total lipid 
concentration was ~50 µM. All the experiments were carried out in 20 mM phosphate buffer, pH 7.4 
at the temperature of 25 °C. 
 
The addition of P9Nal(SR) peptide causes an increase of the anisotropy values of 
DPH up to peptide concentration of about 2 µM. Then, increasing peptide 
concentration, a decrease of anisotropy was observed. This result indicate that the 
effect of peptide is concentration dependent. At low concentration (below 2 µM) the 
peptide doesn’t penetrate in membrane but rather it interacts with lipid polar heads 
groups. These interactions could stabilize the bilayer, reducing the repulsion between 
polar head groups [185,212]. At higher concentration, P9Nal(SR) is able to penetrate 
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in the membrane destabilizing the regular lipid packing. Consequentially, a decrease 
of anisotropy was detected. For the P9Trp(SS), a different phenomenon was 
observed. Its addition to DPPC/DPPG vesicles increases the anisotropy value of 
DPH up to 0.335 at 2 µM which is compatible with a surface binding which stabilize 
the bilayer. Then, the further increase of peptide concentration doesn’t affect the 
anisotropy values. These findings point out that P9Trp(SS) is not able to perturb the 
lipid packing. Probably, as noted for DSC measurements, this could be due to the 
weak capacity of this peptide to penetrate inside the hydrophobic core of the 
membrane. Overall, the obtained results are in very good agreement with the results 
obtained by means of DSC measurements. 
Finally, fluorescence quenching measurements with acrylamide were performed. 
Fluorescence emission spectra of peptide in buffer or in the presence of DPPC/DPPG 
at L/P = 100 were recorded at different acrylamide concentrations. According to the 
equation reported in “Fluorescence quenching” section, a plot of F0/F versus 
acrylamide concentration gives a straight line whose slope is the Stern-Volmer 
constant, indicated as KSV. The value of KSV is an index of the degree of exposure to 
the aqueous solvent of the two fluorophores in the primary sequence of the peptide 
[175,190]. A more exposed residue will be more quenched respect a less exposed 
one. In the first case, the value of KSV will be greater than the value obtained in the 
second case. In Fig. 4.5 are reported the Stern-Volmer plots obtained from the 
acrylamide quenching of P9Nal(SR) and P9Trp(SS) peptides in buffer or in the 
presence of unilamellar vesicles composed by DPPC/DPPG. 
 
 
Fig. 4.5 Stern-Volmer plots obtained from the fluorescence quenching experiments with acrylamide 
of (A) P9Nal(SR) and (B) P9Trp(SS) in the absence (black squares) and in the presence (blue 





For P9Nal(SR) in the absence of DPPC/DPPG lipid vesicles, the value of the KSV is 
72.9±0.5 M-1. It is important to note that, despite that the fluorophores in P9Nal(SS) 
and P9Nal(SR) are the same, the value of KSV are completely different. In fact, the 
value obtained for P9Nal(SS) was of 16.9±0.4 M-1 (section 3.5.4). This discrepancy 
could be ascribed by the presence of Cys(StBu) and Cys(tBu) in P9Nal(SS) and 
P9Nal(SR), respectively. In fact, the longer and more flexible side chains of 
Cys(StBu) residues could shield more the 2Nal residues from the aqueous medium 
respect to the shorter and less flexible Cys(tBu) residues. 
In the presence of DPPC/DPPG vesicles at L/P = 100, a strong decrease of KSV was 
observed (2.0±0.6 M-1), suggesting that the peptide and the 2Nal residues are inserted 
in the membrane and are hidden to acrylamide presents in solution. 
For P9Trp(SS) in solution without lipid vesicles, a value of KSV of 10.5±0.2 M-1 was 
obtained. Upon the addition of DPPC/DPPG vesicles, the value of KSV decreases to 
2.6±0.6 M-1. Again, this result suggest that the P9Trp(SS) is able to insert inside the 
membrane. 
The KSV values for both peptides are similar, even though DSC and anisotropy 
measurements suggested different degrees of penetration. The incongruence with 
fluorescence quenching results could be explained considering that, probably, the 
quenching test is not able to discriminate among different levels of insertion in the 
bilayer. This sounds reasonable, since the hydrophilic acrylamide doesn’t partition 




In this chapter, the results obtained from biophysical studies of two P9Nal(SS) 
derived peptides with DPPC/DPPG liposomes as model of cytoplasmic bacterial 
membrane were presented. The two peptides, named P9Nal(SR) and P9Trp(SS), 
were obtained from the replacement of some residues in the primary sequence of 
P9Nal(SS). In particular P9Nal(SR) was obtained after the substitution of the two 
Cys(StBu) with Cys(tBu) residues. On the contrary, in P9Trp(SS) peptide the two 
2Nal residues were replaced by Trp residues. These substitutions led to peptides with 
comparable hydrophobicities and more hydrophilic respect to the parent peptide 
P9Nal(SS). The final goal of this study was to clarify if these substitutions could 
have an impact on the perturbation of bacterial model membranes. 
All the reported data reveal similarities and differences in the interaction process and 
perturbation activities of the two studied peptides. As demonstrated by CD spectra, 
both peptides change their conformation upon binding to liposomes and it seems that 
they assume a helix-like conformation. The conformational changes of both peptides 
well correlate with their antimicrobial activities in vivo (section 3.4.1). 
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From the reported DSC measurements (Fig. 4.2) is evident that both peptides act 
through a concentration dependent mechanism. Up to L/P = 5, only a binding with 
lipid polar head groups was observed. At the threshold value of L/P = 1, a clear effect 
on the main transition peak of DPPC/DPPG liposomes can be revealed.  
The DSC experiments at this very high peptide concentration point out some 
differences in the mode of interaction of these two peptides. In fact, for P9Nal(SR) 
the formation of a broad multicomponent peak suggest the formation of lipid 
domains and penetration of the peptide in the membrane which perturbs the regular 
lipid packing. In contrast, for P9Trp(SS) these features are not immediately revealed. 
In fact, due to the preference of Trp residues to locate at the membrane-water 
interface, P9Trp(SS) penetrates to a less extent in the bilayer [32,208]. Nevertheless, 
it is able to induce lipid segregation as demonstrated by the result obtained with 
DPPC/POPG mixture (Fig. 4.3). The different degrees of peptides penetration in the 
bilayer are well supported by fluorescence anisotropy measurements (Fig. 4.4). In 
fact, for P9Nal(SR) the increase of DPH anisotropy at low concentration and the 
decrease at high peptide concentration indicate that the surface binding is followed 
by an insertion in the hydrophobic core of the membrane. For P9Trp(SS), at low 
concentration an increase of anisotropy was detected. The further addition of peptide 
doesn’t change the DPH anisotropy embedded in DPPC/DPPG vesicles. This is a 
clear proof that the peptide does not penetrate in the hydrophobic core of the 
membrane and, consequentially, it cannot perturb the lipid packing remaining at 
hydrophobic/hydrophilic interface. 
At this point it is useful to compare P9Nal(SR) and P9Trp(SS) with the parent 
peptide P9Nal(SS). Overall, the reported data in this chapter and in the chapter 3 
suggest that the key step in membrane destabilization is the same for all the three 
peptides: the formation of lipid domains. It is known that the interface between 
domains can act as defects in destabilizing the membrane promoting membrane 
permeabilization [12,87,199,200].  
The main difference among the three peptides is related to their penetration 
capacities inside the bilayer which are correlated with the overall peptides’ 
hydrophobicities. As demonstrated by retention of peptides in reverse phase HPLC 
experiment (Fig. 3.3) the parent peptide P9Nal(SS) is the most hydrophobic, 
followed by P9Nal(SR) and P9Trp(SS). However, the difference between the two 
analog peptides is little. It seems that P9Nal(SS) has the highest penetration ability 
according with its higher hydrophobicity, followed by P9Nal(SR) and P9Trp(SS). 
This is demonstrated by DSC measurements (Fig. 3.6 and Fig. 4.2). In fact, the strong 
perturbation of the DSC peak of DPPC/DPPG vesicles, compatible with P9Nal(SS) 
insertion in the membrane, took place already at L/P = 10. In contrast, only at very 
high peptide concentrations (L/P = 1), P9Nal(SR) gave a similar (but less 
pronounced) phenomenon. Instead, the results obtained for the P9Trp(SS) revealed 
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no deep insertion in the hydrophobic core of the membrane even at L/P = 1, but the 
localization at the hydrophobic/hydrophilic interface. These ideas are also well 
supported by DPH fluorescence anisotropy experiments (Fig. 3.7 and Fig. 4.4). Thus, 
the penetration abilities seem to be in the order: P9Nal(SS) >> P9Nal(SR) ≥ 
P9Trp(SS). 
To conclude, the three peptides act through the same general action mechanism 
which involve peptides absorption on membrane surface, conformational changes 
and formation of lipid domains. Upon reaching a threshold L/P value, the peptides 
insert in the bilayer at different levels perturbing, or not, the regular lipid packing. 
Since all the peptides have similar antimicrobial activities especially against gram-
negative bacteria (Table 1, section 3.4.1), it seems that the partition inside the 
membrane is not fundamental in destabilizing the membrane. Rather, it is sufficient 
that the peptides are able to induce lipid segregation and domains formation. This is 
also supported by the observation that an increase of hydrophobicity in L-V13K 
peptide does not alter its activity against Pseudomonas aeruginosa [46]. The reported 
data cannot explain the reduced activities against gram-positive bacteria, since it is 
widely accepted that the target of AMPs is the cytoplasmic membrane in both kinds 
of bacteria (section 1.4 and 2.4) [215]. As reported in literature [179] the activity 
against gram-positive bacteria is correlated to hydrophobicity, since a decrease of 
this parameter lead to a decrease of antimicrobial potency. Most likely, the 
hydrophobicity could modulate the interaction of peptides with cell wall components 
(e.g. teichoic acids) which can retain peptides preventing their interaction with the 
cytoplasmic membrane [138]. Thus, higher peptides concentrations in biological 



















Chapter 5  
 
The Cytotoxic and Antimicrobial Activities of the Human 




The antimicrobial peptide (P)GKY20 is a natural peptide modelled on the Gly271 to 
Ile290 sequence of the C-terminus region of the human thrombin [178]. The region 
corresponding to the peptide sequence in the protein is highlighted in red in Fig. 5.1. 
The sequence of (P)GKY20 peptide is: (P)GKYGFYTHVFRLKKWIQKVI. The 
proline residue is not present in the original sequence of the peptide [178], but it is 
the result of the expression and the purification procedure of the peptide (see 
Materials section). The (P)GKY20 possesses a net positive charge of 5 at 




Fig. 5.1 The three-dimensional structure of the human thrombin (pbd: 3U69) [216]. In red is 
highlighted the portion of protein which corresponds to the sequence of (P)GKY20 peptide. 
 
It was shown that this peptide is effective against both gram-negative and gram-
positive bacteria as well as against the fungus Candida albicans [178]. For example, 
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the MIC value for the gram-negative bacterium Escherichia coli is in the range 2.5-
10 µM. Instead the MIC value for the gram-positive bacterium Staphylococcus 
aureus is in the range 20-40 µM. Moreover, it was shown that permeabilization of 
human skin fibroblasts after the exposure at 60 µM of (P)GKY20 peptide was largely 
absent, revealing the low cytotoxic effects of the peptide. Consequentially, 
(P)GKY20 peptide could be very suitable as drug for biomedical applications. 
Unfortunately, the molecular basis of the action mechanism, which underlying the 
observed (P)GKY20 antimicrobial activity, is still unknown. Thus, in order to study 
the interaction process with the membrane, a detailed biophysical study was carried 
out by using liposomes composed by POPC and POPG as a simplified model of the 
cytoplasmic bacterial membrane. For comparison, the same study was carried out 
with POPC liposomes as model of the eukaryotic membrane to find the key 
determinants able to explain the low observed cytotoxicity. 
The reported data clearly indicate that, although (P)GKY20 binds both the 
membranes, its effect is strongly dependent on the membrane lipid composition. In 
particular, the peptide is able to drastically perturb the microstructure and stability 
of the bacterial-like membrane whereas no significant perturbation of the eukaryotic-
like membrane was observed. These findings are fully consistent with the reported 
(P)GKY20 selectivity toward bacterial membranes. In addition, a complex action 
mechanism which involves peptide conformational changes, lipid segregation, 
domain formation and micellization as key steps in promoting membrane disruption 
was revealed. The reported results shed a first light on the action mechanism of 
(P)GKY20 providing molecular details at the level of peptide-lipid interaction and 
could represent an important contribution for the development of new peptides 
serving as antimicrobial agents. 
 
5.2 Materials and Methods 
 
Materials. The recombinant peptide (P)GKY20 (molecular weight: 2609.16 g/mol) 
was prepared by heterologous expression in E. coli through fusion to the C-terminus 
of a carrier derived from a modified ribonuclease as previously described [170]. 
After purification the peptide was released by selective hydrolysis of an aspartyl-
prolyl sequence present at the carrier/peptide boundary. Hydrolysis leaves an 
additional proline residue at the N-terminus of the peptide which does not influence 
the biological activity of the peptide [170]. The peptide was expressed in 
collaboration with the research group of Prof. E. Notomista of the Department of 
Biology, University of Naples Federico II. 
The lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-
2-oleoyl-sn-glycero-3- phospho-1’-rac-glycerol (POPG), 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC), 1,2-dipalmitoyl-sn-glycero-3-phospho-1'-rac 
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glycerol (DPPG) and N-(Lissamine rhodamine B sulfonyl) 
phosphatidylethanolamine (N-Rh-DHPE) were purchased from Avanti Polar Lipids 
Inc. (Alabaster, AL, USA) and used without further purifications. The fluorescent 
probe Laurdan (6-dodecanoyl-2-dimethylaminonaphtalene), acrylamide solution 
(40% w/v), chloroform, methanol and dimethylformamide were purchased from 
Sigma Aldrich Chemical. Deionized water was used for the phosphate buffer and all 
sample preparations. 
 
Liposome Preparation. Appropriate amounts of lipids were weighed and dissolved 
in a chloroform/methanol (2/1 v/v) mixture. A thin film was produced by gentle 
evaporation of the organic solvent with nitrogen gas. To remove final traces of 
organic solvent, the sample was placed under vacuum overnight. Then, the sample 
was hydrated with an appropriate volume of 10 mM phosphate buffer, pH 7.4, and 
vigorously mixed obtaining a suspension of multilamellar vesicles (MLVs). Small 
unilamellar vesicles (SUVs) were produced by sonication of multilamellar vesicles 
at room temperature with a Sonics VCX130 (Sonics and Materials Newtown, USA) 
until the suspension appeared clear (~15-20 min). Large unilamellar vesicles (LUVs) 
containing the fluorescent probe Laurdan (6-dodecanoyl-2-
dimethylaminonaphtalene) were obtained by adding to the lipids dissolved in the 
organic mixture a definite amount of a solution of Laurdan in DMF 
(dimethylformamide) at the lipid/Laurdan molar ratio of 500. Large unilamellar 
vesicles (LUVs) were produced by the extrusion method using a Mini-Extruder 
(Avanti Polar Lipid Inc.) passing the MLVs suspension through a 100 nm pore size 
polycarbonate membrane twenty-one times. Dynamic light scattering measurements 
were performed to check the size of the vesicles after both sonication and extrusion. 
The average hydrodynamic radii (RH) of pure and mixed lipids vesicles were ~90 nm 
for SUVs and ~120 nm for LUVs, compatible with the formation of unilamellar 
vesicles. Liposomes with different composition were prepared: POPC, DPPC, 
POPC/POPG (8/2 mol/mol), DPPC/DPPG (8/2 mol/mol), DPPC/POPG (8/2 
mol/mol), and DPPG. Vesicle samples in the presence of peptide were prepared by 
mixing appropriate volumes of peptide solution and liposomes suspension to yield 
the desired lipid-to-peptide (L/P) ratio. 
 
Circular Dichroism (CD). Far-UV circular dichroism spectra of the (P)GKY20 
peptide were recorded using a JASCO J-715 spectropolarimeter (Jasco Corporation, 
Tokyo, Japan) in a 0.1 cm path length quartz cuvette as an average of 3 scans, using 
the following parameters: scan speed of 20 nm/min, 4 s response time, 2 nm 
bandwidth. Samples were prepared in 10 mM phosphate buffer, pH 7.4, at the peptide 
concentration of 17 μM in the absence and presence of SUVs at a total lipid 
concentration of 0.17 mM, 0.85 mM and 1.7 mM. For each sample, a background 
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blank (buffer or lipid suspension alone) was subtracted. An estimation of the 
secondary structure content was obtained from the spectra using “PEPFIT Analyses” 
software [217]. 
 
Steady-state Fluorescence. The steady-state fluorescence binding and quenching 
measurements were performed with a Fluoromax-4 spectrofluorimeter (Horiba, 
Edison, NJ, USA) using a quartz cuvette of 1 cm path length (volume ~1 mL). 
Instead, Laurdan fluorescence emission spectra were acquired with a K2 
fluorescence spectrometer from ISS (Champaign, Illinois, USA) using a full volume 
(~2 mL) quartz cuvette of 1 cm path length. During the measurements, the samples 
were under gentle stirring. 
 
Binding Experiments. The ability of (P)GKY20 peptide to interact with POPC and 
POPC/POPG (8/2 mol/mol) large unilamellar vesicles (LUVs) was studied by 
monitoring the changes in the Trp fluorescence emission spectra of the peptide. The 
titrations were performed, at 25 °C, by recording the spectra of solutions of the 
peptide at a fixed peptide concentration of about 6 μM and lipid vesicles 
concentrations ranging from 0 to ~10−3 M. The excitation wavelength was set to 280 
nm, and the emission spectra were collected from 300 to 500 nm. The slit widths for 
excitation and emission wavelengths were set to 8-10 nm and 10-12 nm, respectively. 
The acquisition of good fluorescence spectra is not straightforward because of light 
scattering associated with liposomes, especially at high lipid concentrations [218]. 
Light scattering can affect the emission spectra leading to erroneous conclusions 
about the interaction of peptides with liposomes (e.g. apparent blue shift). Since the 
light scattered by liposomes has the same polarization of incident light, the 
experiments were carried out by exciting the sample with plane-polarized light and 
recording the light emission in a plane perpendicular to that of exciting light, as 
described in detail in [218]. The binding isotherms were obtained by plotting the 
relative fluorescence intensity at 355 nm as a function of lipid concentration. The 
mole fraction partition constant (Kx) was obtained by fitting the binding curves with 
the following equation [218]: 
 
𝐹 = 1 + (𝐹ஶ − 1) ∙
(𝐾௫ ∙ [𝐿])
([𝑊] + 𝐾௫ ∙ [𝐿])
 
 
where F is the relative fluorescence intensity at each point of the titration, F∞ is the 
relative fluorescence at saturation, [L] is the lipid concentration, [W] = 55.3 M is the 
molar concentration of water, and Kx is the mole fraction partition constant. The 









where [Pb], [Pf], [L] and [W] are the molar concentration of the membrane-associated 
peptide, free peptide in the aqueous phase, lipids and water, respectively. 
 
Laurdan Generalized Polarization. Laurdan fluorescence emission spectra were 
recorded by exciting LUVs labelled with Laurdan at 340 nm. The emission spectra 
were collected from 390 to 620 nm. The slit widths for both excitation and emission 
wavelengths were 8 nm. The final lipid concentration was 50 µM. For DPPC/DPPG 
vesicles, spectra of Laurdan as a function of the temperature in the absence and in 
the presence of (P)GKY20 peptide (L/P = 10) were recorded. For POPC and 
POPC/POPG LUVs, emission spectra of Laurdan were recorded by varying the 








where I440 and I490 are the fluorescence intensities at 440 nm and 490 nm, 
respectively. 
 
Quenching Experiments. Fluorescence quenching experiments were performed at 
25 °C. A 6 μM solution of (P)GKY20 peptide, in the absence or in the presence of 
LUVs at L/P of 200, was titrated with acrylamide solution (40% w/v). The titrations 
were performed at fixed peptide concentration in the absence and presence of 
acrylamide concentrations up to ~ 50 mM. The excitation wavelength was set to 280 
nm. The emission spectra were collected from 300 nm to 500 nm. The slit widths for 
the excitation and emission were 2 nm and 4 nm, respectively. The obtained data 




= 1 + 𝐾ௌ௏[𝑄] 
 
where F0 is the fluorescence intensity of the peptide at its maximum in the absence 
of the quencher, F is the fluorescence intensity at each step of titration in the presence 
of the quencher, [Q] is the concentration of acrylamide, and KSV is the Stern-Volmer 
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quenching constant. The obtained spectra were corrected for the acrylamide 
absorbance at the excitation wavelength as reported in [177]. 
 
Differential Scanning Calorimetry (DSC). DSC measurements were carried out 
by means of a nano-DSC from TA Instruments (New Castle, DE, USA) for DPPC 
and DPPC/DPPG vesicles. Instead, the DSC measurements for the mixture 
DPPC/POPG were performed with a MicroCal VP-DSC from Microcal (now 
Malvern Instruments. MLVs were used for all DSC experiments since they provide 
the better resolution of the phase transition peaks [174]. Briefly, 300 μL of 0.4 mM 
vesicles suspension (DPPC, DPPC/DPPG or DPPC/POPG) in the absence or in the 
presence of peptide was placed in the calorimetry vessel, and successive heating and 
cooling scans were performed at the scan speed of 1 °C/min. The excess heat capacity 
function (<ΔCp>) was obtained after baseline subtraction. A buffer-buffer scan was 
subtracted from the sample scan. The samples composed by lipid suspension and 
peptide were freshly prepared just before the experiments, by adding the appropriate 
amount of peptide to the lipid suspension and waiting at least 30 min to ensure that 
the equilibrium was reached. The reversibility of the process was ensured by the 
superposition of successive heating scans. The data obtained were analyzed by 
means of the NanoAnalyze software supplied with the instrument and plotted using 
the Origin software package (OriginLab, Northampton, MA, USA). 
 
Dynamic Light Scattering (DLS). DLS measurements were carried out to evaluate 
the liposomes mean size before and after the addition of the (P)GKY20 peptide. 
Briefly, 1 mL of 100 µM LUVs suspension in the absence or in the presence of 
(P)GKY20 peptide, at different lipid-to-peptide ratios, was placed in a polystyrene 
cuvette at the temperature of 25 °C and analyzed at the scattering angle of 90° using 
a Zetasizer nano ZSP (Malvern Instruments Ltd., Malvern, Worcestershire, UK) 
equipped with a 10-mW He-Ne laser operating at the wavelength of 633 nm. All 
measurements were carried out as triplicate. 
 
Atomic Force Microscopy (AFM). Samples for atomic force microscopy (AFM) 
experiments were prepared by direct fusion of LUVs composed by POPC/POPG in 
20 mM Tris, 5 mM MgCl2, pH 7.4. The vesicle fusion on mica was performed by 
depositing 300 µL of LUVs suspension, at a total lipid concentration of 2 mg/mL, 
on freshly cleaved mica and incubation for 2 h in a wet chamber at 70 °C. After the 
fusion, to remove the unspread vesicles, the sample was rinsed with Tris buffer. The 
peptide-containing sample was obtained by injecting peptide solution into the AFM 
fluid cell. AFM measurements were performed in tapping mode, at room 
temperature, on a MultiMode scanning probe microscope equipped with a 
NanoScope IIIa controller (Digital Instruments) and usage of a J-scanner (scan size 
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125 µm). Images were obtained in liquid with sharp nitride lever (SNL) probes 
mounted on a fluid cell (MTFML, both Veeco, Karlsruhe, Germany). Tips with 
nominal force constants of 0.24 N m-1 were used at driving frequencies of 9 kHz and 
drive amplitudes between 200 and 800 mV. Scan frequencies were between 1.0 and 
1.94 Hz. Height and phase images of sample regions were acquired with resolutions 
of 512x512 pixels. All measurements were analyzed by using the analysis and 
processing software NanoScope version 5. 
 
Confocal Fluorescence Microscopy. Giant unilamellar vesicles (GUVs) composed 
by POPC/POPG were produced by the electroformation method [221]. Briefly, 25 
µL of 2 mg/mL of lipid mixtures, labelled with N-Rh-DHPE at 0.2 mol%, in organic 
solvent were spread on ITO-coated slides (SPI Supplies, West Chester, USA). The 
slides were placed under vacuum overnight to remove the organic solvent. 
Afterwards, the slides were mounted on a temperature-controlled preparation 
chamber consisting of a closed bath imaging chamber RC-21B (360 µL) mounted on 
a P-2 platform (both Warner Instruments). Then, after addition of a solution of 10 
mM phosphate, 100 mM sucrose, pH 7.4 (via an injection-channel) the 
electroformation was performed at the frequency of 500 Hz at 400 mV for 5 min, 
1.25 V for 20 min and 3.5 V for 90 min. Fluorescence microscopy of GUVs, in buffer 
in the absence or in the presence of (P)GKY20 peptide, was performed by using a 
confocal laser scanning microscope (Biorad MRC 1024) coupled via a side port to 
an inverted microscope (Nikon; Eclipse TE-300DV), enabling fluorescence 
excitation in the focal plane of an objective lens (Nikon Plan Apo 60 WI, NA 1.2). 
A 568-nm line of a Kr/Ar laser (Dynamic Laser, Salt Lake City, UT, USA) was used 
to excite N-Rh-DHPE. Image acquisition was controlled using the software 





5.3.1 The Interaction and the Conformational Behavior of (P)GKY20 with 
Model Membranes 
 
To verify the ability of the peptide (P)GKY20 to interact with liposomes composed 
by POPC and POPC/POPG (8/2 mol/mol) as simplified models of eukaryotic and 
bacterial membranes, respectively, steady state fluorescence spectroscopy 
experiments were performed. Due to the presence of aromatic residues [175], the 
measurements were carried out by exciting the peptide at λex = 280 nm and following 
the changes in emission intensity at the maximum of emission. To avoid spectral 
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distortions due to light scattering induced by liposomes, all the spectra were acquired 
using polarized [218] (see section 5.2). 
In Fig. 5.2 are reported the binding isotherms and emission spectra obtained from 
the titration of a peptide solution with POPC (Panel A) and POPC/POPG (Panel B) 
large unilamellar vesicles. 
 
 
Fig. 5.2 Binding isotherms obtained from the titration of a solution of (P)GKY20 peptide with 
unilamellar vesicles of (A) POPC and (B) POPC/POPG (8/2 mol/mol). Solid lines are the best fit to 
the experimental data using the equation reported in Materials and Methods, Binding Experiments 
section. In the insets are collected the fluorescence spectra. 
 
The experimental points, obtained by following the changes in fluorescence intensity 
at wavelength maximum (λmax = 355 nm) and normalized relative to the emission 
intensity of peptide in the absence of lipid, were fitted in order to obtain the mole 
fraction partition constant (Kx) [218]. The value of Kx is an index of the peptide 
affinity for the membrane. The obtained values of Kx are (1.4±0.4)∙106 and 
(4.7±1.0)∙105 for POPC/POPG and POPC, respectively, indicating that (P)GKY20 
interacts with both model membranes with a difference in the binding constant less 
than one order of magnitude. The small difference on Kx does not account for the 
observed low cytotoxicity towards eukaryotic cells and good antimicrobial activities 
against bacteria [178]. 
Far-UV circular dichroism (CD) spectroscopy experiments were carried out to 
explore the ability of (P)GKY20 peptide to change its secondary structure upon 
interaction with model membranes. Thus, CD spectra of (P)GKY20 in buffer or in 
the presence of POPC and POPC/POPG at lipid-to-peptide ratio of 10, 50 and 100 
were recorded. In Fig. 5.3 are reported the CD spectra of (P)GKY20 peptide in buffer 
and in the presence of SUVs at L/P = 100. In these experiments, SUVs were used in 




Fig. 5.3 CD spectra of (P)GKY20 peptide in 10 mM phosphate buffer, pH 7.4 (black line) and in the 
presence of POPC (blue line) and of POPC/POPG (red line) at L/P = 100. All CD spectra were 
recorded at T = 25°C. 
 
In the absence of liposomes, the CD spectrum of (P)GKY20 peptide is typical of a 
disordered structure as evidenced by the presence of a minimum at about 200 nm 
[173] This is a common feature of many linear AMPs [12]. Upon the addition of 
unilamellar vesicles at L/P = 100, the peptide changes its conformation. In the 
presence of POPC, the spectrum is characterized by a minimum at about 203 nm. A 
very weak band appears at about 225 nm. Moreover, the spectrum in the region 
below 200 nm becomes more positive. In the presence of POPC/POPG vesicles 
similar features were observed. The band around 200 nm of the random-coil peptide 
shifts at about 207 nm. The band at 225 nm is now more intense. In addition, the rise 
of the positive band below 200 nm is evident. These data suggest that the peptide 
assumes a helix-like conformation in the presence of lipid vesicles. However, the 
conformational change is more pronounced in the presence of POPC/POPG. Thus, 




To quantify the percentage of secondary structures adopted by the peptide, 
deconvolution of the recorded CD spectra with the software PEPFIT at different L/P 
ratios were performed (Table 1) [217,224]. 
 
Table 1 Percentage of secondary structure elements of (P)GKY20 peptide obtained from CD spectra 
deconvolution by means of PEPFIT at different lipid-to-peptide molar ratios. 
System L/P ratio % random coil % α-helix % β-turn 
(P)GKY20  100 0 0 
+POPC 10 90 0 10 
 50 79 14 7 
 100 77 13 10 
+POPC/POPG 10 84 0 16 
 50 34 39 27 
 100 37 46 17 
 
An inspection of Table 1 reveals that increasing lipid concentration, the percentage 
of α-helix content increases in the presence of both lipid vesicles. In the presence of 
POPC, a maximum value of ~14% is reached. On the contrary, in the presence of 
POPC/POPG the percentage of α-helix is greater, reaching ~46%. This result is very 
important as the ability to perturb membrane integrity is related to the ability of the 
peptide to adopt helical structure [29,34]. 
 
5.3.2 The Effects of (P)GKY20 on Stability of Eukaryotic and Bacterial Model 
Membranes 
 
The effect of the peptide on the stability of lipid bilayer can provide valuable 
information on the action mechanism as AMPs perform their activity through a 
destabilization of the membrane. Thus, differential scanning calorimetry (DSC) 
measurements were performed on model membranes in the presence of (P)GKY20.  
Since POPC and POPG show a phase transition temperature below 0°C [152,225], 
not suitable for DSC, they were replaced by DPPC and DPPG, respectively. The 
DSC thermogram of DPPC and DPPC/DPPG (8/2 mol/mol) multilamellar vesicles 
in the absence and in the presence of (P)GKY20 at L/P = 10 are reported in Fig. 5.4. 
The thermodynamic parameters for the gel-to-liquid phase transition obtained from 






Fig. 5.4 DSC thermograms of multilamellar vesicles of (A) DPPC and (B) DPPC/DPPG in the 
absence (black line) and in the presence (red line) of (P)GKY20 at L/P = 10. All the experiments were 
carried out in 10 mM phosphate buffer, pH 7.4. 
 
Table 2 Thermodynamic parameters obtained by means of DSC for the phase transitions of DPPC 
and DPPC/DPPG (8/2 mol/mol) liposomes in the absence and presence of (P)GKY20 at a lipid to 
peptide ratio of 10. 
System Tp (°C)[a] ΔHp (kJ/mol)[a] Tm (°C)[b] ΔHm (kJ/mol)[b] 
DPPC 36.3±0.2 3.6±0.2 42.0±0.1 31.2±1.6 
+(P)GKY20 36.0±0.2 2.8±0.3 41.9±0.1 28.4±1.5 
DPPC/DPPG 36.1±0.2 1.7±0.3[c] 42.4±0.1 29.5±1.5[c] 
+(P)GKY20 - - 43-44±0.1[d] 28.4±1.4[c] 
[a] Enthalpy change and temperature of the pre-transition peak.  
[b] Enthalpy change and temperature of the main transition peak. 
[c] Normalization against total lipid moles. 
[d] The reported temperatures refer to the first and second maxima in the DSC thermogram, 
respectively. 
 
As stated in section 3.5.2, the DSC thermograms of DPPC and DPPC/DPPG 
liposomes are quite similar and characterized by the presence of two transitions. The 
first one is the pre-transition at about 36 °C and the second one, named main 
transition, at about 42 °C [93]. The pre-transition is due to the rearrangement of lipid 
polar head groups, whereas the main transition is due to the melting of acyl chains 
of lipids. Analysis of the DSC profile of DPPC in the presence of peptide reveals 
very weak perturbation of both transitions. This result is compatible with the low 
cytotoxicity exhibited by (P)GKY20. On the contrary, the presence of peptide 
drastically perturbs the thermotropic properties of DPPC/DPPG liposomes. The pre-
transition is completely abolished revealing a strong interaction with lipid polar 
heads. The main transition peak is turned into a multicomponent DSC profile which 
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consists of two overlapping peaks which indicates phase segregation and the 
presence of domains of different lipid composition [206]. Moreover, the peak is 
shifted at higher temperature suggesting that the peptide, interacting with lipid polar 
heads, stabilizes the membrane without penetrating deeply in the hydrophobic core. 
Otherwise, a suppression of the main transition peak should be observed [185]. In 
fact, the enthalpy change of the gel-to-liquid phase transition, due to the melting of 
lipid acyl chains (Table 2), of DPPC/DPPG liposomes is not affected by the presence 
of the peptide, confirming that (P)GKY20 peptide is not inserted deeply in the 
membrane and consequently is not able to perturb the lipid packing. 
To better highlight the effects of peptide in the lateral membrane organization and 
lipid order, fluorescence experiments with the probe Laurdan were performed [220]. 
Laurdan, an amphiphilic probe, partitions between polar head groups and the 
hydrophobic core of the membrane with no lipid phase preference [226]. Its 
fluorescence spectrum is sensitive to the accessibility and mobility of water 
molecules near itself (water dipolar relaxation process). Accessibility and mobility 
strictly depend on the packing of lipids in the membrane, making Laurdan a reporter 
of lipid phases. The fluorescence spectrum of Laurdan is composed by two bands 
centered at about 440 nm and 490 nm. The emission from 440 nm is attributed to 
Laurdan molecules in the lipid gel phase, whereas emission from 490 nm is attributed 
to probe molecules in the liquid phase [220,227]. Generalized Polarization (GP) 
function (as defined in Materials and Methods, Laurdan Generalized Polarization 
section) is a way to quantify the degree of order in the membrane. GP values change 
from about 0.5 to -0.3 passing from gel (more compact, high degree of order) to the 
fluid-like phase (less compact, low degree of order). In Fig. 5.5 are reported the GP 
values for Laurdan embedded in DPPC/DPPG large unilamellar vesicles as a 
function of the temperature in the absence and in the presence of (P)GKY20 peptide 
at L/P = 10. 
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Fig. 5.5 Generalized Polarization (GP) function for Laurdan embedded in DPPC/DPPG (50 µM) large 
unilamellar vesicles in buffer (black line) and in the presence of (P)GKY20 peptide (red line) at L/P 
= 10. The temperature was varied in the range 25-60 °C. 
 
Interestingly, the GP values are found to be higher in the presence of (P)GKY20 
peptide. This result suggests that the peptide is able to induce order, especially in the 
fluid-like phase, leading to a more compact membrane. Thus, in good agreement 
with DSC data, the peptide does not penetrate inside the hydrophobic core of the 
membrane but interacts superficially at the level of lipid head groups. A similar result 
was reported for penetratin [227]. 
Finally, the ability of the peptide to induce order was also checked on POPC/POPG 
liposomes. In Fig. 5.6 are reported the GP values of Laurdan embedded in 
POPC/POPG LUVs as a function of peptide concentration at the temperature of 25 
°C. For comparison, the same experiment with POPC was also performed. It is 
important to note that being these vesicles in the fluid phase at 25 °C, GP value in 
the absence of peptide is lower compared to that obtained for DPPC/DPPG in the 
same conditions. The reported results confirm that the peptide has only a minor effect 





Fig. 5.6 Generalized Polarization (GP) function for Laurdan embedded in POPC (black line) and 
POPC/POPG (red line) as a function of peptide concentration. All the experiments were carried out 
in 10 mM phosphate buffer, pH 7.4 at the temperature of 25 °C. 
 
5.3.3 (P)GKY20 Clusters Anionic Lipids: Formation of Lipid Domains 
 
As noted in Fig. 5.4, the DSC profile of DPPC/DPPG vesicles in the presence of 
(P)GKY20 at L/P = 10 appears composed by at least two overlapping peaks. This 
suggest the formation of lipid domains. Most likely, the formation of domains is 
triggered by the preferential interaction of cationic peptide (net charge of +5) with 
the anionic DPPG lipids [209]. To experimentally verify the ability of (P)GKY20 
peptide to induce segregation, a new DSC experiment was performed by replacing 
DPPG with POPG (see section 3.5.3) forming the mixture DPPC/POPG (8/2 
mol/mol). POPG has a transition temperature below 0 °C and is miscible with DPPC. 
Thus, the presence of POPG can affect the transition of DPPC/POPG only by 
changing its local distribution. In Fig. 5.7 are reported the DSC thermogram of 
DPPC/POPG multilamellar vesicles in the absence and in the presence of (P)GKY20 





Fig. 5.7 DSC thermograms of DPPC/POPG multilamellar vesicles in the absence (black line) and in 
the presence of (P)GKY20 peptide at L/P of 100 (red line), 50 (blue line) and 10 (dark cyan line). All 
the experiments were performed in 10 mM phosphate buffer, pH 7.4. 
 
The DSC profile of this DPPC/POPG mixture has a transition temperature around 
34.4 °C. After the addition of the peptide, at L/P = 100, the peak shape changes. The 
transition temperature is now centered at about 34.6 °C. In addition, it is possible to 
note the appearance of a little shoulder at about 36.5 °C. At L/P = 50, the DSC profile 
is now composed by two distinct peaks. The first one has a transition temperature 
very close to that obtained at L/P = 100 (34.6 °C). The second peak instead, is 
centered at about 37.2 °C. This phenomenon is more evident after a further addition 
of peptide, at L/P = 10. In fact, the thermogram appears as formed by at least two 
well separated peaks centered at lower and at higher temperatures revealing DPPC 
domains enriched and depleted of POPG, respectively. The peak at lower 
temperature (~30 °C) can be attributed to a domain of DPPC particularly enriched of 
POPG. On the other hand, the peak at higher temperature (~37.2 °C) appears to be 
due to DPPC enriched domains with a DPPC/POPG ratio higher than 8/2 mol/mol. 
This scenario is also supported by the comparison of DPPC/POPG thermograms 
obtained by varying the relative lipid proportions and reported in the literature [189]. 
In fact, the progressive addition of POPG to DPPC liposomes leads to a decrease of 
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the gel-to-liquid phase transition temperature coupled with a reduction of the peak 
area (enthalpy change). 
Since the (P)GKY20 possess a net positive charge of 5 at pH 7.4, it sounds reasonable 
that the domains formation is due to its preferential interaction with the negatively 
charged PGs. To strongly support this hypothesis, DSC experiments with 
multilamellar vesicles composed by only DPPG were performed. In Fig. 5.8 are 
reported the DSC thermograms of DPPG liposomes in the absence and in the 
presence of peptide at L/P = 10. 
 
 
Fig. 5.8 DSC thermograms of DPPG multilamellar vesicles in the absence (black line) and in the 
presence of (P)GKY20 (red line) at L/P = 10. The experiments were carried out in 10 mM phosphate 
buffer, pH 7.4. 
 
The DSC profile of DPPG vesicles is characterized by the presence of a pre-transition 
at about 34.5 °C and a main transition at 41.2 °C, in good agreement with data 
previously reported [228]. The little shoulder in the temperature range 43-46 °C is 
typical of DPPG vesicles at low ionic strength [229]. The presence of (P)GKY20 
peptide at L/P = 10 causes a strong perturbation of the DSC profile of DPPG.  The 
pre-transition is abolished, revealing a strong interaction on the surface. The gel-to-
liquid phase transition temperature increases of about 1.5 °C. Moreover, in this case 
a perturbation of lipid acyl chains occurred. Upon the interaction with DPPG the 
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peptide is able to induce a different lipid packing which reflects in a different shape 
of the DSC thermogram. However, this result clearly indicates that there is a very 
strong interaction of (P)GKY20 peptide with the anionic DPPG. Combing this result 
with the observation that the DSC thermogram of pure DPPC is only slightly affected 
by the presence of peptide (Fig. 5.4, panel A), the preferential interaction of 
(P)GKY20 peptide with anionic lipids can be revealed. 
 
5.3.4 The Localization of (P)GKY20 Upon Interaction with the Membrane 
 
To explore the ability of peptide to insert in the membrane, fluorescence quenching 
experiments with acrylamide were performed. Fluorescence emission spectra of the 
peptide in the absence and presence of LUVs of POPC and POPC/POPG at L/P = 
200 were recorded at different acrylamide concentrations. Acrylamide is a water-
soluble molecule which cannot partition inside the hydrophobic core of the 
membrane and it is a quencher of fluorescence emission of Trp [175,190]. According 
to the equation reported in “Quenching Experiments” section, a plot of F0/F versus 
acrylamide concentration gives a straight line whose slope is the Stern-Volmer 
constant, indicated as KSV. The value of KSV is an index of the degree of exposure to 
the aqueous solvent of the aromatic residue in the primary sequence of the peptide. 
Fig. 5.9 shows the Stern-Volmer plots for the acrylamide fluorescence quenching 






Fig. 5.9 Stern-Volmer plots for the fluorescence quenching of (P)GKY20 peptide in the absence 
(black line) and in the presence of POPC (red line) and POPC/POPG (blue line) at L/P = 200. All the 
experiments were carried out in 10 mM phosphate buffer, pH 7.4 at the temperature of 25 °C. 
 
As expected, in the absence of vesicles, the highest value of KSV was obtained 
(14.0±0.6 M-1), because of the complete exposure to the aqueous solvent of the Trp 
residue. In the presence of lipid vesicles lower values of the constants were obtained. 
The values of KSV were 8.8±0.6 M-1 and 6.3±0.4 M-1 in the presence of POPC and 
POPC/POPG, respectively. These results indicate that the peptide penetrates, to 
some extent, both lipid vesicles and that it is slightly deeper inserted into 
POPC/POPG bilayer. Additional information on penetration ability can be obtained 
by comparing the shifts on λmax (wavelength position at the maximum of intensity) 
in the emission spectrum of the peptide, obtained in the titration experiments (Fig. 
5.2). In fact, the position of λmax strongly depends on the polarity of the 
microenvironment in which the residue of Trp is embedded [175]. In particular, the 
position of λmax shifts from λmax > 350 nm when a Trp residue is completely exposed 
to a polar environment (e.g. aqueous solution) to up 310 nm when the residue is in 
apolar environment (e.g. cyclohexane) [175]. In Fig. 5.10 are reported the 
normalized emission spectra of (P)GKY20 in buffer and in the presence of POPC 





Fig. 5.10 Normalized fluorescence emission spectra of (P)GKY20 peptide in phosphate buffer (black 
line) and in the presence of POPC (red line) and POPC/POPG (blue line) unilamellar vesicles at a 
lipid-to-peptide ratio of 200. 
 
An inspection of the spectra reported in Fig. 5.10 revealed that λmax is 355 nm, 349 
nm and 346 nm for (P)GKY20 peptide in buffer, in the presence of POPC (L/P~200) 
and in the presence of POPC/POPG (L/P~200), respectively. This trend indicates 
that going from buffer to POPC to POPC/POPG, the Trp residue of the peptide is 
localized in a less polar environment. However, the observed shifts suggest that, 
despite the strong interaction, the aromatic residue is not significantly inserted in the 
hydrophobic core of both membranes, as observed for other peptides [230,231]. 
Thus, it is possible to conclude that (P)GKY20 doesn’t penetrate deeply inside the 
hydrophobic core of the membrane and it remains localized, probably, at the 
membrane-water interface. These data support the previous hypothesis reported in 
section 5.3.2. 
 
5.3.5 Visualizing the Effect of (P)GKY20 on Bacterial Model Membrane: 
Atomic Force Microscopy 
 
Atomic Force Microscopy (AFM) is a powerful technique with which the effects of 
the peptide on model membranes can be directly visualized [232]. In Fig. 5.11 are 
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reported the AFM images of supported bilayer composed by POPC/POPG in the 
absence and in the presence of 50 µM and 100 µM of (P)GKY20 peptide. The 
experiments were carried out in collaboration with Prof. Roland Winter, Technical 
University of Dortmund (Germany). These peptide concentrations roughly 
correspond to L/P = 50 and L/P = 25. Since after the formation of the supported 
bilayer, the fluid cell was rinsed with buffer to remove unspread liposomes, these 
ratios should be considered as a very rough over-estimation of the lipid-to-peptide 
ratios. 
 
Fig. 5.11 AFM height images of a POPC/POPG bilayer (A) before and after the addition of (B) 50 
µM and (C) 100 µM of (P)GKY20 peptide solution into the AFM fluid cell. In the lower part the 
section profiles of the corresponding AFM images are reported. 
 
The interaction process was followed by imaging the same membrane region 60 min 
after the addition of the peptide. Before peptide addition, it was checked if a uniform 
bilayer has formed on the mica support. The flat image reported in Fig. 5.11, panel 
A, indicate that a uniform bilayer was obtained. Upon the addition of 50 µM of 
peptide, the formation of dark regions was observed (Fig. 5.11, panel B). The 
inspection of the section profile of the acquired image revealed that, on average, the 
height of the dark regions is slightly smaller compared to that of surrounding lipid 
regions (the difference is less than 1 nm). Such scenario is consistent with the 
formation of lipid domains, as suggested by DSC measurements reported above. 
Even more dramatically, upon the addition of a 100 µM peptide solution, complete 
disruption of the membrane took place (Fig. 5.11, panel C). In particular, the line 
profile reveals that the average height of the bilayer has become thinner and that part 
of the lipids has been extracted (as indicated by the occurrence of deep dips) forming 
104 
 
mixed peptide-lipids clusters - most likely of micellar type – remaining, at least in 
part, localized on the surface of the membrane. 
 
5.3.6 The Effects of (P)GKY20 on Size and Morphology of Lipid Vesicles 
 
Dynamic light scattering (DLS) measurements were carried out to verify the 
influence of peptide on the size of lipid vesicles. In Fig. 5.12 are reported the 
hydrodynamic radius distribution functions for POPC and POPC/POPG in the 
absence and in the presence of (P)GKY20 peptide at different L/P ratios. 
 
 
Fig. 5.12 Hydrodynamic radius distribution functions for POPC (left panel) and POPC/POPG (right 
panel) large unilamellar vesicles as a function of lipid-to-peptide mole ratio. All the experiments were 
carried out in 10 mM phosphate buffer at the temperature of 25 °C. 
 
In the absence of peptide, both lipid systems form a single population of LUVs with 
similar average hydrodynamic radius (RH) of about 120 nm, as a result of the 
extrusion procedure. The addition of peptide to POPC vesicles does not affect their 
size distribution, even at very high peptide concentration. This result confirms the 
low perturbation activity with eukaryotic-like membrane. For POPC/POPG the 
addition of (P)GKY20 peptide does not affect the size distribution at L/P = 100. At 
L/P = 50 a slight modification occurred and starting from L/P = 25 the presence of a 
population of liposomes with a very large RH was observed. These results suggest 
that the peptide induces the formation of large aggregates or it favours the fusion (or 
even hemifusion) among liposomes composed by POPC/POPG. 
Unfortunately, from this experiment it is not possible to know if the formation of the 
large population is due to an aggregation or a (hemi)fusion process among lipid 
vesicles. A way to try to answer this question is to verify the reversibility of the 
observed process. If an aggregation process occurs, a high dilution of the lipid 
suspension should favour the dissociation of vesicles. In fact, due to a high energetic 
cost is very unlikely that two or more fused vesicles separate in distinct ones. In Fig. 
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5.13 are reported the hydrodynamic radius distribution functions for POPC/POPG 
LUVs in the presence of peptide at L/P = 10 before and after 10-time dilution with 
phosphate buffer. For comparison, the sample composed by POPC/POPG without 
the peptide is also reported.  
 
Fig. 5.13 Hydrodynamic radius distribution functions for POPC/POPG unilamellar vesicles: i) in 
buffer (black line), ii) in the presence of peptide at L/P = 10 (red line) and iii) as the same in ii) but 
diluted 10 times (blue line). 
 
Surprisingly, the formation of the large population is a reversible process. This 
observation strongly supports the idea that an aggregation process among liposomes 
took place and not (hemi)fusion. This unusual phenomenon was already observed 
for the antimicrobial peptide LAH4 [233] and it was ascribed to the ability of the 
positively charged peptide to neutralize the negative charge of liposomes and the 
formation of weak peptide-peptide interactions between peptides on different 
liposomes. 
To directly visualize vesicles topological changes and further support the hypothesis 
of aggregation, confocal fluorescence microscopy experiments were carried out, in 
collaboration with Prof. Roland Winter at the Technical University of Dortmund 
(Germany). The experiments were performed using giant unilamellar vesicles 
(GUVs) labelled with the fluorescent probe N-Rh-DHPE. In Fig. 5.14 are reported 
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Fig. 5.14 Confocal fluorescence microscopy images of POPC/POPG GUVs before (left) and after 
(right) the addition of 10 µM of peptide solution. 
 
The image of GUVs before the addition of the peptide confirms that the 
electroformation protocol was successfully applied and giant unilamellar vesicles 
were formed. Upon the addition of peptide (right panel), dramatic changes both in 
size and shape of GUVs were observed. As suggested by DLS measurements, the 
peptide induces the formation of aggregates. Moreover, upon aggregation, the shape 
of vesicles changes, revealing the ability of the peptide to modulate the morphology 
of the lipid vesicles. These results reflect the ability of the peptide to mediate lipid-
lipid interactions [233]. Most likely, similar peptide-mediated interactions are 
involved in the lipid extraction process and formation of mixed peptide-lipid 




Antimicrobial peptides (AMPs) comprise a particular class of amino acids-based 
antibiotics [52]. Since they interact in a non-specific way with the lipid matrix of the 
bacterial membrane [12], they can overcome the problem of resistance to antibiotics 
in bacteria [6,8], thereby representing an alternative to conventional drugs. 
Understanding the molecular basis of the interaction process with the membrane is 
mandatory for biomedical applications. Moreover, such knowledge is critical for the 
development on AMPs with improved antimicrobial activity and low cytotoxicity.  
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The antimicrobial peptide (P)GKY20 is a peptide composed by 21 amino acids. It is 
modelled on the Gly271 to Ile290 sequence in the C-terminus region of the human 
thrombin [178]. It possesses a net positive charge of 5 at physiological pH of 7.4, a 
low hemolytic activity and a good antimicrobial activity especially against gram-
negative bacteria. However, the underlying mechanism of its action is still unknown. 
Thus, a detailed biophysical study was carried out to elucidate the interaction process 
of (P)GKY20 with model membrane systems. Liposomes with two different lipid 
composition were used. Liposomes composed by POPC can be considered as a 
model of the eukaryotic plasma membrane. Liposomes composed by a mixture of 
POPC and POPG were used as simplified model of the cytoplasmic bacterial 
membrane, since it is mainly composed by zwitterionic and negatively charged lipids 
[12,234]. 
The binding isotherms obtained by means of fluorescence experiments (Fig. 5.2) 
revealed that (P)GKY20 is able to interact with both model membranes with binding 
constants which differ less than one order of magnitude. This small difference does 
not account for the low hemolytic activity and good antimicrobial activity of 
(P)GKY20. Instead, circular dichroism experiments (Fig. 5.3) clearly reveal a 
difference in the secondary structure adopted by the peptide. The deconvolution of 
CD spectra indicate that the percentage of α-helix is sensitive higher in the presence 
of POPC/POPG (46%) than in the presence of POPC (14%). Thus, the capacity of 
(P)GKY20 to adopt a helix structure could be related to membrane perturbation 
activity [29,34,235,236]. The DSC measurements (Fig. 5.4) carried out on DPPC and 
DPPC/DPPG vesicles confirmed the different perturbation ability of (P)GKY20 
peptide on eukaryotic and bacterial model membranes. The presence of peptide does 
not perturb the thermotropic properties of DPPC liposomes. This result was 
confirmed by fluorescence experiments with the probe Laurdan, where only a slight 
increase of the GP value on POPC was detected. In addition, DLS measurements 
showed that the peptide does not perturb the size distribution of POPC LUVs. Thus, 
in good agreement with the low cytotoxicity of (P)GKY20, the peptide is able to 
interact with eukaryotic model membranes, but the lack of a definite secondary 
structure upon interaction prevent the membrane destabilization. 
In the case of bacterial model membrane composed by PCs and PGs, the peptide 
changes significantly its secondary structure adopting a α-helix structure, as 
suggested by CD experiments. Most likely, the conformational change leads to an 
amphipathic structure which facilitates the interaction with and the perturbation of 
the membrane (section 1.2). The value of the mole fraction partition constant (Kx) 
for the interaction with POPC/POPG is (1.4±0.4)∙106. From this value is possible to 
determine the fraction of bound peptide in the CD experiments at L/P = 100 (Fig. 
5.3). A simple calculation reveals that about 98% of peptide should be bound to the 
membrane. Since the deconvolution of the CD spectra at L/P = 100 indicate that the 
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percentage of α-helix is 46%, this means that about half of the peptide amino acids 
should be in helical conformation. Most likely, the portion of peptide that adopts the 
helical structure comprises the amino acids RLKKWIQKVI on the C-terminus side 
of the peptide. This idea is supported by several observations. First, this region leads 
to a perfect amphipathic structure when represented by means of helical wheel 
projection (Fig. 5.15), as evidenced by the calculated hydrophobic moment <µH> of 
0.778. It is widely accepted that linear AMPs adopt an amphipathic helical structure 
upon binding to membrane and it is fundamental for the antimicrobial activity. 
 
 
Fig. 5.15 The helical wheel projection of the RLKKWIQKVI segment of (P)GKY20. The arrow 
represents the hydrophobic moment vector (0.778).  Yellow circles represent hydrophobic residues, 
blue circles positively charged residues and pink circles polar residues with no charge. The projection 
was made by means of Heliquest software [40]. 
 
Second, it is interesting to note that the same region in the human thrombin is in the 
α-helix conformation. The other part assumes a small β-strand with turns and 
unstructured portions (Fig. 5.1) [216]. Finally, a systematic study carried out on the 
antimicrobial potency of (P)GKY20 analog peptides of different lengths showed that 
the peptide composed by GKYGFYTHVF sequence has no antimicrobial activity 
[178]. This region corresponds to the N-terminus region of (P)GKY20. Thus, on 
these bases it is possible to speculate that the region which adopts the amphipathic 
helical structure in the peptide (P)GKY20 is the C-terminus portion with the 
sequence RLKKWIQKVI. 
The interaction with POPC/POPG liposomes and the conformational change of 
(P)GKY20 peptide has several consequences on the stability of the bilayer. 
Differential scanning calorimetry measurements on DPPC/DPPG multilamellar 
vesicles suggest that, upon interaction, (P)GKY20 peptide is able to induce the 
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formation of lipid domains which differ in lipid composition and melt at different 
temperatures (Fig. 5.4). The formation of domains was confirmed by DSC 
experiments where DPPG was replaced by POPG (Fig. 5.6). In these experiments, 
the progressive addition of (P)GKY20 induces the formation of DPPC enriched and 
POPG enriched domains. At L/P = 10 the DSC thermogram is composed by two well 
defined peaks which gave two transitions at higher and lower temperature. The peak 
at higher temperature could be attributed to the DPPC enriched domain. On the 
contrary, the peak at lower temperature could be due to a DPPC domain particularly 
enriched of POPG. The formation of domains has a deep impact on the stability of 
the membrane. The interface among domains act as defects in destabilizing the 
membrane promoting membrane permeabilization [12,87,199,200]. The formation 
of domains is triggered by the preferential interaction of the cationic (P)GKY20 
peptide with the negatively charged lipids PGs, as observed in many other cases 
[86,88,198,237]. The selective interaction with anionic lipids was revealed by DSC 
measurements with liposomes composed by only DPPG (Fig. 5.8). In fact, a strong 
perturbation of the DSC thermogram was observed. In contrast, the DSC 
thermogram of pure DPPC is only slightly affected. 
The DSC results obtained for DPPC/DPPG vesicles in the presence of peptide 
suggested additional features on the action mechanism. An increase of the transition 
temperature compared to that in the absence of peptide strongly suggest that the 
peptide is not able to penetrate inside the hydrophobic core of the membrane but 
remains at the membrane-water interface. This is also supported by the observation 
that the enthalpy change of DPPC/DPPG liposomes is not affected by the presence 
of peptide. The interaction on the surface leads to a more compact membrane, 
because the presence of peptide screens the repulsion among lipid head groups 
[185,212]. This scenario is supported by several experiments. The variation of the 
GP parameter for Laurdan embedded in DPPC/DPPG LUVs confirms this idea (Fig. 
5.5). In fact, in the presence of peptide at L/P = 10, the GP parameter is higher, 
clearly indicating that the peptide leads to a more compact membrane which can be 
rationalized by only assuming that the peptide cannot penetrate deeply in the 
membrane [227]. The same experiment on the GP values obtained for Laurdan in 
POPC/POPG as a function of peptide concentration led to the same conclusion. The 
localization of the peptide at membrane-water interface was finally supported by 
fluorescence quenching experiments and the spectral shifts in the λmax of the 
fluorescence emission spectra of (P)GKY20 (section 5.3.4). In fact, usually peptides 
which insert in the hydrophobic core of the membrane give lower values of KSV 
[238,239]. In addition, the position of λmax is only 346 nm. The shift is quite modest 
compared to the peptide in the absence of lipid vesicles (355 nm). This result indicate 
that the peptides is inserted at some extent in the membrane, but not inside the 
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hydrophobic core, otherwise a more consistent shift toward shorter wavelengths 
should be observed [175]. 
Atomic force microscopy (AFM) experiments gave the possibility to direct visualize 
the effects of (P)GKY20 on the bacterial model membrane composed by 
POPC/POPG (Fig. 5.11). The acquired images revealed the formation of lipid 
domains upon the addition of 50 µM (P)GKY20, as evidenced in DSC experiments. 
In fact, the presence of some dark regions slightly smaller compared to the 
surrounding lipids was detected. At 100 µM of peptide solution (Fig. 5.11, panel C), 
a complete destabilization of the membrane occurred. The inspection of the 
corresponding line profile reveals that the in some membrane regions lipids have 
been extracted (as indicated by the occurrence of deep dips) forming peptide-lipid 
clusters which can remain (in part) localized on the surface of the membrane 
justifying the very high peaks in the section profile. The AFM results pointed out the 
peptide-concentration dependent nature of the action mechanism of (P)GKY20, a 
common feature of many AMPs [12]. 
In agreement with the DSC and AFM results, it is possible to conclude that domain 
formation induced by recruiting anionic lipids is a crucial step in the mechanism of 
the (P)GKY20 peptide-membrane interaction process. It is known that the packing 
defects at the boundaries of such domains represent instability regions of the lipid 
bilayer [12,200]. The concomitant increase of line tension at domain boundaries 
could lead to further accumulation of peptide and formation of larger domains. It is 
reasonable to assume that the increase in the cross-sectional area per lipid in the PG-
enriched domains due to peptide binding induces a local positive curvature of the 
membrane, facilitating lipid extraction and formation of mixed peptide-lipid micelles 
as observed by AFM experiments (Fig. 5.11). 
Finally, dynamic light scattering experiments evidenced that (P)GKY20 is able to 
induce aggregation of POPC/POPG liposomes. As reported in section 5.3.6, it was 
found that the aggregation of liposomes is a reversible process suggesting that only 
weak interaction among peptides on different liposomes are involved. A similar 
phenomenon was reported for the peptide LAH4 [233] and it was ascribed to the 
ability of the positively charged peptide to neutralize the negative charge of 
liposomes. For LAH4 peptide it was conclude that the association of liposomes is 
only driven by electrostatic interactions. This is because the aggregation was only 
observed at a well-defined L/P ratio where the overall liposome charge was 
neutralized by the positive charge of the peptide. In fact, below this L/P, the peptide 
causes an excess of positive charge which leads to the disaggregation of liposomes 
[233]. In the case of (P)GKY20, a complete neutralization of liposomes charge 
should be accomplished at L/P = 25 where the formation of aggregates was observed. 
With the further addition of peptide (L/P = 10) the disaggregation of liposomes was 
not observed, as in the case of LAH4 peptide. This observation strongly indicates 
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that the aggregation of liposomes is mediated not only by electrostatic interactions 
but also by others weak peptide-peptide interactions on different liposomes, as 
hydrophobic ones. The application of confocal fluorescence confirmed the formation 
of aggregates. In addition, it was revealed the ability of peptide to modulate the 
morphology of lipid vesicles. Overall these results strongly support the idea that the 
peptide can modulate interactions among liposomes and, probably, similar forces are 
involved in the lipid extraction and formation of mixed peptide-lipid clusters as 
detected by AFM. The uncommon capacity of (P)GKY20 peptide to induce 
reversible aggregation merits further attentions and it will be explored in detail in the 
future. 
To summarize, the combined array of data suggests that probably the (P)GKY20 
peptide act through a carpet mechanism [80]. The (P)GKY20 peptide, remaining at 
the membrane-water interface, induces irreversible lesions to the bilayer through a 
lipid extraction process promoted by the accumulation of peptides at domains 
enriched in anionic lipids. On these bases, it is possible to summarize the key steps 
in the action mechanism of (P)GKY20 on bacterial model membrane as follows 
(Scheme 1): i) recruitment and preferential electrostatic binding of the random-coil 
peptide to negatively charged lipids, coupled with peptide folding in a helix-like 
conformation; ii) subsequent formation of large domains enriched in negatively 
charged lipids and peptides, which results in a local positive curvature of the 
membrane; iii) finally, upon reaching a certain threshold concentration of the 
peptide, through peptide-mediated lipid-lipid interactions, (P)GKY20 extracts lipids 
from the bilayer leading to a complete disruption of the membrane and formation of 




Scheme 1. Proposed mechanism of action of the (P)GKY20 peptide with bacterial model membranes: 
i) preferential binding of the disordered peptide to the negatively charged lipids coupled with peptide 
folding adopting a helical conformation; ii) consequential formation of large domains enriched of 
negatively charged lipids and peptides which leads to local positive membrane curvature; iii) finally, 
upon reaching a threshold peptide concentration, through peptide-mediated interactions, (P)GKY20 
extracts lipids from the lipid bilayer leading to formation of mixed lipid-peptide micelles and 
complete disruption of the membrane. 
 
 
The reported data have shed a first light on the molecular basis of the action 
mechanism of the natural antimicrobial peptide (P)GKY20, pointing out important 
features at the level of peptide-lipid interactions. Such knowledge can be useful in 



















In this chapter are reported some results concerning the interaction of the 
antimicrobial peptide (P)GKY20 with cyclodextrins. 
As stated in section 1.5, the final goal in studying AMPs is their use in medicine. 
However, the application of natural amino acids containing peptides is seriously 
limited. In fact, peptides are not chemically e physically stable. They are prone to 
hydrolysis and oxidation which can modify the biological activity. In addition, once 
inside the human body, proteases [92] can cleave the peptide at specific site or at the 
C- or N- terminus, reducing the peptides’ half-life in the plasma. Finally, the 
possibility that AMPs can interact with serum proteins (e.g. human serum albumin) 
should be considered [240]. Clearly, all these aspects inevitably lead to the 
unfavorable pharmacological profile of antimicrobial peptides. Encapsulation of 
AMPs could represent a way to protect the peptides improving their pharmacological 
properties. Cyclodextrins (CDs) are cyclic oligosaccharides [241] widely used in 
pharmaceutical, food and cosmetic industries as drug encapsulating agents to 
increase solubility and stability of compounds [242,243]. They are composed by 
glucopyranose units linked through α-(1-4)-glycosidic bonds. There are three 
naturally occurring CDs: α-, β- and γ-CD composed by 6, 7 and 8 glucopyranose 
units, respectively [241] (Fig. 6.1). 
 
 
Fig. 6.1 The chemical structures of natural cyclodextrins: α-, β- and γ-CDs. Taken from 
https://en.wikipedia.org/wiki/Cyclodextrin. 
 
Given the low solubility of natural CDs, a series of modified ones were developed 
[241]. Several chemical groups, such as hydroxypropyl o methyl, can replace the OH 
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groups in the sugar rings improving the affinity for the peptide and/or enhancing its 
solubility and safety. CDs can form inclusion complex in solution where a lipophilic 
guest molecule inserts inside the hydrophobic cavity of the sugar ring [244]. In 
proteins and peptides, CDs interact with hydrophobic side chains of amino acids. 
The type of side chains incorporated inside the cavity depends on the size of CDs. 
The most used CDs are the β-CDs which have the right size to accommodate 
aromatic residues, such as tryptophan and tyrosine [245]. The extent of complexation 
is strongly dependent on the binding constant (Kb) between peptide and CDs [241]. 
It is known that the binding constants for such interaction is very low (in the range 
50-2000 M-1) [244]. Thus, to reach an efficient extent of complexation, a high 
amount of CD is required. Even if CDs are regarded as safety compounds, a high 
amount of the sugar could have adverse effects on human health. In fact, the ability 
of CDs to extract lipids [241,245], such as cholesterol, from the membrane is widely 
known. Thus, it is important to find, for a particular drug (such as AMPs), the right 
CDs which can interact with a suitable binding constant (neither too much low, nor 
to much high) without affecting the drug properties. In this way a good encapsulation 
efficiency can be reached by using a small amount of CDs. 
In this chapter, some preliminary data on the characterization of the interaction 
between the AMP (P)GKY20 and the anionic sulfobutylether-β-cyclodextrin (SBE- 
β-CD) serving as encapsulating agent are reported. For comparison, the interaction 
with the widely used [246,247] neutral hydroxypropyl-β-cyclodextrin (HP-β-CD) 
was also explored. The chemical structures of SBE-β-CD and HP-β-CD are reported 
in Fig. 6.2 
 
Fig. 6.2 The chemical structures of SBE-β-CD (left) and HP-β-CD. Adapted from www.medkoo.com 
 
In chapter 5 it was shown that the antimicrobial peptide (P)GKY20 is able to 
drastically perturb the bacterial model membrane, whereas no effect on eukaryotic 
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model membrane was detected. The reported results well correlate with the observed 
good antimicrobial activity and the low cytotoxicity [178] making (P)GKY20 a good 
candidate for biomedical application. However, being susceptible to the proteases 
action, (P)GKY20 is not stable [93]. Thus, it could be useful to find a suitable 
encapsulating agent that can protect the peptide without compromising its biological 
activity. 
The obtained results indicate that the (P)GKY20 interacts with the anionic SBE-β-
CD forming a 1:1 complex. Most likely the interaction takes place through the 
formation of an inclusion complex where the Trp residue of the peptide inserts inside 
the hydrophobic cavity of the sugar ring. It was found that the binding constant (Kb) 
is in the order of 104 M-1, which is sensitive higher respect to the binding constant 
found for the widely used neutral HP-β-CD (~ 102 M-1). This difference could be 
ascribed to the presence of sulfobutylether groups which confer a net negative charge 
to SBE-β-CD enhancing the affinity for the positively charged peptide. Finally, 
differential scanning calorimetry data revealed that the peptide, even in the presence 
of SBE-β-CD, is still active towards the bacterial model membrane. 
These preliminary data demonstrated that, in principle, SBE-β-CD could be used as 
efficient encapsulating agent for the (P)GKY20 peptide with the intent to improve 
its pharmacological properties. 
 
6.2 Materials and Methods 
 
Materials. The antimicrobial peptide (P)GKY20 was obtained as described in the 
Materials section 5.2. The sulfobutylether-β-cyclodextrin (SBE- β-CD, MW: 1451 
Da, average degree of substitution: 0.28) was purchased from Sigma Aldrich 
Chemical. The hydroxypropyl-β-cyclodextrin (HP-β-CD, MW: 1501 Da, average 
degree of substitution: 0.85-1) was purchased from CycloLab (Budapest, Hungary). 
The lipids 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dipalmitoyl-
sn-glycero-3-phospho-1'-rac-glycerol (DPPG) were obtained from Avanti Polar 
Lipids Inc and used without further purifications. Chloroform and methanol were 
purchased from Sigma Aldrich Chemical. The phosphate buffer, 10 mM pH 7.4, was 
prepared by using deionized water. 
 
Liposomes Preparation. Appropriate amounts of lipids were weighed and dissolved 
in a chloroform/methanol (2/1 v/v) mixture. Then, a thin film was produced by 
evaporation of the organic solvent with nitrogen gas. To remove final traces of 
organic solvent, the sample was placed under vacuum overnight. Then, the sample 
was hydrated with an appropriate volume of 10 mM phosphate buffer, pH 7.4, and 
vigorously mixed obtaining a suspension of multilamellar vesicles (MLVs). 
Liposomes composed by a mixture of DPPC/DPPG (8/2 mol/mol) were prepared as 
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simplified model of the cytoplasmic bacterial membrane, since the bacterial 
membrane is mainly composed by zwitterionic and negatively charged lipids [12]. 
 
Fluorescence. Fluorescence spectroscopy experiments were carried to check the 
ability of the (P)GKY20 peptide to bind to SBE-β-CD and HP-β-CD. Fluorescence 
emission spectra were acquired by means of K2 spectrofluorometer from ISS 
(Champaign, Illinois, USA), using a quartz cuvette with a path length of 1 cm at the 
temperature of 25 °C and under constant stirring. The excitation wavelength was set 
to 280 nm and emission spectra were recorded in the range 315-525 nm. The slit 
widths for excitation and emission wavelengths were set both to 8 nm. The titrations 
were performed by recording the spectra of a solution of peptide at fixed 
concentration of 4.5 μM and SBE-β-CD concentrations ranging from 0 to 800 μM. 
In the case of HP-β-CD, the cyclodextrin concentration was in the range 0-24 mM. 
The binding curve was obtained by plotting F0/F versus cyclodextrin concentration, 
where F0 is fluorescence intensity of the peptide in the absence of CD at 355 nm and 
F is the intensity in the presence of CD at the same wavelength. The binding constant 
was determined by fitting the experimental points with a 1:1 binding model equation 
as reported in detail in [248]. 
 
Job’s Plot. To verify and confirm the binding stoichiometry between (P)GKY20 and 
SBE- β-CD, the continuous variations method (also known as Job’s plot) was applied 
[176] by means of UV/Vis spectrophotometry. The UV/Vis spectra were recorded 
on a Cary 5000 from Agilent Technologies by using a 1-cm quartz cuvette at the 
temperature of 25 °C. In this experiment, the mole fraction of the peptide was varied 
from 0.1 to 1 and the total molar concentration (peptide + CD) was fixed at 200 μM. 
As blank measurements, the same experiment was repeated in the absence of SBE-
β-CD. A plot of ΔA=Acomplex-Apeptide versus the peptide mole fraction (where Acomplex 
is the absorbance of the complex at 280 nm and Apeptide was the absorbance at the 
same wavelength of the peptide alone) was done to determine the final binding 
stoichiometry. The experiments were carried out in triplicate. 
 
Isothermal Titration Calorimetry (ITC). ITC measurements were performed 
using a Nano-ITC III from TA instruments (New Castle, DE, USA) at the 
temperature of 25 °C. Briefly, 30 µM of peptide solution was placed in the 
calorimetry vessel (about 1 mL) and titrated by injecting a 4 mM SBE-β-CD solution 
(250 µL) in 16 aliquots of 15.15 µL with 600 s intervals between the individual 
injections. To account for the heats of dilution of the injected SBE-β-CD, a control 
experiment where the same solution of SBE-β-CD was titrated in the phosphate 
buffer without peptide was performed. The heat peaks obtained from the titration 
117 
 
experiment were integrated by using NanoAnalyze software supplied with the 
instruments. 
The binding enthalpy change (ΔbH) was determined by dividing the cumulative heat 
∑ 𝛥ℎ௞௡ଵ , calculated by summing over all the n = 16 injections the recorded heats at 
each step of titration (Δhk), by the moles of peptide in the calorimetry vessel. To 
determine the binding constant (Kb), a plot of the cumulative heat ∑ 𝛥ℎ௞௡ଵ , 
normalized by peptide moles, as function of SBE-β-CD concentration was fitted with 
a 1:1 binding model equation [205]. The cumulative heat ∑ 𝛥ℎ௞௡ଵ  at the k-th injection 
of CD was obtained by summing the recorded heat from the first to the k-th injection. 
The binding Gibbs energy and its entropic contribution were calculated using the 
relationships ΔbG° = −RT ln Kb (R = 8.314 J mol−1 K−1, T = 298 K) and TΔbS = 
ΔbH−ΔbG°. The experiments were carried out in duplicate. 
 
Circular Dichroism (CD). Far-UV CD spectra of the peptide were recorded in order 
to verify the peptide secondary structure upon interaction with SBE-β-CD. CD 
spectra were recorded by using a JASCO J-715 spectropolarimeter (Jasco 
Corporation, Tokyo, Japan) in a 0.1 cm path length quartz cuvette as an average of 
3 scans, using the following parameters: scan speed of 20 nm/min, 4 s response time, 
2 nm bandwidth. Samples were prepared in 10 mM phosphate buffer, pH 7.4, at the 
peptide concentration of 20 μM in the absence and presence of SBE-β-CD at the 
concentration of 100 µM. For each sample, a background blank (buffer or buffer 
with CDs) was subtracted. 
 
Differential Scanning Calorimetry (DSC). DSC experiments were carried out by 
means of a nano-DSC from TA Instruments (New Castle, DE, USA) MLVs were 
used since they provide the better resolution of the phase transition peaks [174]. 
Briefly, 300 μL of 0.5 mM vesicles suspension of DPPC/DPPG in 10 mM phosphate 
buffer, pH 7.4 was placed in the calorimetry vessel, and successive heating and 
cooling scans were performed at the scan speed of 1 °C/min. Then, DSC experiments 
of the same lipid mixture in the presence of 50 µM of SBE-β-CD, or 50 µM of 
(P)GKY20 or in the presence of 50 µM SBE-β-CD + 50 µM pf (P)GKY20 were 
performed.  
The excess heat capacity function (<ΔCp>) was obtained after baseline subtraction. 
A buffer-buffer scan was subtracted from the sample scan. The samples were freshly 
prepared just before the experiments, by adding the appropriate amount of peptide 
and/or cyclodextrin to the lipid suspension and waiting at least 30 min to ensure that 
the equilibrium was reached. The reversibility of the process was ensured by the 
superposition of successive heating scans. The data obtained were analyzed by 
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means of the NanoAnalyze software supplied with the instrument and plotted using 




6.3.1 The Interaction of (P)GKY20 with CDs: SBE-β-CD versus HP-β-CD 
 
In order to verify the ability of SBE-β-CD to interact with (P)GKY20 peptide, the 
changes in fluorescence emission spectra of peptide as function of cyclodextrin 
concentration was followed. For comparison, the same experiment was performed 
with the widely used HP-β-CD. In Fig. 6.3 are reported the fluorescence emission 
spectra of (P)GKY20 in the presence of increasing amount of SBE-β-CD (panel A) 
and HP-β-CD (panel B) upon excitation at 280 nm. 
 
 
Fig. 6.3 Fluorescence emission spectra of (P)GKY20 peptide in the presence of increasing amounts 
of SBE-β-CD (panel A) and HP-β-CD (panel B). The dashed lines represent the spectra of peptide in 
the absence of CDs. All the experiments were carried out in 10 mM phosphate buffer, pH 7.5 at 25 
°C.  
 
The fluorescence emission spectra of (P)GKY20 is centered at about 355 nm. Upon 
the addition of SBE-β-CD, an increase of fluorescence emission was observed. 
Moreover, the position at the maximum of intensity (λmax) shifts to the lowest value 
of 341 nm in the presence of ~800 µM of SBE-β-CD. This result indicates that, most 
likely, the cyclodextrin forms an inclusion complex with the Trp residue of the 
peptide. The Trp residue is the main responsible of the fluorescence emission in 
peptides and proteins [175]. In addition, Trp is the only environment-sensitive 
fluorescent residue in the peptide. Thus, the observed spectral shift indicates that the 
Trp residue is experiencing a more hydrophobic environment, i.e. the cavity of the 
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cyclodextrin. In contrast, in the presence of HP-β-CD the shift in the λmax is modest. 
In fact, a shift to 352 nm at about 24 mM of HP-β-CD coupled with an increase of 
fluorescence emission was observed. It is important to note the great difference in 
the concentration used for the two experiments: in the range 0-800 µM for SBE-β-
CD, whereas in the range 0-24 mM for HP-β-CD. This observation pointed out that 
the two cyclodextrins have very different affinities for (P)GKY20 peptide. 
In order to obtain the values of binding constants (Kb), isotherm binding curves were 
obtained from the fluorescence spectra in Fig. 6.3 by plotting F0/F versus 
cyclodextrin concentration, where F0 is fluorescence intensity of the peptide in the 
absence of CD at 355 nm and F is the intensity in the presence of CD at the same 
wavelength (Fig. 6.4). Then, to determine the final values of Kb the experimental 
points were fitted with 1:1 binding model equation [248] where the interaction of 
one peptide molecule with one CD is supposed. 
 
Fig. 6.4 The binding curves obtained from the fluorometric titration of a solution of (P)GKY20 
peptide with SBE-β-CD (panel A) and HP-β-CD (panel B). All the experiments were carried out in 
10 mM phosphate buffer, pH 7.4 at the temperature of 25 °C. 
 
Data analysis revealed that the binding constant for SBE-β-CD is (3.9±1.5)∙104 M-1. 
On the contrary, the binding constant for HP-β-CD is only (6.4±4.0)∙102 M-1. Thus, 
the sulfobutylether CD has an affinity two order of magnitude higher respect to 
hydroxypropylated CD. These data clearly show that the anionic CDs could be a 
better encapsulating agent for (P)GKY20 peptide. For this reason, only the 
characterization with SBE-β-CD was further explored. 
 
6.3.2 The (P)GKY20 Peptide Forms a 1:1 Complex with SBE-β-CD 
 
In the previous section, the Kb of (P)GKY20 for the SBE-β-CD was determined. In 
data analysis a 1:1 stoichiometry was supposed, as commonly done in the literature 
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in treating the formation of inclusion complexes involving CDs. To further support 
the formation of 1:1 complex, the continuous variation method, also known as Job’s 
plot, was applied [176,249]. In this method, UV spectra of (P)GKY20 in the presence 
of SBE-β-CD were recorded. The peptide mole fraction was varied in the range 0.1-
1 by holding the total concentration of both compounds, [(P)GKY20] + [SBE-β-CD], 
at 200 µM. Then, spectra of peptide in the absence of CD at the same concentrations 
used before were recorded. A plot of ΔA = Acomplex - Apeptide versus the peptide mole 
fraction (where Acomplex is the absorbance of the complex at 280 nm and Apeptide was 
the absorbance at the same wavelength of the peptide alone) was done in order to 
determine the final binding stoichiometry. In Fig. 6.5 is reported the Job’s plot for 
this system. 
 
Fig. 6.5 The Job’s plot for the system composed by (P)GKY20 and SBE-β-CD. The experiment was 
carried out in 10 mM phosphate buffer, pH 7.4 at 25 °C. 
 
The reported Job’s plot shows only one intersection point at peptide mole fraction of 
0.5, clearly indicating the formation of 1:1 complex, i.e. one peptide molecule 
interacts with one molecule of SBE-β-CD. This result completely validates the 




6.3.3 (P)GKY20 Secondary Structure upon Interaction with SBE-β-CD 
 
Circular dichroism (CD) spectroscopy was carried out to check the secondary 
structure adopted by the peptide in the presence of sulfobutylether-β-CD. In Fig. 6.6 
are reported the CD spectra of 20 µM (P)GKY20 peptide solution in the absence and 
in the presence of 100 µM SBE-β-CD in 10 mM phosphate buffer, pH 7.4 at the 
temperature of 25 °C. 
 
Fig. 6.6 CD spectra of (P)GKY20 in the absence (black line) and in the presence of SBE-β-CD (red 
line) at cyclodextrin-to-peptide ratio of 5. 
 
As described in the section 5.3.1 of the chapter 5, the peptide adopts a random 
structure in solution, as evidenced by the presence of a minimum at about 200 nm. 
Upon the addition of SBE-β-CD at the CD-to-peptide ratio of 5, only minor changes 
in the spectrum are revealed, indicating that the peptide essentially does not change 
its secondary structure. This result supports the formation of complex through an 
inclusion process where the Trp residue is inserted in the hydrophobic cavity of the 
sugar ring. In fact, the strong shift in the fluorescence spectra (Fig. 6.3) can be only 
due to this process since the technique has evidenced no conformational variations 
that could be change the Trp local environment. 
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6.3.4 Thermodynamics of Interaction between (P)GKY20 and SBE-β-CD 
 
To further characterize the interaction process between the AMP (P)GKY20 and the 
sulfobutylether CD, isothermal titration calorimetry (ITC) experiment was carried 
out. ITC is a high-accuracy method for measuring binding affinities [250]. Moreover, 
it is the only technique that directly measures the binding enthalpy. ITC also allows 
to determine enthalpic and entropic components of the free energy of binding 
revealing the overall nature of the forces that drive the binding reaction [251]. In Fig. 
6.7 are reported the ITC trace and the corresponding binding isotherm obtained from 
the titration of 30 µM solution of (P)GKY20 with 4 mM of SBE-β-CD. 
 
 
Fig. 6.7 The ITC trace (left panel) and the corresponding binding isotherm (right panel) obtained from 
the titration of a solution of (P)GKY20 peptide with SBE-β-CD. The red line represents the best curve 
fit obtained using a 1:1 binding model equation. The experiment was carried out in 10 mM phosphate 
buffer, pH 7.4 at 25 °C. 
 
In the ITC experiment, the peptide solution is placed in the calorimeter vessel and a 
solution of SBE-β-CD is injected via the titration syringe. After each addition of 
SBE-β-CD, peptide is bound to the sugar and it is removed from bulk solution. Hence 
with increasing SBE-β-CD concentration in the reaction vessel less and less peptide 
is available for binding. The heat of reaction is therefore no constant but decreases 
with each injection. This leads to the ITC trace reported in Fig. 6.7, left panel. The 
binding enthalpy change (ΔbH) was calculated by summing all the recorded heats at 
each step of titration (corrected for the heat of dilution of the injected SBE-β-CD) 
divided by the peptide moles in the calorimetry vessel. Instead, from the plot of the 
cumulative heat versus the SBE-β-CD concentration (Fig. 6.7, right panel) it was 
possible to determine the Kb by fitting the experimental points with 1:1 binding 
model equation. The use of this binding model was validated by the Job’s plot 
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reported in Fig. 6.5. With ΔbH and Kb determined, using the well-known relations 
ΔbG° = −RT ln Kb (R = 8.314 J mol−1 K−1, T = 298 K) and TΔbS = ΔbH−ΔbG°, a full 
thermodynamic characterization was obtained. In Table 1 are summarized the 
thermodynamic parameters. 
 
Table 1 Thermodynamic parameters obtained from the titration of a solution of (P)GKY20 peptide 
with a solution of SBE-β-CD at the temperature of 25 °C. 
Kb (M-1) ΔbH (kJ/mol) ΔbG° (kJ/mol) TΔbS (kJ/mol) 
(1.6±0.6)∙104 -2.3±0.5 -24.0±1.0 21.7±1.2 
 
The obtained binding constant (Kb) is in excellent agreement with the one determined 
by means of fluorescence experiment. An inspection of the Table 1 reveals that the 
enthalpy change for the binding is low and exothermic, suggesting that weak non-
bonding interactions are involved in the formation of the complex [252]. In addition, 
its contribution to the binding free energy is quite modest. The entropy change for 
the interaction process is positive. This could be due to the release of water 
molecules, that form the hydration shells of the Trp and CD, to the bulk solvent. This 
process leads to an increase of entropy change, as detected. A comparison of the 
obtained enthalpy and entropy changes reveal that the formation of the complex is 
entropically driven. 
 
6.3.5 The Effect of (P)GKY20/SBE-β-CD Complex on the Thermotropic 
Properties of DPPC/DPPG Liposomes 
 
Finally, the effect of the complex formed by a mixture of (P)GKY20 and SBE-β-CD 
on the thermotropic properties of DPPC/DPPG (8/2 mol/mol) liposomes was studied. 
This experiment was carried out to verify if the peptide complexed with cyclodextrin 
is able to perturb the membrane. In Fig. 6.8 are reported the DSC thermogram of 
DPPC/DPPG multilamellar vesicles (0.5 mM) alone and in the presence of a mixture 
composed by 50 µM of (P)GKY20 and 50 µM of SBE-β-CD. For comparison, DSC 
thermograms of DPPC/DPPG in the presence of peptide or cyclodextrin at the same 
concentrations are reported. In Table 2 are reported the thermodynamic parameters 
for the gel-to-liquid phase transition of DPPC/DPPG liposomes in the absence and 





Fig. 6.8 DSC thermograms of 0.5 mM DPPC/DPPG multilamellar vesicles in the absence (black line) 
and in the presence of 50 µM of SBE-β-CD (red line), 50 µM of (P)GKY20 (blue line) and in the 
presence of a mixture of 50 µM (P)GKY20 + 50 µM SBE-β-CD (dark cyan line). All the experiments 
were carried out in 10 mM phosphate buffer, pH 7.4. 
 
Table 2 Thermodynamic parameters obtained by means of DSC for the phase transitions of 
DPPC/DPPG (8/2 mol/mol) liposomes in the absence and presence of 50 µM SBE-β-CD, 50 µM 
(P)GKY20 and a mixture of 50 µM SBE-β-CD + 50 µM (P)GKY20 (complex). 
System Tp (°C)[a] ΔHp (kJ/mol)[a,c] Tm (°C)[b] ΔHm (kJ/mol)[b,c] 
DPPC/DPPG 36.1±0.2 1.7±0.3 42.4±0.1 29.5±1.5 
+SBE-β-CD 36.2±0.2 1.5±0.3 42.4±0.1 29.6±1.6 
+(P)GKY20 - - 43-44±0.1[d] 28.4±1.4 
+Complex - - 43.5±0.1 31.2±1.8 
[a] Enthalpy change and temperature of the pre-transition peak.  
[b] Enthalpy change and temperature of the main transition peak. 
[c] Normalization against total lipid moles. 
[d] The reported temperatures refer to the first and second maxima in the DSC thermogram, 
respectively. 
 
The DSC thermogram of DPPC/DPPG multilamellar vesicles is characterized by the 
presence of two transitions. A pre-transition at about 36 °C and a main transition at 
about 42.4 °C, as reported in section 4.3.2. Upon the addition of SBE-β-CD at the 
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concentration of 50 µM, the DSC thermogram of DPPC/DPPG vesicles does no 
change, pointing out that the cyclodextrin has no effect on the stability of the bilayer. 
In the presence of 50 µM of (P)GKY20, as noted in chapter 5, a strong perturbation 
of the DSC profile was detected. The obtained result was interpreted as the surface 
binding of peptide coupled with the preferential interaction with the anionic lipid 
which leads to the formation of lipid domains (section 5.3.2). Finally, in the presence 
of both peptide and cyclodextrin a complete suppression of the pre-transition was 
observed, indicating again a strong interaction on the surface. In addition, also the 
main-transition is affected by the presence of the complex. The melting temperature 
(Tm) increases from 42.4 °C to 43.5 °C, instead the enthalpy change is not affected 
by the presence of the complex (Table 2), indicating a binding on the surface without 
penetration inside the hydrophobic core of the membrane [185]. However, the effect 
of the complex seems less pronounced respect to the peptide alone. Nevertheless, 
this experiment demonstrated that even in the presence of cyclodextrin, the peptide 




In this chapter, some preliminary data on the interaction of (P)GKY20 peptide with 
sulfobutylether-β-CD (SBE-β-CD) and of the obtained complex with bacterial model 
membrane were reported. The final goal was to verify if the peptide can interact with 
the cyclodextrin to develop, in the near future, a formulation which can increase the 
pharmacological properties of the peptide. In fact, it is known that peptides are not 
physically and chemically stable [91,253]. In addition, AMPs are subject to the 
proteases action which can seriously limit their application as drugs [92]. Finally, the 
interaction with serum proteins can limit their availability [240]. Thus, it is important 
to find some compounds which can improve the pharmacological properties of 
peptides. Clearly, these compounds must not interfere with the biological activity of 
peptides and should be no dangerous for human health. Cyclodextrins (CDs) are a 
class of cyclic oligosaccharides which are very suitable for this purpose [241]. CDs 
are generally recognized as safe for humans and they are used in a wide variety of 
pharmacological applications to increase the stability, the solubility and the safety of 
drugs [241]. In particular, it was demonstrated that SBE-β-CD is safe, and only at 
very high concentration could have some light adverse effects [241]. In addition, this 
CD is already commercialized as Captisol® [254]. Thus, it is available in high 
amount and it is not expensive. For this reason, the complexation of (P)GKY20 
peptide with sulfobutylether-β-CD was studied. For comparison, the interaction with 
the widely used hydroxypropyl-β-CD (HP-β-CD) was also studied. The extent of 
complexation is strongly dependent on the binding constant (Kb) between peptide 
and CD [241,244]. In fact, the value of binding constant should be neither too much 
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low, nor to much high. This is because a good level of complexation must be 
achieved (high Kb) by using a small amount of CD to avoid side effects at high sugar 
concentration. On the other hand, a too much high Kb could prevent the interaction 
of the peptide with the membrane. Thus, the determination of Kb is of fundamental 
importance. 
The reported data demonstrated that the SBE-β-CD has a binding constant of about 
104 M-1 for (P)GKY20. In contrast, HP-β-CD showed a very weak binding to the 
peptide (Kb ~ 6∙102 M-1). Thus, the sulfobutylether CD is more efficient as 
encapsulating agent. For this reason, only the interaction with SBE-β-CD was further 
explored. Most likely, the interaction of SBE-β-CD with peptide occurs through the 
formation of inclusion complex [255] where the Trp residue is inserted in the 
hydrophobic cavity of the sugar ring. This is supported by the strong blue shift in the 
fluorescence emission spectra of the peptide. In fact, tryptophan is the only 
environment-sensitive natural residue in peptides and proteins [175]. In addition, the 
ability of β-CDs to interact with aromatic residues was already reported [245,252]. 
The strong interaction of SBE-β-CD compared to neutral HP-β-CD could be 
attributed to the presence of negatively charge sulfonate groups (two in the used 
SBE-β-CD) which enhance the affinity for the peptide. It is important to note that in 
the primary sequence of (P)GKY20 peptide (GKYGFYTHVFRLKKWIQKVI) the 
Trp residue is very close to positively charged residues (Lys and Arg) leading to a 
cluster of positive charges on the C-terminus region of the peptide.  This can drive 
the initial interaction of SBE-β-CD with this region of the peptide, just before the 
formation of the inclusion complex. 
The reported circular dichroism spectrum of peptide in the presence of cyclodextrin 
(Fig. 6.6) revealed no conformational changes in its secondary structure, supporting 
the formation of inclusion complex. Indeed, the strong spectral shift in fluorescence 
spectra is not due to conformational changes which can alter the environment 
surrounding the Trp residue. In addition, the result obtained from the Job’s plot 
experiment revealed the formation of 1:1 complex, where one peptide molecule 
interacts with one CD. Even if the Job’s plot is not a direct proof, it supports the 
formation of the inclusion complex, since only one Trp residue is present in the 
primary sequence of (P)GKY20. Finally, the formation of the complex was further 
studied by means of isothermal titration calorimetry (Fig. 6.7). The obtained value 
for Kb is in excellent agreement with the value obtained from the spectrofluorimetric 
titration, thus confirming that the Kb is in the order of 104 M-1. The direct 
measurements of the heats involved in the interaction process allowed the 
determination of the binding enthalpy and, consequentially, of the entropy and free 
energy changes. First of all, the free energy change is negative pointing out the 
spontaneity of the interaction process (Table 1). The low and exothermic value of 
ΔbH (-2.3 kJ/mol of peptide) suggests that only non-bonding weak interactions are 
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involved in the interaction, as expected in the formation of an inclusion complex. On 
the contrary, a strong entropy change was detected, highlighting that the formation 
of the inclusion complex is entropically driven [252]. It is known that cyclodextrins 
contains several water molecules inside their cavity [256,257]. Upon the formation 
of the inclusion complex, structured water molecules inside the CD cavity are 
released into the bulk water [255] leading to the positive entropy variation.  
Finally, the interaction of the peptide/CD complex with liposomes mimicking the 
cytoplasmic bacterial membrane was explored by means of differential scanning 
calorimetry (Fig. 6.8). This is an important step, since the complexation of the 
peptide with the cyclodextrin should not influence the peptide antimicrobial activity. 
The obtained data showed that, at the concentration used in the experiment, SBE-β-
CD has no effect on the bilayer stability. The presence of peptide alone, as reported 
in chapter 5, led to a multicomponent peak which suggest the formation of lipid 
domains. The contemporary presence of cyclodextrin and peptide also influences the 
bilayer stability. The suppression of the pre-transition peak indicates that the peptide 
is able to interact superficially even in the presence of CD. In addition, the main 
transition peak seems halfway between the DSC peak of liposomes in the absence 
and in the presence of peptide (Fig. 6.8). In particular, it seems that the formation of 
domains didn’t take place. Most likely, the presence of CD could lower the 
concentration of the membrane-bound peptide leading to a less pronounced effect on 
the recorded DSC peak. Another explanation is represented by the possibility that 
the peptide in the complexed form could directly interact with the membrane, 
lowering the membrane perturbation activity of the peptide. However, this result 
clearly demonstrated that even in the presence of the anionic SBE-β-CD, the 
(P)GKY20 peptide is able to interact with the bacterial model membrane. 
Collectively, the reported preliminary data showed that for (P)GKY20 the SBE-β-
CD should be a good encapsulating agent. The binding constant (Kb) is of the right 
value which allows a good extent of encapsulation without using high amount of 
sugar. In addition, the peptide is able to perturb the bilayer stability in the presence 
of CD, even if the effect is less pronounced respect to the case when the peptide is 
alone. 
Clearly, a lot of work must be done to deeply characterized the interaction of the 
complex with bacterial model membrane. DSC experiments with different peptide-
CD ratios should be performed in order to find the best ratio value which represents 
the right compromise between encapsulation and membranotropic activity. In 
addition, there is the possibility that the peptide could interact with the membrane in 
the complexed form with CD. Thus, the possible involvement of the CD in the 
interaction with the membrane must be verified.  
Biological assays on bacterial strains must be performed in the presence of SBE-β-
CD to verify in vivo the antibacterial activity of the complex. Another important 
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biological assays to perform is the stability to proteases of the complex in serum. 
Finally, the interaction of (P)GKY20 peptide in the absence and in the presence of 
the cyclodextrin with serum proteins (e.g. human serum albumin) should be verified. 
This full characterization could lead to the preparation of a peptide/CD formulation 
which can render possible the pharmacological (and not only) applications of the 
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